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ABSTRACT 
 
Danielle Slomberg: Role of Nanomaterial Physicochemical Properties on Fate and 
Toxicity in Bacteria and Plants  
(Under the direction of Mark H. Schoenfisch) 
 
Nanomaterials, defined as having at least one dimension <100 nm, are ubiquitous 
in nature. However, engineered nanomaterials have gained increasing attention for use in 
drug-delivery applications and consumer goods. Examination of nanomaterial toxicity, 
both beneficial (e.g., drug delivery to bacterial pathogens) and detrimental (e.g., death of 
terrestrial plants), thus warranted. Herein, I present the evaluation of nitric oxide-
releasing nanomaterial toxicity to bacteria and silica particle toxicity to plants as a 
function of nanomaterial physicochemical properties. 
Nanomaterial toxicity toward planktonic (i.e., free-floating) Pseudomonas 
aeruginosa and Staphylococcus aureus bacteria was evaluated as a function of scaffold 
size, shape, and exterior functionality using nitric oxide-releasing (NO) silica particles, 
dendrimers, and chitosan oligosaccharides. Improved bactericidal efficacy was observed 
for silica particles with decreased size and increased aspect ratio due to improved 
particle–cell interactions. Likewise, better nanomaterial–bacteria association and biocidal 
action was noted for more hydrophobic NO-releasing dendrimers and chitosan 
oligosaccharides. Planktonic bacterial killing was not dependent on chitosan molecular 
 iv 
weight due to rapid association between the cationic scaffolds and negatively-charged 
bacterial cell membranes. 
Given the importance of nanomaterial physicochemical properties in planktonic 
bacterial killing, the NO-releasing scaffolds were also evaluated against clinically-
relevant bacterial biofilms. Similar to planktonic studies, smaller particle sizes proved 
more efficient in delivering NO throughout the biofilm. Particles with rod-like shape also 
eradicated biofilms more effectively. The role of NO-releasing dendrimer and chitosan 
oligosaccharide hydrophobicity was prominent in scaffold diffusion through the biofilm 
and subsequent NO delivery, with scaffolds modified with hydrophobic functionalities 
generally exhibiting better bacterial association. Lastly, biofilm eradication was more 
effective for NO-releasing dendrimers exhibiting sustained NO-release compared to 
delivery of NO via an initial burst. 
Phytotoxicity and uptake of silica nanoparticles was evaluated for the plant 
Arabidopsis thaliana as a function of particle size, surface composition, and shape (i.e., 
spherical versus rod-like particles). Overall, the silica nanoparticles examined were found 
to be relatively non-toxic to A. thaliana plants when pH effects were mitigated. Size-
dependent uptake of the silica particles was observed, with smaller particles 
concentrating more heavily in the roots, rosette, and stem; however no shape-dependent 
uptake was noted at the low exposure concentration examined.  
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CHAPTER 1: RECENT ADVANCES IN EVALUATION OF NANOMATERIAL 
TOXICITY TOWARD BACTERIA AND PLANTS 
 In 1959, physicist and Nobel laureate, Richard Feynman, challenged the scientific 
community  to  think  small,  noting  that  “[a]toms on a small scale behave like nothing on a 
large scale.”1 Feynman also suggested that “[the]   problems of chemistry and biology 
[could] be greatly helped”  if  the ability “to do things on an atomic level, [was] ultimately 
developed.” Inspired by these challenges, the field of nanotechnology has rapidly 
developed as researchers work to create materials with new molecular organization, 
properties, and functions relative to the bulk material.2 However, evaluation of the 
toxicity of these engineered nanomaterials toward biological systems has only begun in 
recent years. In this introductory chapter, nanomaterial toxicity, both beneficial (e.g., 
drug delivery to bacterial pathogens) and detrimental (e.g., death of terrestrial plants), 
will be discussed as a function of the  material’s  physicochemical properties. 
1.1 Overview of nanomaterial toxicity 
1.1.1 Engineered nanomaterials 
Since the advent of nanotechnology, a wide variety of nanomaterials have been 
developed for a range of applications including drug delivery, biotechnology, water 
decontamination, and communication technologies.3, 4 These engineered nanomaterials 
(ENMs) have at least one dimension between 1 and 100 nm.5 Nanomaterials synthesized 
2 
for distinct applications include metal (e.g., Fe and Ag) and metal oxide nanoparticles 
(e.g., TiO2 and SiO2), dendrimers, carbon nanotubes, and quantum dots among others.6 
As the quantities and types of ENMs increase and consumers begin to use nanomaterial-
containing products with greater frequency, the need for an improved understanding of 
nanomaterial physicochemical behavior and prevention of unintended biological and 
environmental consequences will also rise.7 Humans and a myriad of other organisms 
will be exposed to ENMs through intended (e.g., common therapeutic use) or incidental 
routes (e.g., release into atmosphere, rivers, soil, etc). Thus, proactive measures are 
necessary to fully evaluate both the beneficial and detrimental implications associated 
with ENMs. 
 The behavior of ENMs, and ultimately their toxicity, is influenced by several 
physicochemical properties, such as increased surface area to volume ratio,8 size, shape, 
exterior functionality,9 and drug-release kinetics.10 Each of these characteristics is 
significant in dictating how a nanomaterial will interact with cells and the surrounding 
environment. Generally, nanomaterials exhibit increased reactivity and toxicity compared 
to their bulk counterparts.8 Midander et al. reported increased DNA damage in human 
lung cells exposed to nano-copper compared to micron-sized copper particles.11 
However, in some cases there is no difference in toxicity between nanomaterials and bulk 
formulations. Heinlaan et al. noted no significant differences in ecotoxicity to select 
bacteria and crustaceans exposed to ZnO, TiO2, and CuO nanoparticles and their bulk 
oxides.12 Likewise, nanoparticulate and bulk ZnO exhibited comparable toxicity to the 
freshwater microalga, Pseudokirchneriella subcapitata, with the toxicity attributed to 
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dissolved Zn and not nanoparticle effects.13 Evaluation of nanomaterial toxicity relative 
to the corresponding bulk material on a case by case basis is thus warranted. 
1.1.2 Nanomaterial-cell interactions 
Nanomaterial-cell interactions will greatly depend on nanomaterial size, shape, 
surface characteristics, and drug-release properties (if any). Generally, improved 
penetration of cell membranes is observed for smaller nanoparticles. Association of 
nanomaterials with the cell membrane may also be governed by nanomaterial shape. 
Nanomaterial surface charge is important in that the cell membrane is negatively-charged 
and will associate more readily with positively-charged materials. In addition, more 
hydrophobic ENMs are better able to penetrate the lipophilic membrane. 
 After association with the cell, nanomaterials can cause DNA damage, degrade 
the membrane, or interrupt key processes for cellular function. The mechanism of action 
varies with nanomaterial composition, size, and shape. For example, Yang et al. studied 
the cytotoxicity, oxidative stress, and genotoxicity as a function of ENM composition 
(i.e., carbon nanotubes and silica and ZnO nanoparticles), size, and shape.14 Particle 
composition played the primary role in cytotoxicity, and genotoxicity was significantly 
influenced by ENM shape. However, no significant toxicity was attributed to size. The 
effects of nanomaterial physicochemical properties on their interactions with cells is 
clear, thus researchers are currently focused on further developing methodology to 
understand and evaluate these interactions and any resulting toxicity.   
1.1.3 Evaluation of nanomaterial toxicity 
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 Given the importance of assessing ENM parameters in toxicity, a variety of in 
vitro and in vivo assays are currently used for screening risk. In vitro systems are ideal in 
that they are cost effective and generate rapid, reproducible results.15 Common methods 
for screening new ENMs include the LDH (cell membrane integrity) and MTT assays 
(mitochondrial function), as well as assays for measuring cell-generated reactive oxygen 
species and immunochemistry markers (apoptosis and necrosis).15, 16 Due to the variety of 
physiological environments and applications in which ENMs may be encountered, these 
in vitro assays are tested against numerous cell types including phagocytic, neural, 
hepatic, epithelial, endothelial, and red blood cells.16 Despite the toxicity data generated 
with in vitro tests, determinations of safety need to be made based on the final fate of 
ENMs in biological systems.15 Thus, tests to evaluate ENM absorption, distribution, 
transformation, and excretion in vivo are ultimately warranted. Researchers are now 
focused on a predictive toxicological approach in which high-throughput screening is 
used in vitro and in vivo to determine ENM structure-activity relationships and hazard 
risk.17-19  
Understanding the nano-bio interface is crucial to elucidating potential ENM 
toxicity in environmental applications as well.20 The transformation and fate of ENMs 
and the potential for biomagnification and biodistribution within a multitude of 
ecosystems necessitate evaluation as risk of exposure is likely to increase.7 Whether 
viewed as beneficial or detrimental, nanomaterial toxicity is likely to play an ever 
increasing role in our daily lives.21 
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1.2 Nanomaterial toxicity toward bacteria 
1.2.1 Bacteria in clinical settings 
 Although bacteria are ubiquitous in aquatic and soil-based ecosystems, their 
prevalence in clinical settings has become particularly problematic, with hospital-
acquired infections being the fourth-leading cause of death in the United States.22, 23 Open 
wounds24, 25 and implanted medical devices such as prosthetic heart valves,23 orthopedic 
implants, and catheters are frequent sites of microbial infection despite aseptic procedures 
and instrument sterilization.23, 26, 27 With  >99% of all bacteria existing in a biofilm state, 
these infections are increasingly difficult to treat.28 Bacterial biofilms have shown 
decreased susceptibility to antibacterials compared to their planktonic (i.e., free-floating) 
counterparts.28-31 Consequently, infected medical implants often necessitate device 
removal,32 and hospital-acquired infections can result in sepsis,33 and even death. Current 
research is focused on developing nanomaterial-based drugs to address these problems. 
Furthermore, understanding the clinical significance of nanomaterial toxicity to bacteria 
will aid in the design of future antibacterial and anti-biofilm agents.   
 Bacterial biofilm formation occurs in several sequential phases as shown in 
Figure 1.1.34 Prior to bacterial adhesion, organic and inorganic nutrients first adsorb to 
the surface. When bacteria come into contact with this conditioned surface, they  
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Figure 1.1 Stages  of  bacterial  adhesion  to  a  substrate  and  subsequent  biofilm  formation. 
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reversibly attach via gravitational, electrostatic, and van der Waals forces. Short range 
(i.e., hydrogen boding, dipole-dipole, ionic, and hydrophobic) interactions also influence 
the degree of bacterial adhesion. After a few hours, the bacteria begin to secrete 
extracellular polymeric substances (EPS) and form cell-to-cell bridges, thus irreversibly 
attaching to the surface.35, 36 Maturation of the biofilm continues as bacterial cells grow, 
divide, and form microcolonies (clusters of bacteria).37 The biofilm formation process 
continues over hours to days depending on several abiotic (e.g., nutrient conditions and 
pH) and biotic (e.g., quorum-sensing) factors. Following maturation, detachment of 
biofilm bacteria from microcolonies may occur via regulated dispersal mechanisms to 
release planktonic cells that can further colonize surfaces.34, 38 
Given the frequency and complexity of bacterial surface colonization, and the rate 
at which bacterial biofilms are increasingly difficult to treat, research into antibacterial 
resistance mechanisms has continued to garner attention. The traditional antibacterial 
resistance mechanisms attributed to planktonic bacteria include efflux pumps, modifying 
enzymes, and target mutations, but these mechanisms do not always explain the 
resistance of biofilm-embedded bacteria.39 Genetic mutation of the biofilm bacteria is not 
likely the main cause of resistance since biofilm cells will once again exhibit 
susceptibility to antibacterial agents upon dispersal.40, 41 Three proposed mechanisms for 
the increased resistance of biofilms are slow antibacterial penetration beyond surface 
layers of the biofilm, differentiation of cells into a resistant phenotype, and reduced 
antibacterial action in altered microenvironments (e.g., regions of nutrient depletion).39 
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As a result, complete eradication of biofilms using common antibacterials has been met 
with increasing difficulty and is often not feasible. 
1.2.2 Current bacteria eradication strategies 
Ideally, hospital-acquired infections would be controlled by eliminating initial 
bacteria attachment to a surface and thus preventing biofilm formation by adherent 
cells.34 However, superhydrophobic,42 heparin-coated,43 and antibacterial-doped 
substrates44, 45 have met varied success in eliminating bacterial adhesion and reducing 
clinical infection. These strategies are also often not amenable to implanted sensor 
applications, which can hinder their utility. As such, additional bacteria eradication 
strategies have been implemented for cases in which surface colonization cannot be 
prevented. Bacterial biofilm formation has been minimized through interference of iron 
metabolism,46, 47 enhancement of macrophage phagocytosis of the bacteria,48 or 
disruption of quorum-signaling.23, 34 Another biofilm control strategy has focused on 
targeting the EPS layer. Hatch and Schiller observed enhanced diffusion of the 
antibiotics, gentamicin and tobramycin, after the enzyme, alginate lyase, degraded the 
EPS layer of P. aeruginosa biofilms.49 Lastly, several researchers are working toward the 
development of new antibacterial agents, that will be effective against current and 
emerging multi-drug resistant bacteria strains.50-53 Successful new antibacterial agents 
will need to not only prevent initial adhesion or eradicate established biofilms, but must 
do so without fostering resistance or harming healthy host cells.  
1.2.3 Nitric oxide as an antibacterial agent 
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 Nitric oxide (NO) is an endogenously-produced, diatomic free radical that 
participates in several concentration-dependent processes within the body.54-56 At low 
concentrations (~pM–nM), NO mediates vasodilation, angiogenesis, and 
neurotransmission.57-59 However, at higher concentrations (~µM), NO can serve as a 
potent antibacterial agent, inducing oxidative and nitrosative stresses that damage the 
bacteria membrane.60-62 In the presence of bacterial pathogens, macrophages utilize 
inducible nitric oxide synthase (iNOS) to generate NO. Once formed, NO can react with 
oxygen or other reactive oxygen intermediates (e.g., superoxide) to yield antibacterial 
byproducts (e.g., peroxynitrite, nitrogen dioxide, and dinitrogen trioxide).60 These 
reactive species can then induce oxidative stress, resulting in lipid peroxidation, tyrosine 
nitrosation, and oxidative DNA cleavage. Concurrently, thiol nitrosation, deamination of 
cellular proteins, and nitrosamine formation occur via nitrosative stress. Through 
disruption of bacterial components and disabling of crucial cell functions, NO and its 
reactive byproducts have proven effective as antibacterial agents against both Gram-
positive and Gram-negative species.63, 64 Additionally, NO is a known anti-biofilm agent, 
capable of eradicating a variety of microbial strains including P. aeruginosa, E. coli, S. 
aureus, S. epidermidis, and C. albicans.62 The utility of NO as an antibacterial and anti-
biofilm agent is demonstrated by its broad-spectrum and multi-mechanistic killing, 
thereby reducing the chance for bacteria resistance to treatment.   
 Although NO exerts the desired toxicity against both planktonic and biofilm-
based bacteria, candidate therapeutics must also exhibit limited toxicity toward healthy 
mammalian cells. Nitric oxide toxicity to mammalian cells is mitigated by a series of 
10 
antioxidant enzymes, including superoxide dismutase, catalase, and peroxidase.65 
Superoxide dismutase converts superoxide formed from the reaction of NO and oxygen 
into hydrogen peroxide. Catalase and peroxidase then convert the produced hydrogen 
peroxide into water. Using these enzymatic pathways, mammalian cells are able to turn 
superoxide and hydrogen peroxide into water, thus reducing NO-induced toxicity. Of 
note, some bacterial cells (e.g., S. aureus) produce lower levels of antioxidant enzymes 
and can adapt to oxidative stress via NO-mediated cytoprotection; however, bacteria are 
generally unable to mitigate the toxic effects of NO and its reactive byproducts as readily 
as mammalian cells.66  
In addition to NO produced endogenously by immune cells, exogenous gaseous 
NO has proven effective in eradicating bacterial infections.67 However, control over the 
dose and location of delivery is challenging due to the highly reactive nature of gaseous 
NO. While administration of gaseous NO is appropriate for topical and pulmonary 
treatments, the use of NO in other clinical applications necessitates greater control of 
dosage and delivery.68 As such, compounds (NO donors) that store NO and release it 
upon an appropriate trigger (e.g., pH change, light, heat) have been developed.56  
1.2.4 Nitric oxide donors 
 Several types of NO donors have been synthesized to store and controllably 
release NO, with major donor classes including metal-NO complexes, nitrosamines, 
nitrosothiols, and diazeniumdiolates. N-diazeniumdiolates, specifically, have found 
widespread use in biomedical applications due to their stability, ability to release NO 
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under physiological conditions, and varied NO-release kinetics.69 The N-
diazeniumdiolate moieties are formed on amine sites of the donor compound upon 
reaction with high pressures (~10 atm) of gaseous NO in the presence of a strong base 
(Figure 1.2 A).70 In the more generally accepted mechanism, the amine reacts with an NO 
dimer (N2O2) to form the N-diazeniumdiolate. Release of NO then occurs via proton-
intitiated decomposition, in which the N-diazeniumdiolate decomposes under aqueous 
conditions to yield 2 moles of NO and the parent secondary amine (Figure 1.2 B). 
Overall, the N-diazeniumdiolate functionality is stable in the absence of a proton source 
and at low temperature, making it an appropriate NO donor for a variety of clinically-
relevant applications. 
N-diazeniumdiolate NO donors have been formed on small molecules such as 
proline (PROLI/NO) and diethylenetriamine (DETA/NO) for treatment of cardiovascular 
disease and respiratory distress.55, 71 However, low molecular weight (LMW) donors 
diffuse rapidly, exhibit short circulation times, and often necessitate higher doses of NO 
to elicit an effect.56 Side effects including hypotension, headaches, and possible tolerance 
have been noted during clinical use.72 Given these shortcomings, macromolecular 
scaffolds can instead be utilized to obtain controlled and localized NO delivery, facilitate 
targeting, and decrease potential for tolerance.56, 61 
Relative to LMW donors, macromolecular NO-releasing scaffolds have numerous 
advantages including increased NO payload, targeted and localized delivery, and tunable 
NO-release kinetics.73 With many clinical applications utilizing the benefits of NO, 
12 
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Figure 1.2 N-diazeniumdiolate  (A)  formation  and  (B)  proton-initiated  decomposition. 
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control over the concentration, location, timing, and duration of NO release can decrease 
the potential for tolerance and unwanted toxic side effects. As such, several types of NO-
releasing protein, organic, inorganic, and hybrid polymer macromolecular scaffolds have 
been designed.73 An ideal NO-releasing macromolecular scaffold would be 
functionalized with multiple NO donors and/or targeting ligands to achieve localized 
release with the desired payload while controlling toxicity. The NO-releasing 
macromolecular scaffolds presented in this work include silica nanoparticles, dendrimers, 
and chitosan oligosaccharides. These NO-release vehicles allow for the tuning of size, 
shape, hydrophobicity, and NO-release kinetics to evaluate the effects of nanomaterial 
physicochemical properties on bactericidal efficacy to planktonic bacteria and biofilms. 
Silica nanoparticles are appealing drug delivery scaffolds in that they are 
chemically stabile, allow for covalent modification, and generally exhibit low 
cytotoxicity.74 Additionally, their size and shape can be tuned to improve nanoparticle–
cell interactions. Silica particles are commonly synthesized via sol-gel chemistry, where 
silane precursors undergo hydrolysis and condensation under basic conditions to form a 
solid silica network.75 Briefly, the sol-gel process begins when a silane precursor is 
hydrolyzed upon attack by a hydroxide ion (Figure 1.3 A). A second hydrolyzed silane 
can then condense with the first to form a siloxane bond (Figure 1.3 B). As hydrolysis 
and condensation continue, a solid silica network forms. Reaction conditions can be 
tailored to control silica particle formation and growth. Specifically, the  Stӧber  method  
offers  a  facile  approach  for  synthesizing  silica  particles  in  a  “one-pot”  reaction.   
14 
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Figure 1.3 Representative   formation   of   silica   particles   via   (A)   hydrolysis   and   (B)  
condensation  under  basic  conditions. 
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Silica  particles  can  be  synthesized  via  the  Stӧber  method   through the hydrolysis 
and condensation of a tetraalkoxysilane in a solution of water, an alcohol solvent (e.g., 
ethanol), and a base catalyst.76 Monodispersity of the synthesized particles is dependent 
on the rates of nucleation and growth during the reaction. Conditions favoring 
simultaneous formation of particle nuclei, with similar subsequent growth result in 
particles with narrow distributions in size. Silica   particles   synthesized   via   the   Stӧber  
method  are  generally  ≥100  nm  as   the  conditions   favor  particle  growth  over  nucleation.  
Alternatively, silica particles with sizes on the low end of the nanoparticle regime (i.e., 
<100 nm) can be synthesized by a reverse microemulsion approach in which particles are 
confined to micelles of a pre-determined size as they form.77 Tuning of particle size is 
critical in biomedical applications since effective drug delivery is generally inversely 
proportional to particle size.  
 Particle size can be tuned by varying the concentration of water or ammonia, the 
chain length of the alcohol solvent, and the reaction temperature.76, 78 Increasing water 
concentration (>9 M) of the reaction promotes hydrolysis, and thus reduces particle size, 
while decreasing the water concentration favors nuclei aggregation and growth of the 
silica particles. Ammonia also influences size and morphology, with larger, non-spherical 
particles observed at low concentrations due to instability of the suspended particles. 
During particle formation, the size is also dictated by the choice of solvent. Long-chain 
(i.e., larger molecular weight) water-miscible alcohol solvents slow hydrolysis and result 
in increased particle size. Similarly, decreasing the reaction temperature hinders 
hydrolysis and increases particle size. 
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In addition to size, the aspect ratio of silica particles can be altered to evaluate 
drug delivery efficiency and nanoparticle–cell interactions as a function of shape. Rod-
like particles of various compositions (e.g., poly(ethylene glycol), silica, and 
poly(lactide-co-glycotide)) have demonstrated increased mammalian cell internalization 
and circulation time compared to spherical particles, thus improving their capacity for 
drug delivery.79-83 Silica nanorods of varied aspect ratio (i.e., 1–8) have been synthesized 
via a surfactant-templated synthesis, where the nanorods are grown along micelles. 
Control over the shape and geometry of the micelle ultimately impacts the final shape of 
the silica nanorod. Particle aspect ratio has been tuned by altering the type of surfactant, 
reaction temperature, ammonia concentration, or solution volume. Despite previous 
studies on mammalian cell interactions and uptake, there is a lack of understanding on 
how nanoparticle shape influences bactericidal efficacy against planktonic and biofilm-
based bacteria. 
Loading of NO onto the aforementioned silica particles and nanorods via N-
diazeniumdiolation necessitates modification of the scaffold with a secondary amine. 
Secondary amine-modified silica particles can either be achieved via co-condensation of 
an aminosilane and a   “backbone” silane (e.g., tetraalkoxysilane) or via surface-grafting 
onto an already formed silica scaffold. These NO-releasing hybrid silica particles are 
capable of storing large payloads of NO, with tunable NO-release to maximize 
bactericidal efficacy.61, 84, 85 
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To fully explore the effects of NO-releasing nanomaterial characteristics on 
toxicity toward bacteria, dendrimers have been evaluated as a second type of delivery 
scaffold. Dendrimers are highly-branched, nano-scale macromolecules.86 Bonds emanate 
from a central core at the interior of the dendrimer, forming a hyper-branched, 
multivalent structure. A wide range of dendritic scaffolds have been used in drug 
delivery,87 gene transfection,88, 89 tissue engineering,90 and even antibacterial applications. 
For example, quaternary ammonium-modified dendrimers have demonstrated efficacy in 
bacterial killing, but their inherent positive charge resulted in significant toxicity to 
mammalian cells.91 Masking this charge with poly(ethylene glycol) (PEG) helped 
mitigate the cytotoxicity while still providing potent antibacterial efficacy. 
Poly(amidoamine) (PAMAM) dendrimers and partially PEG-modified dendrimers were 
also proven effective against planktonic bacteria, with complete eradication of P. 
aeruginosa and S. aureus at µg/mL concentrations.92  
The multi-valency and amine-loading capabilities of dendrimers make them great 
candidates for coupling with NO release to further improve biocidal action. Taite et al. 
synthesized NO-releasing PEG-lysine dendrimers for cell proliferation applications, but 
low NO storage and lack of control over release kinetics make them non-ideal as 
antibacterial agents.93 Instead, the Schoenfisch lab has designed NO-releasing 
poly(propylene imine) (PPI) and PAMAM dendrimers that can store and deliver 
increased NO payloads (~2–5.6 µmol/mg).94-96 The reaction of secondary amine sites on 
the PAMAM dendrimers with high pressures of NO to form N-diazeniumdiolates is 
detailed in Figure 1.4. 
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Figure 1.4 Formation  of  secondary  amine  sites  on  dendrimers  via  Michael  addition  or  
ring-opening  reaction  and  subsequent  N-diazeniumdiolation. 
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In drug delivery applications, important dendrimer parameters to evaluate are size 
(i.e., generation), surface functionalization, and cytotoxicity. Unlike silica particles that 
range from ~10–1000 nm, dendrimers can be reproducibly synthesized with sizes <10 
nm. Of note, as dendrimer generation is increased, the number of surface groups at the 
exterior also increases, likely enhancing biocidal action. The type of functional group 
bound to the dendrimer scaffold has also been shown to influence NO-release properties. 
For example, NO-releasing PAMAM dendrimers functionalized with varied carbon chain 
lengths (i.e., C1–C7) exhibited half-lives of 2.5–86 min, with the longer chain resulting in 
extended NO release.94 
Silica particles and dendrimers are both effective NO delivery vehicles, allowing 
for tailored NO-release through varied size, exterior functionality, and kinetics. However, 
after the NO release has expired, select applications may necessitate degradation of the 
scaffold. Biodegradable scaffolds are best suited for pulmonary,97 oral, and parenteral 
drug delivery,98 as well as tissue engineering.99 The natural biopolymer, chitosan, has 
already shown promise in these applications due to its biocompatibility and 
biodegradability. Chitosan also exhibits antimicrobial properties toward bacteria, fungi, 
and viruses.100 Furthermore, as shown in Figure 1.5, the high secondary amine content of 
the chitosan backbone lends itself to N-diazeniumdiolate modification and subsequent 
NO release, thus increasing potential for antibacterial action. In previous reports, low N-
diazeniumdiolate conversion and NO storage (~0.2 µmol/mg) were observed for chitosan 
polysaccharides (~60–220 kD), likely due to their insolubility in the necessary basic 
conditions. Chitosan oligosaccharides (<20 kD), however, are soluble in basic conditions 
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and thus offer a better approach for designing NO-releasing scaffolds with improved 
conversion efficiency and total storage. 
Similar to NO-releasing silica and dendrimer scaffolds, the physicochemical 
properties (e.g., molecular weight and exterior functionality) of chitosan oligosaccharides 
can be tailored to influence NO-release kinetics and bactericidal action. The molecular 
weight (MW) of chitosan oligosaccharides can be controlled through the oxidative 
degradation of chitosan using hydrogen peroxide. Hydrogen peroxide concentration, 
(0.5–3.5%), reaction temperature (≥80  °C), and reaction time (~2.5–12 h) have all been 
shown to influence the degree of chitosan degradation and the resulting chitosan 
oligosaccharide MW.101 Additionally, a variety of functional groups can be introduced to 
the chitosan oligosaccharides via covalent modification. For example, secondary amine 
functionality can be imparted to the chitosan oligosaccharides via a cationic ring opening 
reaction with 2-methyl aziridine (MAz), after which PEG modification can be achieved 
via the Michael addition. 
1.2.5 Tuning properties of nitric oxide-releasing nanomaterials  
 The physicochemical properties of NO-releasing scaffolds are critical in 
improving NO delivery efficiency and bactericidal action while minimizing cytotoxicity 
to healthy host cells. Nanomaterial size, shape, exterior functionality, and NO-release 
kinetics are all important parameters to consider in evaluating nanomaterial–bacteria 
interactions. Particles of small size exhibit increased surface area to volume ratios 
compared to their larger counterparts. Thus, smaller NO-releasing particles have a greater  
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Figure 1.5 Formation   of   secondary   amine-modified   chitosan   oligosaccharides   and  
subsequent  N-diazeniumdiolation. 
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number of their N-diazeniumdiolates at the particle surface, likely promoting faster NO 
release and bacterial killing. Smaller nanoparticles are also likely to exhibit improved 
bactericidal efficacy due to more rapid diffusion to the bacterial cell surface. Particles 
with high aspect ratios (i.e., rod-like) may also enhance the efficiency of NO delivery 
given the potential for an increased surface area of interaction between the nanoparticle 
and bacterial membrane. Increased bactericidal efficacy of nanomaterials with more 
hydrophobic character will likely be observed due to improved association with the lipid-
containing bacterial membrane; however, cytotoxicity may present a challenge. Lastly, 
evaluating scaffold NO-release kinetics will be crucial to understanding the desired 
release profile (i.e., short burst of NO versus low sustained levels) for eradication of 
planktonic bacteria versus biofilms. 
1.3 Nanomaterial toxicity toward plants 
1.3.1 Phytotoxicity and uptake of nanomaterials 
 Although just recently gaining attention in biomedical and commercial 
applications,  nanomaterials  have  been  a  part  of   the  environment  for  most  of   the  Earth’s  
history.102, 103 Natural nanoparticles have been found in areas as diverse as volcanic dust 
and 10,000 year old glacial ice cores.102 These naturally occurring nanoparticles have 
shown toxicity to some life forms, raising concerns that engineered nanoparticles will 
exhibit similar toxicity. Engineered nanoparticles (ENPs) incorporated into consumer 
goods are now making their way into atmospheric, aquatic, and terrestrial environments 
due to incidental and direct release/disposal (Figure 1.6).104-106 However, while natural  
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Figure 1.6 Transformation   and   key   processes   of   engineered   nanoparticles   in   soil  
(modified  from  Klaine  et  al).10 
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nanoparticles tend to be transient in the environment, disappearing by either dissolution 
or aggregation, some ENPs have been shown to persist due to stabilization by surfactants 
or organic matter. A better understanding of particle fate, behavior, and potential toxicity 
in the environment is thus warranted. As such, researchers are evaluating ENP mobility, 
fate, and bioavailability in the environment as a function of size, shape, and surface 
charge.10, 102 Prior studies have assessed the toxicity of ENPs toward mammalian cells, 
bacteria, aquatic invertebrates, and other terrestrial organisms. However, plant toxicity 
(i.e., phytotoxicity) and potential uptake due to nanoparticle exposure have received less 
attention to date, especially with regard to ENP physicochemical properties.107, 108 Of 
note, ENP–plant interactions may not always result in toxicity, as some nanoparticles 
(e.g., mesoporous silica) have been used for target-specific delivery of proteins, 
nucleotides, or other chemicals for plant biotechnology applications.109  
Previous work with plants has evaluated the toxicity of silica (SiO2), zinc oxide 
(ZnO), nickel hydroxide (Ni(OH)2), copper (Cu), cerium oxide (CeO2), titanium dioxide 
(TiO2), iron oxide  (Fe3O4), gold (Au), silver (Ag), and iron (Fe) nanoparticles, as well as 
CdSe/ZnS quantum dots and carbon nanotubes to Arabidopsis thaliana,105, 110 rye 
grass,111, 112  mesquite,113 and select edible plant species including wheat and mung 
bean,106 alfalfa, tomato, corn, and cucumber.114, 115 Although current research has made 
some progress in determining the effects of nanomaterials on terrestrial plants, systematic 
studies are still lacking in the literature.  
1.3.2 Nanomaterial physicochemical properties in phytotoxicity 
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 Some researchers have started to evaluate phytotoxicity as a function of 
nanomaterial physicochemical properties such as size, shape, and surface charge. 
Nanoparticle size has been the most readily examined parameter, with increased 
phytotoxicity generally observed in correlation with decreased particle size. Lee et al. 
noted that ZnO nanoparticles (~44 nm) were more toxic to Arabidopsis thaliana than 
micron-sized counterparts.105 Similarly, smaller (~3.5 nm) Au NPs were more toxic to 
tobacco plants and exhibited greater uptake compared to larger (~18 nm) particles.116 
After 7 d exposure to silver NPs (20 and 100 nm), size-dependent NP toxicity was 
observed in L. minor.117 However, no significant difference in toxicity was noted between 
the 20 and 100 nm particles after a 14 d exposure. 
 The importance of nanoparticle shape and surface charge in phytotoxicity have 
also been noted, but studies systematically investigating these parameters are not 
currently available.118 Phytotoxicity observed in cabbage, tomato, red spinach, and lettuce 
seedlings exposed to graphene sheets was attributed to the nanomaterial morphology and 
aggregation.119 The graphene sheet form of the carbon-based nanomaterial exhibited 
similar growth inhibition to carbon nanotubes, demonstrating the role of nanomaterial 
shape on phytotoxicity. Aluminum nanoparticle surface charge has been shown to vary 
with environmental conditions (e.g., pH).120 Neutral species resulted in NP flocculation 
while negatively-charged species remained stable in solution. Despite evaluations of 
stability and transport in aqueous media, aluminum species of distinct surface charge 
have not yet been investigated for phytotoxic effects.120  
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1.3.3 Silica nanoparticle phytotoxicity 
 Silica nanoparticles (SiNPs) have received special interest in toxicology studies 
due to their prominence in cosmetic and biomedical applications.121-123 In one study, 12.5 
and 27.0 nm SiNPs (20.0 and 28.8 mg L-1, respectively) were shown to reduce growth of 
green alga by 20% after 72 h.124 Phytotoxicity assays with Cucurbita pepo (zucchini), 
however, showed no significant difference in germination percent, root elongation, or 
biomass after exposure to 1000 mg L-1 bulk silicon powder and SiNPs (< 100 nm) for 5–
14 d.125 Lee and coworkers found that 42.8 nm SiNPs promoted Arabidopsis thaliana 
root elongation at a low concentration (400 mg L-1), but resulted in toxicity at higher 
concentrations (≥   2000  mg   L-1).105 While prior work on the phytotoxicity of SiNPs to 
higher plants has established a strong foundation, lack of toxicity examination as a 
function of increased SiNP size range (i.e., < 42.8 nm and > 100 nm), shape (i.e., rod-like 
versus spherical), duration of exposure, and surface composition necessitated further 
investigation. Additionally, visualization of SiNPs in the plant cells and determination of 
uptake location (i.e., roots, rosette, and stem) had not been previously observed. 
1.4 Summary of dissertation research 
 The goal of my dissertation research was to evaluate how nanomaterial physical 
and chemical properties influence toxicity toward biological systems such as bacteria and 
plants. The specific aims of my research were to: 
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1. determine the bactericidal efficacy of NO-releasing silica, dendrimer, and chitosan      
scaffolds against planktonic and biofilm bacteria as a function of size, shape, and surface 
exterior functionality; 
2. evaluate the mechanisms of antibacterial activity for these scaffolds using confocal 
microscopy; and, 
3. determine the phytotoxicity and uptake of silica nanoparticles for Arabidopsis thaliana 
as a function of the physical properties of this scaffold. 
In this introductory chapter, the potential of NO-releasing silica, dendrimer, and 
chitosan scaffolds are justified for antibacterial applications. The physicochemical 
properties of these NO-release vehicles are critical for tuning the influence of 
nanomaterial–cell interactions and drug (i.e., NO) delivery efficiency. Likewise, these 
properties prove important in dictating nanoparticle toxicity to plants. In order to develop 
safe nanomaterials with minimal risk, we must examine how they act in the body and on 
the environment. In Chapter 2, planktonic bacterial killing with NO using three distinct 
sizes and shapes of silica nanoparticles, dendrimers with varied exterior functionalities, 
and chitosans of different molecular weights and hydrophobicities is described. 
Subsequent studies in Chapter 3 utilize these NO-releasing scaffolds to evaluate the 
eradication of more clinically-relevant bacterial biofilms as a function of nanomaterial 
size, shape, exterior functionality, and molecular weight. In Chapter 4, NO-releasing 
dendrimers with identical NO storage but varied NO-release kinetics are used to evaluate 
the desired NO-release profiles for killing of planktonic and biofilm bacteria. The 
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importance of size and shape on silica nanoparticle phytotoxicity to Arabidopsis thaliana 
is described in Chapter 5. Finally, Chapter 6 provides an overall summary of my 
dissertation work and details possible future directions in evaluating nanomaterial 
physicochemical properties and their relation to potential toxicity.   
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CHAPTER 2: ROLE OF NITRIC OXIDE-RELEASING SCAFFOLD 
PROPERTIES ON ANTIBACTERIAL EFFICACY AGAINST PLANKTONIC 
BACTERIA 
2.1 Introduction 
The prevalence of bacteria in clinical settings has become particularly 
problematic, with hospital-acquired infections being the fourth-leading cause of death in 
the United States.1, 2 Open wounds3, 4 and implanted medical devices such as prosthetic 
heart valves,2 orthopedic implants, and catheters are frequent sites of microbial infection 
despite aseptic procedures and instrument sterilization.2, 5, 6 While several antibacterial 
agents have proven effective against planktonic (i.e., free-floating) bacteria,4, 7 there is 
concern of the bacteria developing resistance to the treatment over time.8-10 Indeed, 
antibacterial resistance mechanisms including efflux pumps, modifying enzymes, and 
target mutations have been attributed to planktonic bacteria.11 Clinically-relevant 
infections including those associated with medical implants, non-healing wounds, 
diabetic mellitus, and cystic fibrosis are often the result of bacterial biofilms, which are 
generally more resistant than their planktonic counterparts.12-14 Since >99% of bacteria 
exist in the biofilm state, researchers are ultimately aiming to develop potent anti-biofilm 
agents.15 However, prior to treating biofilms, a proposed antibacterial agent must prove 
effective at eradicating planktonic bacteria, without fostering resistance. Thus, 
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understanding the clinical significance of nanomaterial toxicity to planktonic bacteria will 
aid in the design of future antibacterial and anti-biofilm agents.   
Nitric oxide (NO) is an endogenously-produced, diatomic free radical that serves 
various roles in the body.16-18 Specifically, at higher concentrations (µM), NO can serve 
as a potent antibacterial agent, inducing oxidative and nitrosative stresses that can 
damage the bacteria membrane of both Gram-positive and Gram-negative species.19-23  
The broad-spectrum and multi-mechanistic killing of nitric oxide further demonstrate its 
potential as an antibacterial agent, with a reduced chance for bacterial resistance to 
treatment. Due to the reactive nature of gaseous NO, several N-diazeniumdiolate-
modified scaffolds (e.g., silica particles,20 dendrimers,24 and chitosans25) have been 
designed to store and controllably release NO. Selective tuning of the physicochemical 
properties (e.g., size, shape, and exterior functionality) of NO-releasing scaffolds to 
enhance killing of planktonic bacteria is a necessary first step in realizing a successful 
therapeutic. Herein, the evaluation of the bactericidal efficacy of several NO-releasing 
nanomaterials (i.e., silica particles, dendrimers, and chitosan oligosaccharides) to 
planktonic Pseudomonas aeruginosa and Staphylococcus aureus is reported as a function 
of nanomaterial size, shape, exterior functionality, and molecular weight. 
2.1.1 Nitric oxide-releasing silica particles 
 Silica nanoparticles are attractive antibacterial scaffolds due to the capability for 
functionalization and their generally low toxicity to healthy host cells.26 N-
diazeniumdiolate-modified silica nanoparticles (~100 nm) have thus been developed to 
43 
deliver large NO payloads and kill planktonic bacteria.20 However, these scaffolds could 
be further tuned to enhance efficacy, as particle size and shape have previously been 
shown to influence bacterial killing. Morones et al. observed improved killing of E. coli 
for small silver particles (1–10 nm).27 Size-dependent bacterial killing was also examined 
by Nair et al., with the smaller particles exhibiting greater biocidal action.28 Additionally, 
Pal et al. studied the role of silver nanoparticle shape (i.e., nanoplates, spherical, or rod-
shaped) in the eradication of E. coli.29 Given the observed effects of nanomaterial size 
and shape in bacterial eradication, the role of NO-releasing silica nanoparticle size (i.e., 
50, 100, 200 nm) and shape (i.e., aspect ratio 1, 4, and 8) on the killing of planktonic 
Gram-negative Pseudomonas aeruginosa and Gram-positive Staphylococcus aureus was 
investigated.  
2.1.2 Nitric oxide-releasing dendrimers 
In addition to exploring the effects of silica nanoparticle physicochemical 
properties on bactericidal efficacy, dendrimers have been evaluated as an NO-releasing 
scaffold. Dendrimers are highly-branched, nano-scale macromolecules with bonds 
emanating from a central core at the interior of the dendrimer.30 Dendritic scaffolds have 
been used in drug delivery,31 gene transfection,32, 33 tissue engineering,34 and even 
antibacterial applications. For example, Chen et al. demonstrated the efficacy of 
quaternary ammonium-modified dendrimers in bacterial killing, but the inherent positive 
charge of the dendrimers resulted in significant toxicity to mammalian cells.35 
Cytotoxicity was subsequently reduced by masking the charge with poly(ethylene glycol) 
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(PEG). Poly(amidoamine) (PAMAM) dendrimers and partially PEG-modified 
dendrimers have also proven effective against planktonic bacteria, with complete 
eradication of P. aeruginosa and S. aureus at µg/mL concentrations.36  
Due to the inherent biocidal action of dendrimers, NO-release has been coupled to 
these scaffolds to further enhanace their efficacy. For example, NO-releasing 
poly(propylene imine) (PPI) and PAMAM dendrimers that can store and deliver 
increased NO payloads (~2–5.6 µmol/mg) have been reported.24, 37, 38 In drug delivery 
applications, important dendrimer parameters to evaluate are size (i.e., generation), 
surface functionalization, and cytotoxicity. Dendrimers can be reproducibly synthesized 
with sizes <10 nm, likely improving their bactericidal activity compared to silica particles 
(~100 nm) that have been previously evaluated.20 The exterior functionality of the 
dendrimers may also prove important in both bacterial killing and cytotoxicity. As such, 
NO-releasing PPI dendrimers were evaluated against planktonic P. aeruginosa and S. 
aureus as a function of dendrimer size (i.e., generation 2 or 5) and exterior modification 
(i.e., propylene oxide, styrene oxide, or poly(ethylene glycol)). 
2.1.3 Nitric oxide-releasing chitosan oligosaccharides 
Although silica particles and dendrimers enable tuning of NO-release through 
varied size, shape, and exterior functionality, pulmonary,39 oral, and parenteral drug 
delivery,40 as well as tissue engineering41 applications necessitate biodegradable 
scaffolds. The natural biopolymer, chitosan, has already shown promise in these 
applications due to its biocompatibility and biodegradability. Chitosan also exhibits 
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antimicrobial properties toward bacteria, fungi, and viruses.42 Furthermore, the high 
secondary amine content of the chitosan backbone lends itself to N-diazeniumdiolate 
modification and subsequent NO release, thus increasing potential for antibacterial 
action. Chitosan oligosaccharides (<20 kD) are soluble in the basic conditions necessary 
for N-diazeniumdiolation and thus offer a promising approach for designing 
biodegradable NO-releasing therapeutics. 
Similar to NO-releasing silica and dendrimer scaffolds, the physicochemical 
properties (e.g., molecular weight and exterior functionality) of chitosan oligosaccharides 
can be tailored to influence NO-release kinetics and bactericidal action. The molecular 
weight (MW) of chitosan oligosaccharides can be controlled through the oxidative 
degradation of chitosan using hydrogen peroxide.43 Additionally, a variety of functional 
groups (e.g., secondary amines and PEG) can be introduced to the chitosan 
oligosaccharides via covalent modification. Herein, the bactericidal efficacy of NO-
releasing chitosan oligosaccharides was evaluated against planktonic P. aeruginosa as a 
function of molecular weight (i.e., 2.5k, 5k, and 10k) and exterior hydrophobicity. 
2.2 Materials and Methods 
Note: Silica particle, dendrimer, and chitosan synthesis, characterization, and 
evaluation of cytotoxicity were supported by other members of the Schoenfisch lab 
Tetraethylorthosilicate (TEOS), N-(6-aminohexyl)aminopropyltrimethoxysilane 
(AHAP), and N-(2-aminoethyl)-3-amino-isobutyl-dimethyl-methoxysilane (AEAI) were 
purchased from Gelest (Morrisville, PA). Triton X-100, 1-hexanol, heptane, pentane, 
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N,N-dimethylformamide (DMF), methanol, cetyltrimethylammonium bromide (CTAB), 
was obtained from Acros Organics (Geel, Belgium). Ethanol (EtOH), butanol, 1-
propanol, and ammonium hydroxide (28 wt%) were purchased from Fisher Scientific 
(Fair Lawn, NJ). Sodium methoxide (5.4 M in methanol), sulfanilamide, N-1-
napthylethylenediamine dihydrochloride, rhodamine B isothiocyanate  (RITC), 
propidium iodide (PI), fetal bovine serum (FBS), Dulbecco's Modified Eagle's Medium 
(DMEM), phenazine methosulfate (PMS), 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS), trypsin, 
phosphate buffered saline (PBS) used for cell culture, and Pen Strep solution (10,000 
u/mL penicillin, 10,000 µg/mL streptomycin), propylene oxide (PO), styrene oxide (SO), 
medium molecular weight chitosan, 2-methyl aziridine (MAz), and poly(ethylene glycol) 
methyl ether acrylate (average Mn = 480) (PEG) were purchased from the Sigma Aldrich 
Corp. (St. Louis, MO). Tryptic soy broth (TSB) and tryptic soy agar (TSA) were obtained 
from Becton, Dickinson, and Company (Franklin Lakes, NJ). Pseudomonas aeruginosa 
(ATCC #19143) and Staphylococcus aureus (ATCC# 29231) were obtained from the 
American Type Culture Collection (Manassas, VA). L929 mouse fibroblasts (ATCC 
#CCL-1) were purchased from the University of North Carolina Tissue Culture Facility 
(Chapel Hill, NC). Spectra/Por Float-A-Lyzers for dialysis of the dendrimers were 
purchased from Spectrum Laboratories, Inc. (Rancho Dominguez, CA). 4,5-
Diaminofluorescein diacetate (DAF-2 DA) was purchased from Calbiochem (San Diego, 
CA). Glass bottom microscopy dishes were received from MatTek Corporation (Ashland, 
MA). Nitric oxide (NO) was purchased from Praxair (Bethlehem, PA). Argon (Ar) gas 
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was obtained from Airgas National Welders (Raleigh, NC). A Millipore Milli-Q UV 
Gradient A10 System (Bedford, MA) was used to purify distilled water to a final 
resistivity  of  18.2  MΩ·cm  and  a  total  organic  content  of  ≤6  parts  per  billion  (ppb).  Other  
solvents and chemicals were analytical-reagent grade and used as received. Nuclear 
magnetic resonance (NMR) spectra were recorded on a 400 MHz Bruker instrument. 
Elemental (carbon, hydrogen, nitrogen or CHN) analysis was performed using a 
PerkinElmer Elemental Analyzer Series 2400 instrument (Waltham, MA). 
2.2.1 Synthesis of nitric oxide-releasing silica particles 
To evaluate the effects of nanoparticle size on bactericidal efficacy, secondary 
amine-functionalized silica nanoparticles of select sizes (i.e., 50, 100, and 200 nm) were 
synthesized using a reverse-microemulsion technique.44 Size was controlled by varying 
the type (i.e., pentane or heptane) and volume of the organic solvent used in the reverse 
microemulsion. Seed particles (TEOS) were formed in the reverse micelles and AHAP 
was subsequently added to impart secondary amine functionality. The three particle sizes 
(i.e., 50, 100, and 200 nm) were then functionalized with N-diazeniumdiolates by 
suspending the particles in a 1:9 (v/v) mixture of DMF and methanol (5 mg/mL) and 
adding sodium methoxide (5.4 M in MeOH). Vials of the suspensions were then placed in 
a Parr hydrogenation vessel and stirred. Residual oxygen in the suspensions was removed 
by purging the vessel with argon (Ar) three times quickly, followed by three longer (10 
min) Ar purges. The vessel was then pressurized to 10 atm with purified gaseous NO. 
The hydrogenation vessel was maintained at 10 atm throughout a 3 d period after which 
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the Ar purging procedure was repeated to remove unreacted NO prior to removal of the 
vials from the vessel. The N-diazeniumdiolated particles were recollected by 
centrifugation (3645 g for 5 min, 25 °C), washed three times with EtOH, dried under 
vacuum, and stored at -20 °C until use.  
Silica particles of three distinct aspect ratios (AR1, AR4, and AR8) were 
synthesized via a surfactant-templated approach as previously described by varying 
reaction temperature and ammonia concentration.45 Elevated temperature (30 vs. 20 °C) 
was used to increase the aspect ratio of the particles (AR8), while a greater ammonia 
concentration (1.0 vs. 0.5 M) allowed for the synthesis of a more spherical particle 
(AR1). Of note, cetyltrimethylammonium bromide (CTAB) removal was confirmed via 
CHN analysis prior to surface grafting. Monoalkoxysilane, N-(2-aminoethyl)-3-amino-
isobutyl-dimethyl-methoxysilane (AEAI) was then surface grafted onto the particle/rods 
to impart secondary amine functionality for N-diazeniumdiolation as described below. N-
diazeniumdiolate-functionalized AR1, AR4, and AR8 silica particles were prepared by 
suspending the AEAI-functionalized particles (15 mg) in a 9:1 (v/v) solution of DMF and 
MeOH, and adding 50 µL sodium methoxide (5.4 M in MeOH). Vials of the suspensions 
were placed in the Parr hydrogenation vessel, purged with Ar, exposed to NO, and the 
resulting particles were recollected and stored following the same protocol.  
2.2.2 Synthesis of nitric oxide-releasing PPI dendrimers 
Secondary amine-functionalized PPI dendrimers (G2 and G5) of varied exterior 
functionality were synthesized as described previously.46 Briefly, 100 mg primary amine-
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functionalized G2-PPI dendrimer 7 (G2-PPI-NH2) was dissolved in methanol (2 mL). A 
total of 1 molar equivalent of PO, SO, or PEG was then added to the G2-PPI-NH2 
solution (methanol) with constant stirring at room temperature for 4 d to yield the 
secondary amine-functionalized G2-PPI conjugates (i.e., G2-PPI-PO 1, G2-PPI-PEG 3, 
G2-PPI-SO 5). Likewise, secondary amine-functionalized G5-PPI conjugates (i.e., G5- 
PPI-PO 2, G5-PPI-PEG 4, G5-PPI-SO 6) were formed via the reactions of G5-
PPI-NH2 8 with PO, PEG, and SO, respectively. Dendrimers 1−6 were dissolved in 
water, dialyzed against water, and subsequently lyophilized. N-diazeniumdiolate-
functionalized PPI dendrimers 1a−6a were prepared by adding 5.4 M sodium methoxide 
solution in MeOH (1 equivalent with respect to the molar amount of primary amine 
functionalities in PPI-NH2 used to synthesize dendrimers 1−6) to a vial containing 
dendrimers 1−6 in methanol (2 mL). Vials of the dendrimer solutions were then placed in 
the Parr hydrogenation vessel, purged with Ar, exposed to NO, and stored following the 
aforementioned protocol.  
2.2.3 Synthesis of nitric oxide-releasing chitosan oligosaccharides 
Chitosan oligosaccharides of varied molecular weights were prepared by 
oxidative degradation using hydrogen peroxide. Medium molecular weight chitosan (2.5 
g) was suspended in a hydrogen peroxide solution (15 or 30 wt%) under stirring for 1 h at 
65–85 oC. After removal of undissolved chitosan via filtration, the chitosan 
oligosaccharides were precipitated with acetone, collected by centrifugation, washed 
twice with ethanol, and dried under vacuum.  
50 
The chitosan oligosaccharides were then grafted with 2-methyl aziridine (MAz) 
based on a previously reported procedure.47 Briefly, a mixture of concentrated HCl (11 
µL), water (100 µL) and MAz with a 1:1 (Chitosan 1) or 2:1 (Chitosan 2) molar ratio to 
primary amines on the chitosan oligosaccharides was added dropwise to a solution of 
chitosan oligosaccharides (100 mg) in deionized water (5 mL). The resulting solution was 
stirred at room temperature for 5 d, and then 75 oC for 24 h. The MAz-grafted chitosan 
oligosaccharides were then purified by dialysis and collected by lyophilization. The 
chitosan oligosaccharides were further functionalized with PEG by adding poly(ethylene 
glycol) methyl ether acrylate (Chitosan 3) to tune hydrophobicity. The resulting PEG-
functionalized chitosan oligosaccharides were purified by dialysis and collected by 
lyophilization. The chitosan oligosaccharides were characterized by nuclear magnetic 
resonance (NMR) spectroscopy (data not shown). 
N-diazeniumdiolation of the secondary amine-functionalized chitosan 
oligosaccharides (Chitosan 1, Chitosan 2, and Chitosan 3) was achieved by adding the 
chitosan and 5.4 M sodium methoxide (75 µL) to a water/methanol mixture (2 mL). The 
suspensions were then placed in a Parr hydrogenation vessel, purged with Ar, exposed to 
NO, and stored following the aforementioned protocol.   
2.2.4 Fluorescently-labeled scaffolds 
  Fluorescently-labeled silica nanoparticles,44 dendrimers,46 and chitosan 
oligosaccharides48 were achieved via covalent modification with rhodamine B 
isothiocyanate (RITC) based on a previously published procedures. The silica particles 
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(50 mg) were suspended in EtOH (100 mL) with RITC (5 mg) and stirred in the dark for 
48 h. Following fluorescent modification, the particles were collected and washed 
copiously with EtOH using the collection/centrifugation protocol described above. After 
a clear supernatant was achieved, the particles were dried under vacuum, N-
diazeniumdiolated, and stored until use. Fluorescently-labeled dendrimers were prepared 
by dissolving G2-PPI-NH2 7(100 mg) and RITC (7.5 mg) in methanol (2 mL). The 
solution was stirred for 24 h, dialyzed, and lyophilized to yield RITC-labeled dendrimers 
that were then modified with PO (1 equivalent) and further reacted with NO. To obtain 
fluorescently-labeled chitosan, chitosan oligosaccharides (50 mg) were dissolved in water 
(2 mL) at pH 9.0 and RITC was added to the solution in a 1:100 molar ratio to the 
primary amine of the chitosan oligosaccharides prior to the grafting of 2-methyl aziridine. 
The solution was then stirred at room temperature for 3 d, dialyzed, lyophilized, and 
further reacted with NO to achieve fluorescently-labeled NO-releasing chitosan 
oligosaccharides.  
2.2.5 Scaffold characterization and nitric oxide release  
Size and shape (i.e., aspect ratio) of the silica particles were determined using 
transmission electron microscopy (TEM) and scanning electron microscopy (SEM). 
Transmission electron micrographs of the 50, 100, and 200 nm silica particles were 
obtained on a JEOL 100 CX II transmission electron microscope (Tokyo, Japan). 
Scanning electron micrographs of the AR1, AR4, and AR8 silica particles were recorded 
using a Hitachi S-4700 scanning electron microscope (Tokyo, Japan). Real-time NO-
release from the silica particles, dendrimers, and chitosan oligosaccharides was measured 
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using a Sievers 280i Chemiluminesence Nitric Oxide Analyzer (NOA; Boulder, CO). The 
NO-releasing silica particles (1 mg), dendrimers (1 mg), or chitosan oligosaccharides 
(aliquot in water/methanol mixture) were added to a sample vessel containing 30 mL 
deoxygenated PBS (pH 7.4, 37 °C). Liberated NO was carried from the sample vessel to 
the NOA at a flow rate of 70 mL/min. To match the collection rate of the NOA (200 
mL/min), additional nitrogen flow was supplied to the sample vessel. Nitric oxide-release 
measurements were terminated when the levels fell below 10 ppb NO/mg scaffold. The 
real-time NO-release data was used to determine the total NO-release duration and half-
life (t1/2). Total NO storage (t[NO]) was also characterized using the Griess assay.49, 50 
2.2.6 Planktonic bactericidal assays 
 Pseudomonas aeruginosa and Staphylococcus aureus bacterial cultures were 
grown from frozen stock (-80 °C) in TSB overnight at 37 °C. An aliquot of the 
suspension (0.5 mL) was added to fresh TSB (50 mL) and incubated at 37 °C until the 
bacteria reached mid-exponential phase (~1 × 108 colony forming units (cfu)/mL) as 
determined by the optical density at 600 nm (OD600). The relationship between the 
concentration of the bacteria in suspension and the OD600 was calibrated for each strain 
using an Eppendorf BioPhotometer Plus Spectrophotometer (Hamburg, Germany); the 
colony forming units were enumerated from culture dilutions grown on TSA plates. The 
bacterial suspension was then centrifuged (3645 g for 10 min, 25 °C), resuspended in 
PBS, and diluted to ~1 × 106 cfu/mL in PBS. 
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The minimum bactericidal concentration (MBC) of the NO-releasing 50, 100, and 
200 nm silica particles for planktonic P. aeruginosa was defined as the concentration that 
resulted in a 3-log reduction in viability versus untreated cells after 2 or 24 h. The MBC 
of the NO-releasing AR1, AR4, and AR8 silica particles and dendrimers for planktonic P. 
aeruginosa and S. aureus was defined as the concentration that resulted in a 3-log 
reduction in viability versus untreated cells after 4 and 2 h, respectively. The MBC of the 
NO-releasing chitosan oligosaccharides for planktonic P. aeruginosa was defined as the 
concentration that resulted in a 3-log reduction in viability versus untreated cells after 4 
h. The bacterial suspensions (106 cfu/mL) were incubated with the NO-releasing 
scaffolds over a range of concentrations for the duration noted. After exposure, the 
samples were nanomaterial–bacteria suspensions were diluted and plated on TSA, with 
counting of resulting colonies to determine viability. 
2.2.7 Confocal microscopy  
To observe association of the silica particles with the bacteria, P. aeruginosa (106 
cfu/mL) was first incubated in a glass bottom confocal dish and allowed to adhere for 45 
min at 37 °C. The slide was rinsed with fresh PBS to remove loosely or unadhered 
bacteria. A suspension of the RITC-modified silica nanoparticles  (500  μL  of  10  μg/mL in 
PBS) was then added to the bacteria on the glass slide. To observe association of NO-
releasing particles with bacteria over time, fluorescence images were taken immediately 
following the addition of the 50 nm particles at 20 s intervals for 40min. To compare the 
influence of particle size on the extent of particle–bacteria association, fluorescence 
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images were obtained of bacteria treated with the 50, 100, and 200 nanoparticles (10 
µg/mL) for 10 min. After the 10 min incubation period, the suspension was removed, and 
the bacteria were copiously washed with fresh PBS to remove unassociated particles. 
Fresh PBS was then added, and the bacteria were imaged. 
 Intracellular NO levels and subsequent cell death were evaluated for the AR1 and 
AR8 NO-releasing silica particles using confocal microscopy. Bacteria ( P. aeruginosa 
and S. aureus ) were cultured in TSB to a concentration of 1 × 108 CFU/mL, collected via 
centrifugation (3645 g for 10 min), resuspended in sterile PBS, and adjusted to 1 × 106 
CFU/mL   in  PBS   supplemented  with   10  μ  M DAF-2 DA and  30  μ  M  PI.  The   bacteria  
solution (2.5 mL) was incubated in a glass bottom confocal dish for 45 min at 37 ° C. 
Suspensions (1.5 mL) of AR1 or AR8 NO-releasing silica particles (44  μ  g/mL) in PBS 
(supplemented with   10   μ   M   DAF-2   DA   and   30   μ   M PI) were added to the bacteria 
solution (1.5 mL) in the glass confocal dish. Images were collected every 5 min to 
observe intracellular NO concentrations and cell death.  
Similarly, intracellular NO, cell death, and scaffold-bacteria association were 
observed for the NO-releasing PPI dendrimers. P. aeruginosa was cultured in TSB to a 
concentration of 1 × 108 CFU/mL, collected via centrifugation (3645 × g for 10 min), 
resuspended in sterile PBS, and adjusted to 1 × 106 CFU/mL in PBS supplemented with 
10  μM  DAF-2  DA  and  30  μM  PI.  Aliquots  of  the  bacteria solution were incubated in a 
glass bottom confocal dish for 45 min at 37 °C. Suspensions (1.5 mL) of G2 (17.4 
μg/mL)  or  G5  (20.0  μg/mL) PPI-SO NO-releasing dendrimers (5a and 6a) or 50 nm NO-
releasing AHAP3/TEOS nanoparticles44 (44.0  μg/mL) in PBS supplemented with 10 μM  
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DAF-2   DA   and   30   μM   PI   were   added   to   the   bacteria   solution   (1.5 mL) in the glass 
confocal dish. Images were collected every 2 min to observe intracellular NO 
concentrations and bacteria cell death temporally. For association experiments, S. aureus 
was cultured in TSB to a concentration of 1 × 108 CFU/mL, collected via centrifugation 
(3645 × g for 10 min), resuspended in sterile PBS, and adjusted to 1 × 106 CFU/mL. 
Aliquots of the bacteria solution were incubated in a glass bottom confocal dish for 45 
min at 37 °C. Solutions of RITC-labeled   control   (400   μg/mL) or NO-releasing (400 
μg/mL) G2-PPI-PO dendrimers in PBS (1.5 mL) were added to the bacteria solution (1.5 
mL) in the glass confocal dish to achieve a final concentration   of   200   μg/mL. Images 
were collected every 2 min to monitor association of the dendrimers with S. aureus 
temporally. 
Prior to examining association of the chitosan oligosaccharides with the bacteria, 
P. aeruginosa was cultured in TSB to a concentration of ~1 × 108 CFU/mL, collected via 
centrifugation (3645  g for 10 min), resuspended in sterile PBS, and adjusted to ~1 × 106 
CFU/mL. Aliquots of the bacteria solution were incubated in a glass bottom confocal dish 
for 1.5 h at 37 °C. Solutions of RITC-labeled NO-releasing chitosan oligosaccharides in 
PBS (1.5 mL) were added to the bacteria solution (1.5 mL) in the glass confocal dish to 
achieve   a   final   concentration   of   150   μg/mL.   Images   were   collected   every   2   min   to  
characterize the association, if any, of the chitosan oligosaccharides with P. aeruginosa 
temporally.  
A Zeiss 510 Meta inverted laser scanning confocal microscope (Carl Zeiss, 
Thornwood, NY) with a 488 nm Ar excitation laser (2.0% intensity) and a BP 505–530 
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nm filter was used to obtain DAF-2 (green) fluorescence images. A 543 nm HeNe 
excitation laser (25.3% intensity) with a BP 560–615 nm filter was used to obtain PI and 
RITC (red) fluorescence images. The images were collected using a Zeiss C-apochromat 
lens (20 or 40x, 1.2 numerical aperture).  
2.2.8 In vitro cytotoxicity  
L929 mouse fibroblasts were cultured in DMEM supplemented with 10% (v/v) 
FBS and 1 wt% Pen Strep solution, and incubated in 5% (v/v) CO2 under humidified 
conditions at 37 oC. After reaching 80% confluency, the cells were trypsinized, seeded 
onto tissue culture-treated polystyrene 96-well plates at a density of 3 × 104 cells/mL and 
incubated at 37 oC for 48 h. The supernatant was then aspirated prior to adding fresh 
DMEM  (200  μL)  with  control  (i.e.,  non-NO-releasing) or NO-releasing scaffolds to each 
well. After incubation at 37 oC for 24 h, the supernatant was aspirated and the cells rinsed 
3x with PBS. A mixture  of  DMEM/MTS/PMS  (105/20/1,  v/v/v)  (120  μL)  was  then  added  
to each well. The absorbance of the resulting colored solution after 1.5 h incubation at 37 
oC was quantified at 490 nm using a Thermo Scientific Multiskan EX plate reader 
(Thermo Fisher Scientific, Inc., Waltham, MA). The mixture of DMEM/MTS/PMS and 
untreated cells were used as the blank and control, respectively. Cell viability was 
calculated by taking the ratio of the absorbance of treated to untreated cells after 
subtracting the absorbance of the blank from each.  
2.3 Results and Discussion 
2.3.1 Nitric oxide-releasing silica particles 
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 Three distinct silica particle sizes (56 ± 7, 93 ± 14, and 199 ± 27 nm for the 50, 
100, and 200 nm particles, respectively) were synthesized via reverse microemulsion for 
evaluation of P. aeruginosa eradication as a function of particle size.44 Following N-
diazeniumdiolation, the NO-releasing particles were characterized for NO storage and 
release at 2 and 24 h to mimic bactericidal assays. At 2 h, the total NO storage was 
similar for the three sizes of particles (0.47 ± 0.02, 0.38 ± 0.01, and 0.42 ± 0.01 µmol/mg 
for the NO-releasing 50, 100, and 200 nm particles, respectively). Likewise, the total NO 
released within the 24 h bactericidal assay was similar for all three systems (1.49 ± 0.29, 
1.26 ± 0.17, and 1.01 ±0.08 µmol/mg , for the NO-releasing 50, 100, and 200 nm 
particles, respectively), confirming their utility for evaluation of efficacy as a function of 
size. 
 The role of nanoparticle shape (i.e., aspect ratio) on antibacterial activity was 
evaluated using silica particles of three varied aspect ratios (i.e., 1, 4, and 8), but identical 
particle volume. Nitric oxide released over the 4 h planktonic killing assay was 0.63 ± 
0.07, 0.59 ± 0.07, and 0.64 ± 0.09 µmol/mg for the AR1, AR4, and AR8 particles, 
respectively. Given their identical NO storage, the NO-releasing AR1, AR4, and AR8 
particles allowed for examination of the influence of nanoparticle shape on bactericidal 
efficacy against both P. aeruginosa and S. aureus. 
2.3.1.1 Bactericidal efficacy against planktonic bacteria as a function of size and shape 
 As expected, the smaller NO-releasing 50 nm particles exhibited the greatest 
biocidal action against P. aeruginosa. For the 2 h MBC assay, the 50, 100, and 200 nm 
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particles had MBC values of 0.8, 1.5, and 1.5 mg/mL, respectively. However, the 
increased treatment time of 24 h reduced the necessary dose further, resulting in 24 h 
MBC values of 0.2, 0.2, and 0.4 mg/mL for the 50, 100, and 200 nm particles, 
respectively. Of note, no reduction in P. aeruginosa viability was observed for control 
(i.e., non-NO-releasing) particles at the MBC concentrations. 
 Assays for evaluating the influence of particle shape on bacterial killing were 
conducted over 4 h. Increased antibacterial activity was observed for the NO-releasing 
AR8 particles over the AR4 and AR1 particles for both P. aeruginosa and S. aureus. The 
MBC values for the NO-releasing AR8, AR4, and AR1 particles against P. aeruginosa 
were 150, 250, and 500 µg/mL, respectively. However, increased NO doses were 
necessary for killing of S. aureus, with MBCs of 300, 1000, and 2000 µg/mL for the 
AR8, AR4, and AR1 particles, respectively. No reduction in viability of P. aeruginosa or 
S. aureus was noted when exposed to control scaffolds at the maximum MBC 
concentration of the NO-releasing particles.  
2.3.1.2 Confocal microscopy 
 The bactericidal assays confirmed the enhanced efficacy of the smaller NO-
releasing 50 nm particles over the 100 and 200 nm particles. However, it was unclear 
how nanoparticle–bacteria interactions played a role in the NO-induced bacterial killing. 
Thus, confocal microscopy was used to evaluate association between the P. aeruginosa 
cells and the 50, 100, and 200 nm silica particles. The RITC-labeled 50, 100, and 200 nm 
particles (10 µg/mL) were incubated with P. aeruginosa cells for 10 min, and after 
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washing, increased nanoparticle–bacteria association was observed for the 50 nm 
particles as expected (Figure 2.1). Although interactions between the 100 and 200 nm 
particles and the bacteria were visible, the degree of association was significantly less as 
particle size was increased. Particle–bacteria association was further examined by 
incubating P. aeruginosa cells with RITC-modified 50 nm particles and imaging the cells 
every 20 s over 40 min (Figure 2.2). This time-based experiment revealed that the 50 nm 
particles associate rapidly (~2 min post-addition) with the P. aeruginosa cells, even at 
low concentrations (10 µg/mL). Given the improved association of the 50 nm particles 
with the P. aeruginosa cells, it is likely that they exhibited more efficient NO delivery, 
and thus better antibacterial activity.  
 Confocal microscopy was also utilized to evaluate intracellular NO levels in P. 
aeruginosa and S. aureus cells exposed to NO-releasing AR1 and AR8 particles. Since S. 
aureus required greater NO doses for eradication, it was hypothesized that the improved 
killing of P. aeruginosa may result from more efficient NO delivery. The bacteria were 
exposed to NO-releasing AR1 or AR8 particles (22 µg/mL) and intracellular NO 
concentrations were subsequently monitored with the DAF-2 (green) fluorescent probe. 
As shown in Figure 2.3, P. aeruginosa cells exhibited increased DAF-2 fluorescence 
upon exposure to the higher aspect ratio (i.e., AR8) particles, thus confirming the 
increased efficiency in NO delivery for the rod-like particles. Of note, minimal DAF-2 
fluorescence was observed in S. aureus cells exposed to the same NO-releasing particle 
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Figure  2.1  Confocal  microscopy  images  of  RITC-modified  (A)  50,  (B)  100,  and  (C)  200  
nm  silica  nanoparticle  (10  µg/mL)  association  with  planktonic  P.  aeruginosa  after  10  min  
incubation.  Scale  bar  is  5  µm. 
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Figure   2.2   Confocal   images   of   50   nm   RITC-modified   NO-releasing   silica   particle  
association   with   planktonic   P.   aeruginosa.   Images   were   acquired   (A)   0   (addition   of  
particles),  (B)  2.4,  (C),  6.4,  (D)  19.5,  and  (E)  39  min  after  addition  of  nanoparticles  at  10  
µg/mL.  Scale  bar  is  10  µm. 
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Figure  2.3  Intracellular  DAF-2  fluorescence  from  P.  aeruginosa  bacterial  cells  incubated  
with  22  µg/mL  AR1(Bright   field   (A),  120  min  (B),  125  min  (C))  and  AR8(Bright   field  
(D),   95  min   (E),   100  min   (F))   and   from   S.   aureus   bacterial   cells   incubated  with  AR1  
(Bright  field  (G),  135  min  (H),  155  min  (I))  AR8  (Bright  field  (J),  100  min  (K),  130  min  
(L)).  Intensity  of  DAF-2    (green)  fluorescence  indicates  intracellular  NO  levels. 
 
63 
concentration (22 µg/mL). This corroborates the higher MBC values for S. aureus 
compared to P. aeruginosa. The greater bactericidal NO doses necessary to kill S. aureus 
vs. P. aeruginosa are attributed to several possible factors including differential thickness 
of the peptidoglycan layer in the cell membrane,51 varied production of antioxidant 
enzymes (e.g., superoxide dismutase) to mitigate the effects of NO,52 and S. aureus’  use  
of NO as a cytoprotection agent.53  
2.3.1.3 In vitro cytotoxicity 
 To ensure the therapeutic utility of the silica scaffolds, the 50, 100, and 200 nm 
particles as well as the AR1, AR4, and AR8 particles were tested for in vitro cytotoxicity 
against L929 mouse fibroblasts. The fibroblasts were selected as a model host cell due to 
their ubiquitous presence in connective tissue.54 Cytotoxicity of the control and NO-
releasing 50, 100, and 200 nm silica particles was evaluated at 2 and 24 h to mimic 
bacteria assays. All three particles sizes were non-toxic to mammalian cells at the highest 
concentrations necessary for planktonic killing of P. aeruginosa (i.e., 1.6 and 0.4 mg/mL 
for the 2 and 24 h exposures, respectively). Likewise, the control and NO-releasing AR1, 
AR4, and AR8 particles were non-toxic at MBCs for P. aeruginosa eradication. 
However, some reduction in fibroblast was noted for particle concentrations necessary to 
kill S. aureus.  
2.3.1.4 Conclusions 
 Both NO-releasing nanoparticle size and shape played a role in bactericidal 
efficacy against Gram-negative P. aeruginosa and Gram-positive S. aureus. As expected, 
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particles with decreased size and increased aspect ratio exhibited greater biocidal action. 
Bacterial killing was shown to improve with longer treatment times (i.e., 2 vs 24 h) and 
thus future work should evaluate assay duration to achieve the lowest therapeutic dose. 
Additionally, the NO-releasing 50, 100, and 200 nm and AR1, AR4, and AR8 silica 
scaffolds were effective against bacteria with minimal cytotoxicity and should be 
investigated as anti-biofilm agents. 
2.3.2 Nitric oxide-releasing dendrimers 
 Nitric oxide-releasing dendrimers were synthesized with varied size (i.e., G2 and 
G5) and exterior functionalities (i.e., PO, SO, and PEG) (Figure 2.4).46 Total nitric oxide 
release from the scaffolds ranged from 0.65 to 2.61 µmol/mg over the 2 h planktonic 
killing assays. In addition to varied hydrophobicity and total NO storage, the PO, SO, and 
PEG scaffolds had a range of NO-release kinetics, with t1/2 ranging from 0.67 to 1.70 h. 
The varied NO-release characteristics of the NO-releasing PPI dendrimers allowed from 
evaluation of bactericidal efficacy against planktonic P. aeruginosa and S. aureus as a 
function of size (i.e., G2 versus G5) and exterior modification.  
2.3.2.1 Bactericidal efficacy against planktonic bacteria as a function of exterior 
functionality 
 Details on the planktonic MBCs for the control (i.e., non-NO-releasing) and NO-
releasing PPI dendrimers has been reported by Sun et al.46 In general, the SO-modified 
dendrimers exhibited greater antibacterial activity to both P. aeruginosa and S. aureus 
due to the improved association with the cell membrane. Likewise, the hydrophilic PEG-
modified dendrimers were less effective. For example, ~600x the bactericidal NO dose 
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(1254 versus 2 µmol NO/L) was required for P. aeruginosa eradication for the G2-PEG-
NO dendrimers compared to the G2-SO-NO dendrimers. Size effects were also noted, 
with greater biocidal action for the larger dendrimers (i.e., G5-SO-NO versus G2-SO-
NO). 
2.3.2.2 Confocal microscopy 
 Confocal microscopy was used to determine if larger size dendrimers exhibited 
improved bacterial killing due to more localized NO delivery to the cell. As shown in 
Figure 2.5, larger intracellular NO concentrations (DAF-2 fluorescence) were observed 
for P. aeruginosa cells exposed to G5-SO-NO dendrimers compared to G2-SO-NO, thus 
confirming improved NO delivery efficiency for the larger dendrimer. Additionally, 
dendrimer–bacteria interactions were evaluated for S. aureus to explain the improved 
killing of the control G2-PO dendrimers compared to the NO-releasing G2-PO 
dendrimers (MBC of 484.0 versus 967.9 µg/mL). S. aureus cells were exposed to the 
RITC-modified dendrimers and imaged over time to evaluate association (Figure 2.6). 
Indeed, the control G2-PO dendrimers exhibited more rapid association with S. aureus 
cells compared to their NO-releasing counterparts, likely due to more favorable 
electrostratic interactions with the negatively-charged cell membrane (zeta potentials 
were +7.1 ± 0.6 and -14.0 ± 5.4 mV for the control and NO-releasing G2-PO dendrimers, 
respectively. 
2.3.2.3 In vitro cytotoxicity 
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Figure  2.4  Confocal  microscopy  images  of  P.  aeruginosa  cells  exposed  to  the  same  NO  
dosage   (10  μmol/L)  via   incubation  with  NO-releasing  G2-   and  G5-PPI-SO  (8.7  and  10  
μg/mL,   respectively)   and   50   nm  AHAP3/TEOS  nanoparticles   (22   μg/mL).   Intracellular  
NO   is   indicated   by   the   appearance   of   DAF-2   green   fluorescence,   while   PI   red  
fluorescence   indicates  compromised  membranes  (cell  death).   Images  were  acquired  (A)  
30,  (B)  46,  (C)  60,  (D)  64,  (E)  86,  and  (F)  94  min  after  dendrimer/nanoparticle  addition. 
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Figure  2.5  Confocal  microscopy  images  of  RITC-modified control  and  NO-releasing  G2  
PPI-PO  dendrimer   (400  μg/mL) association  with  S.  aureus  cells.   Images  were  acquired  
(A)  4,  (B)  12,  (C)  18,  (D)  30,  and  (E)  45  min  following  dendrimer  addition. 
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 In vitro cytotoxicity to L929 mouse fibroblasts was evaluated for the control and 
NO-releasing PPI dendrimers to determine their potential for therapeutic use. Although 
many of the PPI dendrimer scaffolds exhibited potent antibacterial activity against both 
P. aeruginosa and S. aureus, significant reductions in fibroblast viability (>80%) were 
observed for many control and NO-releasing scaffolds at the corresponding MBC. 
2.3.2.4 Conclusions 
 The planktonic killing of P. aeruginosa and S. aureus was dependent on both NO-
releasing PPI dendrimer size and hydrophobicity. Larger, hydrophobic dendrimers (i.e., 
G5-SO-NO) were most effective. Despite the low scaffold does necessary for bacterial 
eradication, these scaffolds were significantly toxic to healthy host cells, thus limiting 
their widespread utility. Further tailoring of the exterior modification or use of a less 
toxic dendritic scaffold (e.g., poly(amidoamine)) is thus warranted to maintain biocidal 
action while reducing unwanted cytotoxic effects. 
2.3.3 Nitric oxide-releasing chitosan oligosaccharides 
 Nitric oxide-releasing chitosan oligosaccharides with varied exterior functionality 
and molecular weight were synthesized (Figure 2.7). The chitosan oligosaccharides were 
modified with different ratios of 2-methyl aziridine to tune the exterior functionality 
(Chitosan 1 and 2). Chitosan 2 was further modified with PEG (Chitosan 3) to evaluate a 
wider range of functionalities. Additionally, three different molecular weights of 
Chitosan 2 (2.5k, 5k, and 10k)were synthesized to study the influence of molecular 
weight on chitosan antibacterial activity. 
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Chitosan 1 x=1
Chitosan 2 x=2
Chitosan 1/NO x=1
Chitosan 2/NO x=2
Chitosan 3 x=2 Chitosan 3/NO x=2
Figure   2.6   Synthesis   of   secondary   amine-   and   N-diazeniumdiolate-functionalized  
chitosan  oligosaccharide  derivatives.  A)  Chitosan  1  and  Chitosan  2)   and  subsequent  N-
diazeniumdiolate   formation   of   the   resulting   materials   (Chitosan   1/NO   and   Chitosan  
2/NO);;   B)   Modification   of   secondary   amine-functionalized   chitosan   oligosaccharides  
with  PEG  (Chitosan  3  and  Chitosan  3/NO). 
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2.3.3.1 Bactericidal efficacy against planktonic bacteria as a function of exterior 
functionality and molecular weight 
 The NO-releasing chitosan oligosaccharides (Chitosan 1–3) were evaluated for 
planktonic killing against P. aeruginosa. Minimum bactericidal concetrations for the NO-
releasing Chitosan 2-2.5k, Chitosan 2-5k, and Chitosan2-10k were 0.12, 0.12, and 0.12, 
µmol NO/mL respectively. Thus chitosan molecular weight did not significantly impact 
P. aeruginosa killing. Exterior functionality did influence antibacterial activity, with 
MBCs of 0.32, 0.10, and 0.45 for Chitosan 1/NO, Chitosan 2/NO, and Chitosan 3/NO, 
respectively. Based on previous work published with dendrimers,46 it was expected that 
the PEG-modified chitosan would be the least biocidal, likely due to decreased 
interaction with the bacteria membrane. 
2.3.3.2 Confocal microscopy 
 Confocal microscopy was used to evaluate the association of both Chitosan 2/NO 
and Chitosan 3/NO with P. aeruginosa to gain insight into the mechanism by which the 
PEG-modified chitosan exhibited reduced bactericidal efficacy (Figure 2.8). Planktonic 
P. aeruginosa cells were incubated with either RITC-labeled Chitosan 2/NO or Chitosan 
3/NO (150 µg/mL) and imaged over time. Significant red fluorescence was noted for the 
cells exposed to Chitosan 2/NO within ~24 min. However, even at 82 min, minimal red 
fluorescence was observed in cells exposed to Chitosan 3/NO, likely due to less 
association between the neutral PEG functionality and the bacterial membrane. 
2.3.3.3 In vitro cytotoxicity 
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Figure   2.7  Confocal  microscopy   images   of  RITC-modified  Chitosan   2/NO-5k;;   (A)   24  
min,  (B)  28  min,  (C)  42  min  and  Chitosan  3/NO-5k;;  (D)  82  min,  (E)  86  min,  (F)  110  min,  
(H)   120  min   association  with  P.   aeruginosa   cells   (150   μg/  mL).  Overlay   images   of  P.  
aeruginosa   cells   incubated   with   (G)   Chitosan   2/NO-5k   at   44   min   and      (H)   Chitosan  
3/NO-5k  at  120  min.   
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Control and NO-releasing chitosan oligosaccharides were evaluated for their 
influence on L929 mouse fibroblast viability. As expected for the natural biopolymer, the 
chitosan oligosaccharides were not toxic at concentrations necessary for planktonic 
killing of P. aeruginosa. Fibroblast proliferation was observed for the NO-releasing 
chitosans in some cases,55 which may further the potential for use of these scaffolds as 
anti-biofilm agents. 
2.3.3.4 Conclusions 
 The evaluation of NO-releasing chitosan oligosaccharides in the killing of 
planktonic P.aeruginosa showed the importance of exterior functionality. Molecular 
weight of the chitosan oligosaccharides was not observed to influence planktonic bacteria 
killing. However, it is likely that some molecular-weight dependent effects would be 
noted for these scaffolds against bacterial biofilms. 
 
 
 
 
 
 
 
73 
REFERENCES 
1. Neal, A. L., What can be inferred from bacterium-nanoparticle interactions about 
the potential consequences of environmental exposure to nanoparticles? 
Ecotoxicol. 2008, 17, 362-371. 
 
2. Bryers, J. D., Medical biofilms. Biotechnol. Bioeng. 2008, 100, 1-18. 
 
3. D'Avignon, L. C.; Hogan, B. K.; Murray, C. K.; Loo, F. L.; Hospenthal, D. R.; 
Cancio, L. C.; Kim, S. H.; Renz, E. M.; Barillo, D.; Holcomb, J. B.; Wade, C. E.; 
Wolf, S. E., Contribution of bacterial and viral infections to attributable mortality 
in patients with severe burns: An autopsy series. Burns 2010, 36, 773-779. 
 
4. Goswami, A. P.; Goswami, N.; Patel, T.; Tripathi, C.; Trivedi, H., Antibiotic 
sensitivity profile of bacterial pathogens in postoperative wound infections at a 
tertiary care hospital in Gujarat, India. J. Pharmacol. Pharmacother. 2011, 2, 
158-164. 
 
5. Nablo, B. J.; Prichard, H. L.; Butler, R. D.; Klitzman, B.; Schoenfisch, M. H., 
Inhibition of implant-associated infections via nitric oxide release. Biomaterials 
2005, 26, 6984-6990. 
 
6. Rutala, W. A.; Weber, D. J., Infection control: the role of disinfection and 
sterilization. J. Hosp. Infect. 1999, 43, Supplement 1, S43-S55. 
 
7. Cerca, N.; Martins, S.; Cerca, F.; Jefferson, K. K.; Pier, G. B.; Oliveira, R.; 
Azeredo, J., Comparative assessment of antibiotic susceptibility of coagulase-
negative staphylococci in biofilm versus planktonic culture as assessed by 
bacterial enumeration or rapid XTT colorimetry. J. Antimicrob. Chemother. 2005, 
56, 331-336. 
 
8. Anderl, J. N.; Franklin, M. J.; Stewart, P. S., Role of antibiotic penetration 
limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and 
ciprofloxacin. J. Antimicrob. Chemother. 2000, 44, 1818-1824. 
 
9. Nickel, J. C.; Ruseska, I.; Wright, J. B.; Costerton, J. W., Tobramycin resistance 
of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter 
material. J. Antimicrob. Chemother. 1985, 27, 619-624. 
 
10. Lindsay, D.; von Holy, A., Bacterial biofilms within the clinical setting: what 
healthcare professionals should know. J. Hosp. Infect. 2006, 64, 313-325. 
 
74 
11. Stewart, P. S.; William Costerton, J., Antibiotic resistance of bacteria in biofilms. 
The Lancet 2001, 358, 135-138. 
 
12. Costerton, J. W.; Stewart, P. S.; Greenberg, E. P., Bacterial biofilms: A common 
cause of persistent infections. Science 1999, 284, 1318-1322. 
 
13. Lyczak, J. B.; Cannon, C. L.; Pier, G. B., Lung infections associated with cystic 
fibrosis. Clin. Microbiol. Rev. 2002, 15, 194-222. 
 
14. Dowd, S. E.; Wolcott, R. D.; Sun, Y.; McKeehan, T.; Smith, E.; Rhoads, D., 
Polymicrobial nature of chronic diabetic foot ulcer biofilm infections determined 
using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PloS one 
2008, 3, e3326. 
 
15. Smith, A. W., Biofilms and antibiotic therapy: Is there a role for combating 
bacterial resistance by the use of novel drug delivery systems? . Adv. Drug Deliv. 
Rev. 2005, 57, 1539-1550. 
 
16. Ignarro, L. J.; Buga, G. M.; Wood, K. S.; Byrns, R. E.; Chaudhuri, G., 
Endothelium-derived relaxing factor produced and released from artery and vein 
is nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 9265-9269. 
 
17. Ignarro, L. J.; Napoli, C.; Loscalzo, J., Nitric oxide donors and cardiovascular 
agents modulating the bioactivity of nitric oxide: an overview. Circulation 
Research 2002, 90, 21-28. 
 
18. Carpenter, A. W.; Schoenfisch, M. H., Nitric oxide release: Part II. Therapeutic 
applications. Chem. Soc. Rev. 2012, 41, 3742-3752. 
 
19. Fang, F. C., Perspectives series: host/pathogen interactions. Mechanisms of nitric 
oxide-related antimicrobial activity. J. Clin. Invest. 1997, 99, 2818-2825. 
 
20. Hetrick, E. M.; Shin, J. H.; Stasko, N. A.; Johnson, C. B.; Wespe, D. A.; 
Holmuhamedov, E.; Schoenfisch, M. H., Bactericidal efficacy of nitric oxide-
releasing silica nanoparticles. ACS Nano 2008, 2, 235-246. 
 
21. Hetrick, E. M. S., J.-H.; Paul, H.S.; Schoenfisch, M.H., Anti-biofilm efficacy of 
nitric oxide-releasing silica nanoparticles. Biomaterials 2009, 30, 2782-2789. 
 
22. De Groote, M. A.; Fang, F. C., NO inhibitions: antimicrobial properties of nitric 
oxide. Clinical infectious diseases 1995, 21, S162-S165. 
 
23. Privett, B. J.; Deupree, S. M.; Backlund, C. J.; Rao, K. S.; Johnson, C. B.; 
Coneski, P. N.; Schoenfisch, M. H., Synergy of nitric oxide and silver 
75 
sulfadiazine against gram-negative, gram-positive, and antibiotic-resistant 
pathogens. Mol. Pharm. 2010, 7, 2289-2296. 
 
24. Stasko, N. A.; Schoenfisch, M. H., Dendrimers as a scaffold for nitric oxide 
release. J. Am. Chem. Soc. 2006, 128, 8265-8271. 
 
25. Diwan, A. D.; Wang, M. X.; Jang, D.; Zhu, W.; Murrell, G. A., Nitric oxide 
modulates fracture healing. J. Bone Miner. Res. 2000, 15, 342-351. 
 
26. Brinker, C. J.; Scherer, G. W., Sol-gel science: the physics and chemistry of sol-
gel processing. Elsevier: 1990. 
 
27. Morones, J. R.; Elechiguerra, J. L.; Camacho, A.; Holt, K.; Kouri, J. B.; Ramirez, 
J. T.; Yacaman, M. J., The bactericidal effect of silver nanoparticles. 
Nanotechnology 2005, 16, 2346-2353. 
 
28. Nair, S.; Sasidharan, A.; Rani, V. D.; Menon, D.; Nair, S.; Manzoor, K.; Raina, 
S., Role of size scale of ZnO nanoparticles and microparticles on toxicity toward 
bacteria and osteoblast cancer cells. J. Mater. Sci.: Mater. Med. 2009, 20, 235-
241. 
 
29. Pal, S.; Tak, Y.-K.; Song, J.-M., Does the antibacterial activity of silver 
nanoparticles depend on the shape of the nanoparticle? A study of the Gram-
negative bacterium Eschericia coli. Appl. Environ. Microbiol. 2007, 73, 1712-
1720. 
 
30. Tomalia, D. A.; Naylor, A. M.; Goddard, W. A., Starburst dendrimers: molecular-
level control of size, shape, surface chemistry, topology, and flexibility from 
atoms to macroscopic matter. Angew. Chem., Int. Ed. Engl. 1990, 29, 138-175. 
 
31. Patri, A. K.; Kukowska-Latallo, J. F.; Baker Jr, J. R., Targeted drug delivery with 
dendrimers: comparison of the release kinetics of covalently conjugated drug and 
non-covalent drug inclusion complex. Adv. Drug Deliv. Rev. 2005, 57, 2203-
2214. 
 
32. Patil, M. L.; Zhang, M.; Taratula, O.; Garbuzenko, O. B.; He, H.; Minko, T., 
Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA 
delivery: effect of the degree of quaternization and cancer targeting. 
Biomacromolecules 2009, 10, 258-266. 
 
33. Taratula, O.; Garbuzenko, O. B.; Kirkpatrick, P.; Pandya, I.; Savla, R.; Pozharov, 
V. P.; Minko, T., Surface-engineered targeted PPI dendrimer for efficient 
intracellular and intratumoral siRNA delivery. J. Controlled Release 2009, 140, 
284-293. 
76 
 
34. Wathier, M.; Jung, P. J.; Carnahan, M. A.; Kim, T.; Grinstaff, M. W., Dendritic 
macromers as in situ polymerizing biomaterials for securing cataract incisions. J. 
Am. Chem. Soc. 2004, 126, 12744-12745. 
 
35. Chen, C. Z.; Beck-Tan, N. C.; Dhurjati, P.; van Dyk, T. K.; LaRossa, R. A.; 
Cooper, S. L., Quaternary ammonium functionalized poly (propylene imine) 
dendrimers as effective antimicrobials: structure-activity studies. 
Biomacromolecules 2000, 1, 473-480. 
 
36. Calabretta, M. K.; Kumar, A.; McDermott, A. M.; Cai, C., Antibacterial activities 
of poly(amidoamine) dendrimers terminated with amino and poly(ethylene 
glycol) groups. Biomacromolecules 2007, 8, 1807-1811. 
 
37. Lu, Y.; Sun, B.; Li, C.; Schoenfisch, M. H., Structurally diverse nitric oxide-
releasing poly(propylene imine) dendrimers. Chem. Mater. 2011, 23, 4227-4233. 
 
38. Stasko, N. A.; Fischer, T. H.; Schoenfisch, M. H., S-Nitrosothiol-modified 
dendrimers as nitric oxide delivery vehicles. Biomacromolecules 2008, 9, 834-
841. 
 
39. Yang, Y.; Bajaj, N.; Xu, P.; Ohn, K.; Tsifansky, M. D.; Yeo, Y., Development of 
highly porous large PLGA microparticles for pulmonary drug delivery. 
Biomaterials 2009, 30, 1947-1953. 
 
40. Jameela, S. R.; Jayakrishnan, A., Glutaraldehyde cross-linked chitosan 
microspheres as a long acting biodegradable drug delivery vehicle: studies on the 
in vitro release of mitoxantrone and in vivo degradation of microspheres in rat 
muscle. Biomaterials 1995, 16, 769-775. 
 
41. Agrawal, C. M.; Ray, R. B., Biodegradable polymeric scaffolds for 
musculoskeletal tissue engineering. J. Biomed. Mater. Res., Part A 2001, 55, 141-
150. 
 
42. Rabea, E. I.; Badawy, M. E. T.; Stevens, C. V.; Smagghe, G.; Steurbaut, W., 
Chitosan as antimicrobial agent: Applications and mode of action. 
Biomacromolecules 2003, 4, 1457-1465. 
 
43. Chang, K. L. B.; Tai, M.-C.; Cheng, F.-H., Kinetics and products of the 
degradation of chitosan by hydrogen peroxide. Journal of Agric. and Food Chem. 
2001, 49, 4845-4851. 
 
77 
44. Carpenter, A. W. S., D.L.; Rao, K.S.; Schoenfisch, M.H., Influence of scaffold 
size on bactericidal activity of nitric oxide-releasing silica nanoparticles. ACS 
Nano 2011, 5, 7235-7244. 
 
45. Lu, Y.; Slomberg, D. L.; Sun, B.; Schoenfisch, M. H., Shape- and nitric oxide 
flux-dependent bactericidal activity of nitric oxide-releasing silica nanorods. 
Small 2013, 9, 2189-2198. 
 
46. Sun, B.; Slomberg, D. L.; Chudasama, S. L.; Lu, Y.; Schoenfisch, M. H., Nitric 
oxide-releasing dendrimers as antibacterial agents. Biomacromolecules 2012, 13, 
3343-3354. 
 
47. Wong, K.; Sun, G. B.; Zhang, X. Q.; Dai, H.; Liu, Y.; He, C. B.; Leong, K. W., 
PEI-g-chitosan, a novel gene delivery system with transfection efficiency 
comparable to polyethylenimine in vitro and after liver administration in vivo. 
Bioconjugate Chemistry 2006, 17 (1), 152-158. 
 
48. Tokura, S.; Ueno, K.; Miyazaki, S.; Nishi, N., Molecular weight dependent 
antimicrobial activity by chitosan. Macromolecular Symposia 1997, 120, 1-9. 
 
49. Coneski, P. N.; Schoenfisch, M. H., Nitric oxide release: Part III. Measurement 
and reporting. Chem. Soc. Rev. 2012, 41, 3753-3758. 
 
50. Hunter, R. A.; Storm, W. L.; Coneski, P. N.; Schoenfisch, M. H., Inaccuracies of 
nitric oxide measurement methods in biological media. Anal. Chem. 2013, 85, 
1957-1963. 
 
51. Silhavy, T. J.; Kahne, D.; Walker, S., The bacterial cell envelope. Cold Spring 
Harb. Perspect. Biol. 2010, 1-16. 
 
52. Mandell, G., Catalase, superoxide dismutase, and virulence of Staphylococcus 
aureus. In vitro and in vivo studies with emphasis on staphylococcal--leukocyte 
interaction. J. Clin. Invest. 1975, 55, 561-566. 
 
53. Gusarov, I.; Nudler, E., NO-mediated cytoprotection: Instant adaptation to 
oxidative stress in bacteria. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 13855-13860. 
 
54. Alberts, B.; Johnson, A.; Lewis, J., Molecular Biology of the Cell. 4th ed.; 
Garland Science: New York, 2002. 
 
55. Cooke, J. P.; Losordo, D. W., Nitric oxide and angiogenesis. Circulation 2002, 
105, 2133-2135. 
 
 
  
CHAPTER 3: ROLE OF NITRIC OXIDE-RELEASING SCAFFOLD 
PROPERTIES ON ANTIBACTERIAL EFFICACY AGAINST BIOFILM-BASED 
BACTERIA 
3.1 Introduction 
The prevalence of bacteria in clinical settings continues to pose a great challenge 
in treating and eradicating nosocomial (hospital-acquired) infections, with an estimated 
1.7 million infections resulting in ~99,000 deaths in the United States alone each year.1, 2 
Most infections are the result of biofilm-based bacteria that irreversibly adhere to a 
surface and secrete an exopolysaccharide (EPS) matrix.3 Bacteria utilize the EPS matrix 
to retain nutrients and impede the diffusion of antibacterial agents.2, 4 Antibiotic-
inactivating enzymes, anoxic regions, and the differentiation of cell subpopulations into a 
more resistant, dormant metabolic state4 are also employed by the biofilm bacteria to 
further prevent eradication. As a result, biofilm-based bacteria exhibit increased 
resistance to treatment and are less susceptible to antibacterial agents compared to 
planktonic suspensions.2, 5-7 In turn, complete eradication of bacterial biofilms is complex 
and often not feasible.1, 8, 9  
Ideally, implant-associated infections would be controlled by eliminating initial 
bacteria attachment to a surface and thus preventing biofilm formation of adherent cells.3 
However, superhydrophobic,10 heparin-coated,11 and antibacterial-doped substrates12, 13 
have not proven effective clinically in reducing infection rates.3 Researchers have thus 
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turned to more aggressive strategies involving the active release of antibacterial agents.14 
Nitric oxide (NO), a diatomic free radical, serves a number of roles in the body, including 
the immune response to pathogens, with antibacterial properties via oxidative and 
nitrosative stresses when sustained at mid-pM or higher concentrations.15-17 The effects of 
NO release on bacterial biofilms are generally concentration dependent, with biofilm 
dispersal occurring at low NO concentrations (~nM) and killing of the embedded bacteria 
at higher concentrations (~µM).18-20 Barraud et al. reported NO-mediated dispersal of 
Pseudomonas aeruginosa biofilms with exposure to 25–500 nM sodium nitroprusside, 
after which the bacteria were more susceptible to antibacterials (i.e., tobramycin, 
hydrogen peroxide, and sodium dodecyl sulfate).18 At greater NO-release levels (total 
release ~10 µmol NO) using an enzymatic gaseous NO-releasing dressing, Sulemankhil 
et al. reported the eradication of Acinetobacter baumannii, methicillin-resistant 
Staphylococcus aureus, and Pseudomonas aeruginosa biofilms (6 h exposure).19   
Due to enhanced delivery of NO compared to small molecule NO donors, our lab 
and others have focused on the synthesis of macromolecular NO donors including silica, 
metallic nanoparticles, and dendrimers.21 For example, N-diazeniumdiolate-modified 
silica nanoparticles were developed to deliver large NO payloads and kill planktonic 
bacteria.21, 22 Using such scaffolds, Hetrick et al. reported the bacterial killing property of 
N-diazeniumdiolate-modified silica nanoparticles (~100 nm) against Pseudomonas 
aeruginosa, Escherichia coli, Staphylococcus aureus, Staphylococcus epidermidis,  and 
Candida albicans biofilms.20 Nitric oxide released from the particles (~61 µmol/mL) 
eradicated >99% of the biofilm-embedded bacteria. Selective tuning of the 
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physicochemical properties of NO-releasing scaffolds to enhance killing of bacterial 
biofilms has not been investigated, although initial work with planktonic bacteria 
indicates that scaffold size,23 shape,24 and exterior functionality25 are important. 
3.1.1 Nitric oxide-releasing silica particles 
 As discussed in Chapter 2, silica nanoparticle size and shape proved influential in 
planktonic bacterial killing. Carpenter et al. reported improved killing of Pseudomonas 
aeruginosa with smaller (50 nm) silica particles.23 Lu et al. observed improved biocidal 
efficacy for rod-like particles vs. silica spheres.24 Herein, the role of NO-releasing silica 
nanoparticle size (i.e., 14, 50, 150 nm) and shape (i.e., aspect ratio 1, 4, and 8) on the 
eradication of established Gram-negative Pseudomonas aeruginosa and Gram-positive 
Staphylococcus aureus biofilms was investigated. Such studies are important since >99% 
of all bacteria exist in a biofilm state and such communities are increasingly difficult to 
treat.2 
 3.1.2 Nitric oxide-releasing dendrimers 
Nitric oxide-releasing dendrimers have also demonstrated biocidal action against 
planktonic bacteria as a function of physicochemical properties. Sun et al. reported the 
efficacy of NO-releasing PPI dendrimers against both P. aeruginosa and S. aureus as a 
function of size (i.e., generation) and exterior functionality.25 Enhanced bacterial killing 
was observed for the higher generation (i.e., G5), hydrophobic SO-modified dendrimers, 
however, the control PPI dendrimers were also toxic to mammalian cells (i.e., >80% 
viability reduction) at bactericidal concentrations. As such, NO-releasing amphiphilic 
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PAMAM dendrimers with varied exterior hydrophobicity were evaluated for maximum 
bactericidal efficacy against P.aeruginosa biofilms and minimal toxicity to healthy host 
cells.  
3.1.3 Nitric oxide-releasing chitosan oligosaccharides 
Similar to NO-releasing silica and dendrimer scaffolds, the exterior functionality 
of NO-releasing chitosan oligosaccharides (as detailed in Chapter 2) played a role in 
planktonic bacterial killing. However, significant differences in efficacy against P. 
aeruginosa were not observed for chitosan oligosaccharides of varied molecular weight 
(i.e., 2.5k, 5k, and 10k). Both NO-releasing and control chitosan scaffolds were non-toxic 
to L929 mouse fibroblasts at concentrations necessary to eradicate planktonic bacteria, 
thus necessitating their evaluation against more clinically-relevant bacterial biofilms.   
3.2 Materials and Methods 
Note: Silica nanorod, dendrimer, and chitosan synthesis, characterization, and 
evaluation of cytotoxicity were supported by other members of the Schoenfisch lab 
Tetraethylorthosilicate (TEOS), N-(6-aminohexyl)aminopropyltrimethoxysilane 
(AHAP), and N-(2-aminoethyl)-3-amino-isobutyl-dimethyl-methoxysilane (AEAI) were 
purchased from Gelest (Morrisville, PA). Cetyltrimethylammonium bromide (CTAB), 
propylene oxide (PO), and 1,2-epoxy-9-decene (ED) were obtained from Acros Organics 
(Geel, Belgium). Ethanol (EtOH), ammonium hydroxide (28 wt%), Tris base, and Tris 
hydrochloride were purchased from Fisher Scientific (Fair Lawn, NJ). Organosilicasol 
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MT-ST silica particles (14 nm) in methanol were obtained from Nissan Chemical 
Corporation (Houston, TX). Tetramethylorthosilicate (TMOS), sodium methoxide (5.4 M 
in methanol), sulfanilamide, N-1-napthylethylenediamine dihydrochloride, rhodamine B 
isothiocyanate  (RITC), propidium iodide (PI), fetal bovine serum (FBS), Dulbecco's 
Modified Eagle's Medium (DMEM), phenazine methosulfate (PMS), 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
inner salt (MTS), trypsin, phosphate buffered saline (PBS) used for cell culture, and Pen 
Strep solution (10,000 u/mL penicillin, 10,000 µg/mL streptomycin), medium molecular 
weight chitosan, 2-methyl aziridine (MAz), and poly(ethylene glycol) methyl ether 
acrylate (average Mn = 480) (PEG) were purchased from the Sigma Aldrich Corp. (St. 
Louis, MO). Tryptic soy broth (TSB) and tryptic soy agar (TSA) were obtained from 
Becton, Dickinson, and Company (Franklin Lakes, NJ). Pseudomonas aeruginosa 
(ATCC #19143) and Staphylococcus aureus (ATCC# 29231) were obtained from the 
American Type Culture Collection (Manassas, VA). The Centers for Disease Control and 
Prevention (CDC) bioreactor was purchased from BioSurface Technologies Corporation 
(Bozeman, Montana). Medical grade silicone rubber (1.45 mm thick) was purchased from 
McMaster Carr (Atlanta, GA) and doubled in thickness using Superflex Clear RTV 
silicone adhesive sealant (Loctite, Westlake, OH) to fabricate coupons to fit the CDC 
reactor (thickness ~4 mm and diameter ~12.7 mm). L929 mouse fibroblasts (ATCC 
#CCL-1) were purchased from the University of North Carolina Tissue Culture Facility 
(Chapel Hill, NC). Spectra/Por Float-A-Lyzers for dialysis of the dendrimers were 
purchased from Spectrum Laboratories, Inc. (Rancho Dominguez, CA). Syto 9 green 
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fluorescent nucleic acid stain was purchased from Life Technologies (Grand Island, 
NY).4,5-Diaminofluorescein diacetate (DAF-2 DA) was purchased from Calbiochem 
(San Diego, CA). Glass bottom microscopy dishes were received from MatTek 
Corporation (Ashland, MA). Nitric oxide (NO) was purchased from Praxair (Bethlehem, 
PA). Argon (Ar) gas was obtained from Airgas National Welders (Raleigh, NC). A 
Millipore Milli-Q UV Gradient A10 System (Bedford, MA) was used to purify distilled 
water   to   a   final   resistivity   of   18.2  MΩ·cm   and   a   total   organic   content   of   ≤6   parts   per  
billion (ppb). Other solvents and chemicals were analytical-reagent grade and used as 
received. Nuclear magnetic resonance (NMR) spectra were recorded on a 400 MHz 
Bruker instrument. Elemental (carbon, hydrogen, nitrogen or CHN) analysis was 
performed using a PerkinElmer Elemental Analyzer Series 2400 instrument (Waltham, 
MA). 
3.2.1 Synthesis of nitric oxide-releasing silica particles  
Three silica nanoparticle systems (i.e., 14, 50, and 150 nm) were utilized to 
evaluate anti-biofilm efficacy over a range of sizes. Secondary amine-functionalized 14 
nm silica particles were prepared via surface grafting according to a modified previously 
reported procedure.26 Briefly, 600 µL of 14 nm Organosilicasol MT-ST particles in 
methanol (225 mg/mL) and 1 mL N-(6-aminohexyl)aminopropyltrimethoxysilane 
(AHAP) were added to a stirred solution of EtOH (100 mL) and allowed to react 
overnight (~18 h) with heating (48 °C). The particles were collected by adding water to 
the solution in a 2:1 ratio (v/v) and centrifugation (4696 g for 15 min, 4 °C). Following 
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collection, the particles were resuspended in EtOH via sonication and collected again by 
centrifugation. This washing procedure was performed twice. The particles were then 
dried under vacuum. The 50 nm silica particles were synthesized by adding TEOS (2.28 
mL) to a stirred solution of EtOH (110 mL), ammonium hydroxide (4.05 mL), and water 
(1.74 mL). After 5 h, the 50 nm silica particles were surface-grafted with AHAP by 
adding an aliquot of the silane (5.02 mL) to the reaction flask and allowing the reaction to 
proceed overnight (~18 h). The particles were then collected by adding hexane to the 
solution in a 2:1 ratio (v/v) and centrifugation (4696 g for 15 min, 4 °C). Following 
collection, the 50 nm particles were resuspended in EtOH via sonication and collected 
again by centrifugation. This washing procedure was carried out twice. The particles 
were then dried under vacuum. Secondary amine-functionalized 150 nm silica particles 
were synthesized by adding TMOS (0.71 mL) and AHAP (1.17 mL) to a stirred solution 
of EtOH (59.16 mL), ammonium hydroxide (9.8 mL), and water (27.84 mL). After 2 h, 
the 150 nm particles were collected via centrifugation (4696 g for 15 min, 4 °C), washed 
with EtOH, and dried according to the aforementioned procedure.  
Silica particles of three distinct aspect ratios (AR1, AR4, and AR8) were 
synthesized via a surfactant-templated approach as previously described by varying 
reaction temperature and ammonia concentration.24 Elevated temperature (30 vs. 20 °C) 
was used to increase the aspect ratio of the particles (AR8), while a greater ammonia 
concentration (1.0 vs. 0.5 M) allowed for the synthesis of a more spherical particle 
(AR1). Of note, cetyltrimethylammonium bromide (CTAB) removal was confirmed via 
CHN analysis prior to surface grafting. Monoalkoxysilane, N-(2-aminoethyl)-3-amino-
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isobutyl-dimethyl-methoxysilane (AEAI) was then surface grafted onto the particle/rods 
to impart secondary amine functionality for N-diazeniumdiolation as described below. 
The 14, 50, and 150 nm silica particles were functionalized with N-
diazeniumdiolate NO donors by suspending the particles (20 mg) in a 9:1 (v/v) solution 
of N,N-dimethylformamide (DMF) and methanol (MeOH) and adding 37, 25, and 50 µL 
of 5.4 M sodium methoxide in MeOH for the 14, 50, and 150 nm particles, respectively. 
Vials of the solution suspensions were then placed in a Parr hydrogenation vessel and 
stirred. Residual oxygen in the suspensions was removed by purging the vessel with 
argon (Ar) three times quickly, followed by three longer (10 min) Ar purges. The vessel 
was then pressurized to 10 atm with purified gaseous NO. The hydrogenation vessel was 
maintained at 10 atm throughout a 3 d period after which the Ar purging procedure was 
repeated to remove unreacted NO prior to removal of the vials from the vessel. The N-
diazeniumdiolated particles were recollected by centrifugation (4696 g for 15 min, 25 
°C), washed three times with EtOH, dried under vacuum, and stored at -20 °C until use. 
Similarly, N-diazeniumdiolate-functionalized AR1, AR4, and AR8 silica particles were 
prepared by suspending the AEAI-functionalized particles (15 mg) in a 9:1 (v/v) solution 
of DMF and MeOH, and adding 50 µL sodium methoxide (5.4 M in MeOH). Vials of the 
suspensions were placed in the Parr hydrogenation vessel, purged with Ar, exposed to 
NO, and the resulting particles were recollected and stored following the same protocol.  
3.2.2 Synthesis of nitric-oxide releasing amphiphilic dendrimers 
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Secondary amine-functionalized PAMAM dendrimers (generation 1 or G1 and 
generation 3 or G3) were synthesized as described previously.27 Briefly, primary amine-
functionalized G1-PAMAM dendrimer (100 mg) was dissolved in methanol (2 mL). One 
molar equivalent of PO, ED, or a mixture of PO and ED relative to the primary amines 
was subsequently added to the G1-PAMAM-NH2 solution under constant stirring at room 
temperature for 4 d to yield secondary amine-functionalized G1-PAMAM conjugates. 
Secondary amine-functionalized G3-PAMAM conjugates were synthesized in a similar 
manner. The resulting G1- and G3-secondary amine-functionalized dendrimers were 
characterized by nuclear magnetic resonance (NMR) spectroscopy (data not shown). 
The PAMAM dendrimers were subsequently N-diazeiumdiolated by adding one 
equivalent of sodium methoxide (5.4 M in methanol) (with respect to the molar amount 
of primary amine functionality in PAMAM-NH2 used to synthesize dendrimers) to a vial 
containing dendrimers (100 mg) in methanol (1 mL). The glass vials were then inserted 
in a Parr hydrogenation vessel and exposed to gaseous NO following the aforementioned 
procedure for N-diazeniumdiolation of silica particles. 
3.2.3 Synthesis of nitric oxide-releasing chitosan oligosaccharides 
 Chitosan oligosaccharides of varied molecular weights were prepared by 
oxidative degradation using hydrogen peroxide. Medium molecular weight chitosan (2.5 
g) was suspended in a hydrogen peroxide solution (15 or 30 wt%) under stirring for 1 h at 
65–85 oC. After removal of undissolved chitosan via filtration, the chitosan 
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oligosaccharides were precipitated with acetone, collected by centrifugation, washed 
twice with ethanol, and dried under vacuum.  
The chitosan oligosaccharides were then grafted with 2-methyl aziridine (MAz) 
based on a previously reported procedure.28 Briefly, a mixture of concentrated HCl (11 
µL), water (100 µL) and MAz with a 1:1 (Chitosan 1) or 2:1 (Chitosan 2) molar ratio to 
primary amines on the chitosan oligosaccharides was added dropwise to a solution of 
chitosan oligosaccharides (100 mg) in deionized water (5 mL). The resulting solution was 
stirred at room temperature for 5 d, and then 75 oC for 24 h. The MAz-grafted chitosan 
oligosaccharides were then purified by dialysis and collected by lyophilization. The 
chitosan oligosaccharides were further functionalized with PEG by adding poly(ethylene 
glycol) methyl ether acrylate (Chitosan 3) to tune hydrophobicity. The resulting PEG-
functionalized chitosan oligosaccharides were purified by dialysis and collected by 
lyophilization. The chitosan oligosaccharides were characterized by nuclear magnetic 
resonance (NMR) spectroscopy (data not shown). 
N-diazeniumdiolation of the secondary amine-functionalized chitosan 
oligosaccharides (Chitosan 1, Chitosan 2, and Chitosan 3) was achieved by adding the 
chitosan and 5.4 M sodium methoxide (75 µL) to a water/methanol mixture (2 mL). The 
suspension was added to vials in a Parr hydrogenation vessel and exposed to gaseous NO 
as previously discussed. 
3.2.4 Fluorescently-labeled scaffolds 
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  Fluorescently-labeled silica nanoparticles,23 dendrimers,25 and chitosan 
oligosaccharides29 were achieved via covalent modification with rhodamine B 
isothiocyanate (RITC) based on a previously published procedures. The 14, 50, or 150 
nm silica particles (50 mg) were suspended in EtOH (100 mL) with RITC (5 mg) and 
stirred in the dark for 48 h. Following fluorescent modification, the particles were 
collected and washed copiously with EtOH using the collection/centrifugation protocol 
described above. After a clear supernatant was achieved, the particles were dried under 
vacuum and stored until use. Fluorescently-labeled dendrimers were prepared by 
dissolving G1 or G3-PAMAM-NH2 (100 mg) and RITC (3 mg) in methanol (2 mL). The 
solution was stirred for 3 d, dialyzed, and lyophilized to yield RITC-labeled dendrimers 
that were then modified with PO or ED alone, or a PO/ED mixture, and further reacted 
with NO. Chitosan oligosaccharides (50 mg) were dissolved in water (2 mL) at pH 9.0 
and RITC was added to the solution in a 1:100 molar ratio to the primary amine of the 
chitosan oligosaccharides prior to the grafting of 2-methyl aziridine. The solution was 
then stirred at room temperature for 3 d, dialyzed, and lyophilized to collect the RITC-
labeled chitosan oligosaccharides.  
3.2.5 Scaffold characterization and nitric oxide release  
Size and shape (i.e., aspect ratio) of the silica particles were determined using 
transmission electron microscopy (TEM) and scanning electron microscopy (SEM). 
Transmission electron micrographs of the 14, 50, and 150 nm silica particles were 
obtained on a JEOL 100 CX II transmission electron microscope (Tokyo, Japan). 
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Scanning electron micrographs of the AR1, AR4, and AR8 silica particles were recorded 
using a Hitachi S-4700 scanning electron microscope (Tokyo, Japan). Real-time NO-
release from the silica particles, dendrimers, and chitosan oligosaccharides was measured 
using a Sievers 280i Chemiluminesence Nitric Oxide Analyzer (NOA; Boulder, CO). The 
NO-releasing silica particles (1 mg), dendrimers (1 mg), or chitosan oligosaccharides 
(aliquot in water/methanol mixture) were added to a sample vessel containing 30 mL 
deoxygenated PBS (pH 7.4, 37 °C). Liberated NO was carried from the sample vessel to 
the NOA at a flow rate of 70 mL/min. To match the collection rate of the NOA (200 
mL/min), additional nitrogen flow was supplied to the sample vessel. Nitric oxide-release 
measurements were terminated when the levels fell below 10 ppb NO/mg scaffold. The 
real-time NO-release data was used to determine the total NO-release duration and half-
life (t1/2). Total NO storage (t[NO]) was also characterized using the Griess assay.30, 31 
3.2.6 Planktonic bactericidal assays 
 Pseudomonas aeruginosa and Staphylococcus aureus bacterial cultures were 
grown from frozen stock (-80 °C) in TSB overnight at 37 °C. An aliquot of the 
suspension (0.5 mL) was added to fresh TSB (50 mL) and incubated at 37 °C until the 
bacteria reached mid-exponential phase (~1 × 108 colony forming units (cfu)/mL) as 
determined by the optical density at 600 nm (OD600). The relationship between the 
concentration of the bacteria in suspension and the OD600 was calibrated for each strain 
using an Eppendorf BioPhotometer Plus Spectrophotometer (Hamburg, Germany); the 
colony forming units were enumerated from culture dilutions grown on TSA plates. The 
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bacterial suspension was then centrifuged (3645 g for 10 min, 25 °C), resuspended in 
PBS, and diluted to ~1 × 106 cfu/mL in PBS (dendrimer and chitosan oligosaccharide 
exposures) or PBS supplemented with 1% (w/w) glucose, 0.5% (v/v) TSB, and 100 mM 
Tris (silica nanoparticle exposures) for planktonic bactericidal assays. 
The minimum bactericidal concentration (MBC) of the NO-releasing silica 
particles for planktonic P. aeruginosa and S. aureus was defined as the concentration that 
resulted in a 3-log reduction in viability versus untreated cells after 24 h. The MBC of the 
NO-releasing dendrimers and chitosan oligosaccharides for planktonic P. aeruginosa was 
defined as the concentration that resulted in a 3-log reduction in viability versus untreated 
cells after 4 h. The bacterial suspensions (106 cfu/mL) were incubated with the NO-
releasing scaffolds over a range of particle concentrations for the duration noted. After 
exposure, the samples were nanomaterial–bacteria suspensions were diluted and plated 
on TSA, with counting of resulting colonies to determine viability. 
3.2.7 Bacterial biofilm assays  
A CDC bioreactor was used to grow P. aeruginosa and S. aureus biofilms over 48 
h.32 Growth conditions (e.g., nutrient concentrations, additives, flow rate) were optimized 
for both the P. aeruginosa and S. aureus biofilms. Briefly, medical grade silicone rubber 
substrates were mounted in the coupon holders within the CDC reactor. After 
autoclaving, the reactor effluent line was clamped and 500 mL sterile 1% (w/v) TSB (P. 
aeruginosa growth) or 10% (w/v) TSB and 0.1% (w/v) glucose (S. aureus growth) was 
added aseptically. Similar to planktonic experiments, P. aeruginosa and S. aureus 
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bacterial cultures were grown from frozen stock (-80 °C) overnight in TSB at 37 °C, 
reinoculated, and grown to mid-exponential phase. The reactor was then inoculated with 
an aliquot (1 mL) of the resulting 1 × 108 cfu/mL bacterial suspension (final 
concentration ~2 × 105 cfu/mL). The completed assembly was incubated at 37 °C for 24 h 
with stirring (150 rpm). Following   this   “batch   phase”   growth,   the   effluent   line   was  
opened and the reactor media was refreshed continuously with 0.33% (v/v) TSB at 6 
mL/min (P. aeruginosa growth) or 1% (v/v) TSB at 2.7 mL/min (S. aureus growth) for 
another 24 h to complete growth of the biofilms.  
The MBCs for biofilm eradication were determined as the concentrations of NO-
releasing silica particles, dendrimers, or chitosan oligosaccharides that resulted in 
bacterial viability below the limit of detection for the plate counting method (2.5 x 103 
cfu/mL).23 Each scaffold was tested in triplicate over an optimized concentration range. 
For determination of NO-releasing silica nanoparticle anti-biofilm efficacy, P. 
aeruginosa and S. aureus biofilms grown on silicone rubber substrates were exposed to 
several particle concentrations in 3 mL PBS supplemented with 1% (w/w) glucose, 0.5% 
(v/v) TSB, and 100 mM Tris at 37 °C with slight agitation for 24 h. Nitric oxide-releasing 
dendrimer and chitosan oligosaccharide anti-biofilm assays were conducted by exposing 
P. aeruginosa biofilms to several scaffold concentrations in PBS (static conditions) at 37 
°C with slight agitation for 24 h. After 24 h of incubation, the samples were sonicated 
and vortexed to disrupt the biofilm. Aliquots of the cell/nanoparticle suspensions were 
diluted in PBS, plated on TSA, and incubated at 37 °C overnight. Bacterial viability was 
then determined by counting the observed colonies.  
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3.2.8 Confocal microscopy  
P. aeruginosa biofilms were grown on glass substrates (Biosurface Technologies) 
and subsequently exposed to NO-releasing silica nanoparticles or dendrimers to evaluate 
intracellular NO levels and cell death. P. aeruginosa biofilms were incubated with NO-
releasing silica nanoparticles (1 mg/mL) in PBS supplemented with DAF-2 DA (10 µM) 
and PI (30 µM) for 15–60 min or RITC-labeled 14 or 150 nm control (i.e., non-NO-
releasing) silica nanoparticles (0.1 mg/mL) in PBS supplemented with Syto 9 (10 µM) 
for 30 min. Similarly, the efficiency of NO delivery was also evaluated as a function of 
dendrimer composition by incubating P. aeruginosa biofilms with NO-releasing 
dendrimers (20 µg/mL) in PBS supplemented with 10 μM  DAF-2  DA  and  30  μM  PI  for  
60 min. For examination of dendrimer diffusion within the biofilm, P. aeruginosa 
biofilms were incubated with RITC-labeled NO-releasing dendrimers (50 µg/mL) for 60 
min and stained with Syto 9 (10 µM) before imaging Likewise, RITC-labeled chitosan 
oligosaccharides (0.15 mg/mL in PBS) were incubated with P. aeruginosa biofilms for 
150 min. Before imaging, the substrates were dipped in PBS to remove excess dye and 
loosely adhered cells. A Zeiss 510 Meta inverted laser scanning confocal microscope 
(Carl Zeiss, Thornwood, NY) with a 488 nm Ar excitation laser (2.0% intensity) and a 
BP 505–530 nm filter was used to obtain DAF-2 and Syto 9 (green) fluorescence images. 
A 543 nm HeNe excitation laser (25.3% intensity) with a BP 560–615 nm filter was used 
to obtain PI and RITC (red) fluorescence images. The images were collected using a 
Zeiss C-apochromat lens (20x, 1.2 numerical aperture).  
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3.2.9 In vitro cytotoxicity  
L929 mouse fibroblasts were cultured in DMEM supplemented with 10% (v/v) 
FBS and 1 wt% Pen Strep solution, and incubated in 5% (v/v) CO2 under humidified 
conditions at 37 oC. After reaching 80% confluency, the cells were trypsinized, seeded 
onto tissue culture-treated polystyrene 96-well plates at a density of 3 × 104 cells/mL and 
incubated at 37 oC for 48 h. The supernatant was then aspirated prior to adding fresh 
DMEM (200  μL) with control (i.e., non-NO-releasing) or NO-releasing nanoparticles to 
each well. After incubation at 37 oC for 24 h, the supernatant was aspirated and the cells 
rinsed 3x with PBS. A mixture of DMEM/MTS/PMS (105/20/1, v/v/v) (120   μL) was 
then added to each well. The absorbance of the resulting colored solution after 1.5 h 
incubation at 37 oC was quantified at 490 nm using a Thermo Scientific Multiskan EX 
plate reader (Thermo Fisher Scientific, Inc., Waltham, MA). The mixture of 
DMEM/MTS/PMS and untreated cells were used as the blank and control, respectively. 
Cell viability was calculated by taking the ratio of the absorbance of treated to untreated 
cells after subtracting the absorbance of the blank from each.  
3.3 Results and Discussion 
3.3.1 Nitric oxide-releasing silica particles 
Although several studies have evaluated the effects of metal and metal oxide 
nanoparticle physicochemical properties on planktonic bacteria killing, 23, 24, 33-35 most 
bacteria exist in a biofilm state where the secreted EPS matrix impedes antibacterial 
agent diffusion and prevents eradication. In turn, the results of such studies must be 
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considered carefully, particularly with respect to antibacterial efficacy. The potential to 
realize an effective bacterial biofilm killing scaffold using NO-releasing silica 
nanoparticles warrants a detailed study of particle size and shape on bacterial biofilm 
eradication.  
Since smaller (<200 nm) NO-releasing silica nanoparticles were previously 
reported to be more bactericidal than larger scaffolds,23 experiments using particles 
spanning 14–150 nm were initiated to enable a thorough evaluation of anti-biofilm 
efficacy as a function of particle size.36, 37 The sizes of the as obtained/prepared particles 
measured by electron microscopy are provided in Table 3.1. Nitric oxide release was 
achieved by modifying the particles with N-(6-aminohexyl)aminopropyltrimethoxysilane 
(AHAP), and reacting the amines with NO. As expected based on the amount of sodium 
methoxide used in the N-diazeniumdiolation process, the three particle systems exhibited 
similar NO-release kinetics with total NO-release durations of ~5–6 h.  
To study the role of nanoparticle shape on NO-mediated bactericidal action, silica 
particles of varied aspect ratio (AR1, AR4, and AR8) were synthesized via a surfactant-
templating method in which aspect ratio (1.1 ± 0.2, 4.3 ± 0.5, and 8.2 ± 0.6 for the AR1, 
AR4, and AR8 particles, respectively) was controlled by tuning temperature and 
ammonia concentration.24 Similar to the spherical particles, the rod-like scaffolds were 
surface modified with N-(2-aminoethyl)-3-amino-isobutyl-dimethyl-methoxysilane 
(AEAI), and reacted with NO to obtain NO-releasing AR1, AR4, and AR8 silica 
particles. To ensure any differences in bactericidal action were the result of shape (i.e., 
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aspect ratio) alone, the overall particle volume (~0.02 µm3) and total NO release (~0.7 
µmol/mg) were tuned to be identical for each particle system (Table 3.2).24 
  
Scaffold Size 
(nm)
Total NO release
(µmol/mg)
14 nm 14.8 ± 2 0.24 ± 0.01
50 nm 56.1 ± 5 0.26 ± 0.02
150 nm 139.9 ± 13 0.25 ± 0.03
Table  3.1  Particle  size  as  determined  by  transmission  electron  microscopy  (TEM)  and  
total  micromoles  NO  released  per  mg  of  particle  as  measured  by  the  Griess  assay.  Size  
measurements  are  n≥20  and  total  NO  release  is  n≥3  syntheses.   
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Scaffold Aspect
Ratio
Length (nm) Width (nm) Total NO release
(µmol/mg)
AR1 1.1 ± 0.2 312 ± 26 285 ± 31 0.66 ± 0.14
AR4 4.3 ± 0.5 736 ± 49 170 ± 42 0.65  ± 0.04
AR8 8.2 ± 0.6 1115 ± 62 137 ± 45 0.68 ± 0.14
Table   3.2   Size   and   aspect   ratio   of   silica   nanorods   as   determined   by   scanning   electron  
microscopy  (SEM)  and  total  micromoles  NO  released  per  mg  of  particle  as  measured  by  the  
Griess  assay.  Size  measurements  are  n≥50  and  total  NO  release  is  n≥3  syntheses.   
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The three rod-like NO-releasing silica particles (i.e., AR1, AR4, and AR8) exhibited 
similar NO-release kinetics with NO-release half-lives of ~0.7 h. 
3.3.1.1 Bactericidal efficacy against planktonic bacteria as a function of size and shape 
Prior to evaluating the biofilm eradication ability of NO-releasing silica particles 
as a function of size, the bactericidal activity of 14, 50, and 150 nm NO-releasing silica 
was evaluated against planktonic P. aeruginosa and S. aureus suspensions. Minimum 
bactericidal concentration (MBC) assays were carried out over a 24 h period in bacteria 
solutions containing nutrients (i.e., PBS supplemented with 1% (w/w) glucose, 0.5% 
(v/v) TSB, and 100 mM Tris) to ensure survival of the bacteria and mimic conditions for 
the anti-biofilm assays. As expected, the smaller 14 and 50 nm particles were more 
effective against planktonic P. aeruginosa compared to the 150 nm silica particles 
(MBC24h of 0.5 mg/mL for the 14 and 50 nm versus 1 mg/mL for 150 nm) (Table 3.3). 
Likewise, the 14 nm particles were more effective against planktonic S. aureus compared 
to the larger particles, with an MBC24h of 2 versus 4 mg/mL for the 50 and 150 nm 
particles. As discussed in Chapter 2, the greater bactericidal NO doses necessary to kill S. 
aureus vs. P. aeruginosa (0.48–1.0 vs. 0.12–0.25 µmol NO/mL) are attributed to several 
factors including differential thickness of the peptidoglycan layer in the cell membrane,38 
varied production of antioxidant enzymes (e.g., superoxide dismutase) to mitigate the 
effects of NO,39 and S. aureus’  use  of  NO  as  a  cytoprotection  agent.40 
The planktonic bactericidal efficacy of the NO-releasing nanorods was evaluated 
similarly against P. aeruginosa and S. aureus suspensions. As reported previously in a 4 
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h assay,24 the higher aspect ratio AR8 particles were more effective at killing P. 
aeruginosa after 24 h than the AR4 and AR1 scaffolds (MBC24h values of 0.125, 0.250, 
  
P. aeruginosa S. aureus
Scaffold MBC24h(mg/mL)
Bactericidal NO 
Dose
(µmol/mL)
MBC24h
(mg/mL)
Bactericidal NO
Dose
(µmol/mL)
Planktonica Biofilmb Planktonic Biofilm Planktonica Biofilmb Planktonic Biofilm
14 nm 0.5 6 0.12 ± 5.0 x 10-3 1.44 ± 0.06 2 10 0.48 ± 2.0 x 10-2 2.40 ± 0.10
50 nm 0.5 6 0.13 ± 1.0 x 10-2 1.56 ± 0.12 4 12 1.0 ± 8.0 x 10-2 3.12 ± 0.24
150 nm 1 10 0.25 ± 3.0 x 10-2 2.50 ± 0.30 4 14 1.0 ± 1.2 x 10-2 3.50 ± 0.42
bMBC: Minimum Bactericidal Concentration resulting in bacterial viability below the limit of detection for the plating method (2.5 x 103 cfu/mL).
aMBC: Minimum Bactericidal Concentration resulting in 3-log reduction in bacterial viability.
Table  3.3  Determination  of  planktonic  and  biofilm  MBCs
  
and  bactericidal  NO  doses  for  
NO-releasing   14,   50,   and   150   nm   silica   particles   against  P.   aeruginosa      and  S.   aureus  
biofilms. 
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P. aeruginosa S. aureus
Scaffold MBC24h(mg/mL)
Bactericidal NO 
Dose
(µmol/mL)
MBC24h
(mg/mL)
Bactericidal NO
Dose
(µmol/mL)
Planktonica Biofilmb Planktonic Biofilm Planktonica Biofilmb Planktonic Biofilm
AR1 0.250 8 0.17 ± 3.2 x 10-2 5.28 ± 1.12 0.500 12 0.33 ± 7.0 x 10-2 7.92 ± 1.68
AR4 0.250 1 0.16 ± 1.0 x 10-2 0.65 ± 4.0 x 10-2 0.500 4 0.33 ± 2.0 x 10-2 2.60 ± 0.16
AR8 0.125 1 0.09 ± 1.8 x 10-2 0.68 ± 0.14 0.125 4 0.09 ± 1.8 x 10-2 2.72 ± 0.56
bMBC: Minimum Bactericidal Concentration resulting in bacterial viability below the limit of detection for the plating method (2.5 x 103 cfu/mL).
aMBC: Minimum Bactericidal Concentration resulting in 3-log reduction in bacterial viability.
Table   3.4   Determination   of   planktonic   and   biofilm  MBCs
  
and   bactericidal   NO   doses   for   NO-
releasing  AR1,  AR4,  and  AR8  silica  particles  against  P.  aeruginosa    and  S.  aureus  biofilms. 
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 and 0.250 mg/mL for the AR8, AR4, and AR1 particles, respectively) (Table 3.4).24 An 
identical trend in bactericidal action was noted against planktonic S. aureus with an 
MBC24h of 0.125 versus 0.500 mg/mL for the AR4 and AR1 particles. Slightly greater 
NO doses (0.09–0.33 µmol NO/mL) were also required for S. aureus killing compared to 
those for Gram-negative P. aeruginosa (0.09–0.17 µmol NO/mL). 
3.3.1.2 Biofilm killing assays as a function of size and shape  
The anti-biofilm efficacy of the particles/rods was evaluated next to assess their 
utility in eradicating bacteria under more clinically relevant conditions. P. aeruginosa (~3 
x 108 cfu per substrate) and S. aureus (~3 x 107 cfu per substrate) biofilms were exposed 
to NO-releasing 14, 50, and 150 nm silica particles for 24 h in PBS supplemented with 
1% (w/w) glucose, 0.5% (v/v) TSB, and 100 mM Tris buffer. Based on the size-
dependent efficacy against planktonic bacteria, we hypothesized that the smaller NO-
releasing particles would show enhanced biofilm killing compared to the larger particles.  
As shown in Table 3.3, the NO-releasing 14 and 50 nm particles proved more effective 
than the 150 nm particles, with concentrations as low as 6 mg/mL killing P. aeruginosa 
biofilms compared to 10 mg/mL for the 150 nm particles. As in the planktonic assays, the 
Gram-positive S. aureus biofilms required a greater NO dose for eradication compared to 
the Gram-negative P. aeruginosa biofilms, with MBC24h values of 10, 12, and 14 mg/mL 
for the 14, 50, and 150 nm particles, respectively. Overall, the smaller (i.e., 14 nm) silica 
particles were characterized by more effective killing of both P. aeruginosa and S. aureus 
biofilms compared to the 50 and 150 nm particles. The biofilm bactericidal NO doses 
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were ~10–12x those required for planktonic killing of P. aeruginosa, but only ~3–5x the 
NO levels required for planktonic killing of S. aureus. The increased NO dose necessary 
for P. aeruginosa biofilm eradication compared to S. aureus may arise from general 
differences  in  biofilm  formation,  cell  density,  and  the  biofilm’s  propensity  to  disperse.18, 
41, 42 Control (i.e., non-NO-releasing) 14, 50, and 150 nm particles did not significantly 
reduce P. aeruginosa biofilm viability (<1 log killing at their respective MBC 
concentrations). Control 50 and 150 nm particles slightly reduced S. aureus biofilm 
viability at their respective MBCs (~1.5 log), while the 14 nm control particles did not 
affect S. aureus cells (<1 log killing) at 10 mg/mL.  
Determination of the role of nanoparticle shape on P. aeruginosa and S. aureus 
biofilm killing showed a dependence on aspect ratio similar to that observed in 
planktonic studies. We hypothesized that higher particle aspect ratios (i.e., AR4 and 
AR8) would improve NO delivery to bacteria within the biofilm based on the planktonic 
assays.  As shown in Table 3.4, the 24 h MBCs for the NO-releasing AR8 and AR4 rod-
like particles were 1 and 4 mg/mL for P. aeruginosa and S. aureus biofilms, respectively. 
The more spherical, NO-releasing AR1 particles were significantly less effective, with 
biofilm MBCs of 8 and 12 mg/mL for P. aeruginosa and S. aureus. The biofilm 
bactericidal NO doses were ~4–31x those required for planktonic killing of P. aeruginosa 
and ~8–30x the NO levels required for planktonic killing of S. aureus. As mentioned 
above, these differences may arise from a variety of biological factors.18, 41, 42 Control 
AR1, AR4, and AR8 particles at their respective biofilm MBCs resulted in negligible 
reduction in P. aeruginosa biofilm viability (<1 log killing). However, the control 
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scaffolds resulted in a greater reduction in S. aureus biofilm viability at their respective 
biofilm MBCs (~2.5, 2, and 1.5 log killing for the AR1, AR4, and AR8 particles, 
respectively) due to the increased scaffold concentration required for eradication. Of 
note, the MBC values for the NO-releasing 14, 50, and 150 nm silica particles and the 
AR1, AR4, and AR8 nanorods must be evaluated independently due to differences in NO 
loading   capacity   between   the   particles   synthesized   via   the   Stӧber  method   (14,   50,   150  
nm) and surfactant-templated approach (AR1, AR4, AR8).23  
3.3.1.3 Confocal microscopy  
To determine whether the enhanced anti-biofilm efficacy observed for smaller 
particles (i.e., 14 and 50 nm) and higher aspect ratio nanorods (i.e., AR4 and AR8) was 
due to improved NO delivery, confocal microscopy was used to visualize intracellular 
NO concentrations and subsequent cell death. Intracellular NO levels were monitored by 
using 4,5-diaminofluorescein diacetate (DAF-2 DA), a membrane permeable dye that 
enters the cell and is then hydrolyzed to an impermeable form, DAF-2, via intracellular 
esterases.22 Once in the cell, DAF-2 will react with NO to form a green fluorescent 
derivative, triazolofluorescein, resulting in fluorescence that scales with NO 
concentration. Cell death was visualized using propidium iodide (PI), a dye that only 
permeates cells with compromised membranes; red fluorescence is produced upon 
binding with nucleic acids (i.e., DNA and RNA).43 The build-up of intracellular NO has 
previously been shown to precede PI signal at sub-MBC particle exposures.22, 44 
Intracellular NO levels and cell death were visualized for P. aeruginosa biofilms exposed 
to NO-releasing 14, 50, or 150 nm particles (1 mg/mL in a solution of PBS supplemented 
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30 min 60 min
DAF-2 PIDAF-2 PI
A
B
C
35 µm 28 µm
Figure   3.1   Fluorescent   images   of   P.   aeruginosa   biofilm   exposed   to   the   same   particle  
concentration  (1  mg/mL)  and  NO  dosage  (~250  µmol/L)  of  NO-releasing  (A)  14,  (B)  50,  or  (C)  
150  nm  particles  for  30  or  60  min.  DAF-2  green  fluorescence  indicates  increased  intracellular  NO  
and  PI  red  fluorescence  indicates  compromised  cell  membranes  (i.e.,  cell  death). 
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with DAF-2 DA and PI) for 30 or 60 min. Of  note,  intracellular  NO  levels,  cell  death,  and  
particle   diffusion   were   not   evaluated   for   S.   aureus   biofilms   as   killing   trends   were  
identical  to  P.  aeruginosa.  As shown in Figure 3.1, the DAF-2 (green) signal was greatest 
for the 14 nm scaffold after incubation with the NO-releasing particles. Such efficient 
delivery of NO also lead to more rapid cell death for the smallest silica particle NO-
release vehicle.   Greater   intracellular   NO   (i.e.,   green   fluorescence)   was   ultimately  
observed  within  the  P.  aeruginosa  biofilm  after  60  min  when  using  150  nm  NO-releasing  
particles,  despite  no  visible  cell  death  (red  fluorescence).  Conversely,  the  14  and  50  nm  
NO-releasing   particles   effectively   dispersed   the   P.   aeruginosa   biofilm   at   60   min,18  
resulting  in  decreased  DAF-2  and  PI  fluorescence  from  the  few  biofilm  cells  remaining  
on  the  substrate  (Figure  3.1). 
Intracellular   NO   levels   and   cell   death   were   also   measured   for   P.   aeruginosa  
biofilms  exposed  to  NO-releasing  particles  of  varied  aspect  ratio  (AR1–AR8).  Based  on  
confocal   experiments   with   planktonic   bacterial   suspensions,24   we   hypothesized   that  
increased  DAF-2   and   PI   fluorescence  would   also   be   observed   for   biofilms   exposed   to  
higher   aspect   ratio   scaffolds   due   to   improved   efficiency   of   NO   delivery.  As   shown   in  
Figure  3.2,  significant  DAF-2  and  PI  fluorescence  were  observed  throughout  the  entire  P.  
aeruginosa  biofilm  after  exposure  to  NO-releasing  AR4  or  AR8  particles  at  1  mg/mL  for  
15  min.  Although  intracellular  NO  and  cell  death  were  detected  for  the  biofilm  exposed  
to   the  NO-releasing  AR1   particles   (1  mg/mL),   the   fluorescence  was   localized   to   small  
regions  of  the  biofilm  (Figure  3.2).  Furthermore,  bacteria  killing  was  not  observed  until  
60  min.  Conversely,  the  visibility  of  the  DAF-2  and  PI  fluorescence  decreased  for  the 
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DAF-2 PI DAF-2 PI
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35 µm28 µm
Figure   3.2   Fluorescent   images   of  P.   aeruginosa   biofilm   exposed   to   the   same   particle  
concentration  (1  mg/mL)  and  NO  dosage  (~700  µmol/L)  of  NO-releasing  (A)  AR1,  (B)  
AR4,   or   (C)   AR8   particles   for   15   or   60   min.   DAF-2   green   fluorescence   indicates  
increased   intracellular   NO   and   PI   red   fluorescence   indicates   compromised   cell  
membranes  (i.e.,  cell  death).   
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NO-releasing   AR4   and   AR8   nanorods   at   the   60   min   timepoint   due   to   effective   P.  
aeruginosa  biofilm  dispersal.18   
The   role   of   particle   diffusion   into   the   biofilm  on  bacteria   killing  was   evaluated  
next   to   understand   if   the   vehicle   or   just  NO   penetrated   the   biofilms. To carry out this 
study, the biofilm was stained with a membrane-permeable dye, Syto 9, to enable 
visualization of the biofilm bacteria.45 P. aeruginosa biofilms were incubated with RITC-
labeled  14  and  150  nm  control  particles   (0.1  mg/mL)   for  30  min,  and   then   rinsed  with  
PBS   to   determine   whether   the   particles   could   penetrate   and   diffuse   into   the   biofilm.  
Although  particle  diffusion  into  the  P.  aeruginosa  biofilm  was  observed  for  both  the  14  
and  150  nm  RITC-labeled  particles,  more  significant  RITC  (red)  fluorescence  was  noted  
for  the  14  nm  particles,  indicating  faster  diffusion  for  the  smaller  vs.  larger  particles  at  30  
min   (Figure  3.3).  Comparison  of   the  biofilm   regions   stained  with  Syto  9   to   those  with  
RITC  fluorescence  also  confirmed  that  the  150  nm  particles  did  not  adequately  penetrate  
the  P.  aeruginosa  biofilm.  Of  note,  the  rod-like  particles  were  too  large  (e.g.,  AR1  ~300  
nm)46   to   readily   diffuse   into   the   biofilm,   and   thus   particle–biofilm   associations   for   the  
nanorods  were  not  visualized.   
3.3.1.4 In vitro cytotoxicity  
The utility of NO-release scaffolds for eradicating biofilms will be governed by 
both their ability to kill bacteria and not impact healthy host cells or tissue. To assess 
cytotoxicity, we exposed L929 mouse fibroblasts to NO-releasing and control silica 
particles. L929 mouse fibroblasts were selected as a model host cell due to their 
ubiquitous presence in connective tissue.47 Normalized cell viability was determined after 
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B
RITC Syto 9
28 µm
Figure  3.3  Fluorescent  images  of  RITC-modified  (A)  14  and  (B)  150  nm  control  particle  (0.1  
mg/mL)   diffusion   in   P.   aeruginosa   biofilm   30   min   after   particle   addition.   Green   Syto   9  
fluorescence   shows   biofilm   cells.   Increased  RITC   red   fluorescence   indicates  more   efficient  
particle  diffusion  within  biofilm. 
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a 24 h exposure using the MBCs for P. aeruginosa and S. aureus biofilm eradication. As 
shown in Figure 3.4, the NO-releasing 50 nm, AR4, and AR8 particles were non-toxic to 
the L929 fibroblasts at the MBCs necessary to eradicate P. aeruginosa biofilms, with 
~30, 22, and 15% reduction in fibroblast viability, respectively. Likewise, control 50 nm, 
AR4, and AR8 particles did not greatly impact the L929 cells at these concentrations. The 
cytotoxicity of both control and NO-releasing scaffolds was significantly greater for all 
other particle systems (e.g., 14  and  150  nm  and  AR1  particles)  at  the  concentrations  (≥6  
mg/mL) necessary to kill P. aeruginosa biofilms. Similarly, Hetrick et al. reported 
significantly reduced fibroblast viability for both control and NO-releasing silica particles 
at 8 mg/mL (50 and 70% reductions, respectively).20 At concentrations necessary to 
eradicate S. aureus biofilms, all particle systems proved cytotoxic (36–71% viability 
reduction). Overall, the NO-releasing particles decreased fibroblast viability to a greater 
extent than control systems at the MBCs for S. aureus killing, which might be expected 
given the increased concentration of both scaffold and NO required to eradicate S. aureus 
biofilms. Despite the greater scaffold concentration required to eradicate S. aureus 
biofilms, the fibroblast viabilities for control particles at MBCs for P. aeruginosa and S. 
aureus were identical, indicating that the greater NO-release levels play a significant role 
in the observed toxicity.  
3.3.1.5 Conclusions 
 Despite the moderate cytotoxicity observed for the NO-releasing silica scaffolds 
at concentrations necessary for biofilm eradication, this work successfully demonstrates 
the benefits of NO as an anti-biofilm agent. Both particle size and shape clearly play 
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Figure  3.4  Cytotoxicity  of  NO-releasing  (white)  and  control  (gray)  silica  particles  against  
L929   mouse   fibroblasts   at   MBC   concentrations   required   for   biofilm   killing   listed   in  
Tables  3  and  4;;  (A)  P.  aeruginosa  and  (B)  S.  aureus. 
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important roles in biofilm eradication, with smaller sizes and higher aspect ratios being 
most effective.  The use of NO can effectively eradicate P. aeruginosa and S. aureus 
biofilms at concentrations only 3–31x those required for planktonic killing with minimal 
concern about antibacterial resistance.48 In contrast, other anti-biofilm agents (e.g., 
antibiotics) exhibit significantly decreased efficacy toward biofilm bacteria and often 
promote resistance upon repeated exposure.2 Future work should focus on reducing the 
toxicity of the NO-release scaffolds to healthy cells and tissue. Additionally, the 
combination of NO with other antibacterial agents (e.g., antibiotics, silver) should be 
explored, as biofilm dispersal by low, non-toxic levels of NO is likely to make the action 
of current antibiotics more effective.  
3.3.2 Nitric oxide-releasing amphiphilic dendrimers 
The bactericidal efficacy of NO-releasing dendrimers as a function of exterior 
functionality has previously been demonstrated.49 Functionalization with hydrophobic 
groups (e.g., SO) at the dendrimer exterior improved bactericidal efficacy, but also 
resulted in significant toxicity towards mammalian cells (~80% reduction in viability) 
even at low concentrations (< 50 µg/mL). Thus, NO-releasing amphiphilic dendrimers 
with tunable exterior hydrophobicity were synthesized to evaluate the impact of 
dendrimer structure on both bactericidal action and cytotoxicity.  
In addition to PO and ED-modified dendrimers, the feed molar ratio of PO and 
ED was tuned to yield PO/ED ratios of 7:3 (i.e., G1-PE 73, G3-PE 73), 5:5 (i.e., G1-PE 
55), and 3:7 (i.e., G1-PE 37) to study the effects of relative hydrophobicity on biofilm 
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eradication and cytotoxicity. As noted in Chapter 2, dendrimer size (i.e., dendrimer 
generation) plays a significant role in antibacterial activity, with higher generation (e.g., 
G5 versus G2) NO-releasing dendrimers being more effective due to the greater 
concentration of N-diazeniumdiolates at the dendrimer surface.49 Thus, two sizes of 
amphiphilic dendrimers (i.e., G1 and G3) were utilized to understand the influence of 
dendrimer size on the eradication of P. aeruginosa biofilms. Of note, the dendrimers 
exhibited similar NO storage (~1 µmol/mg) and NO-release kinetics (i.e., half -life ~1 h) 
regardless of modification. Prior to evaluating the NO-releasing amphiphilic dendrimers 
against bacterial biofilms, the dendrimers were first tested against planktonic bacteria to 
confirm efficacy.  
3.3.2.1 Bactericidal efficacy against planktonic bacteria as a function of exterior 
functionality 
Planktonic P. aeruginosa was exposed to control and NO-releasing dendrimers 
over 4 h (static conditions) to evaluate the effects of the varied hydrophobicity (i.e., 
PO/ED ratio) on bacterial killing. Amphiphilic control dendrimers functionalized with 
ED alone or a PO/ED mixture (e.g., G1-ED, G1-PE 37, G1-PE 55, G1-PE 73) exhibited 
enhanced biocidal activity against planktonic P. aeruginosa compared to the more 
hydrophilic PO-modified dendrimers (Table 3.5).  
3.3.2.2 Biofilm killing assays as a function of function of exterior functionality 
112 
  
Dendrimer
Bactericidal NO Doses
(nmol/mL)
G1-ED 3.55 
G1-PE 37 3.72
G1-PE 55 7.70 
G1-PE 73 17.6 
G1-PO 182 
G3-PE 73 13.4 
Table  3.5.  Bactericidal  doses  (3-log  reduction  in  bacterial  viability)  for  NO-releasing  
dendrimers    against  planktonic  Gram-negative  P.  aeruginosa  after  4  h  exposure. 
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While planktonic killing assays are important in evaluating potential antibacterial 
agents, most medically-relevant infections arise from biofilm-based bacteria.50 Thus, P. 
aeruginosa biofilms were exposed to a range of NO-releasing dendrimer concentrations 
(10–800 µg/mL) for 24 h. Similar to the planktonic P. aeruginosa bactericidal assays, the 
amphiphilic control dendrimers (G1-PE 73, G1-PE 55, G1-PE 37, and G1-ED) proved 
more effective in eradicating the biofilm compared to the hydrophilic dendrimer (G1-
PO). The MBCs for the NO-releasing dendrimers were 800, 80, 20, 10, and 15 µg/mL for 
the G1-PO-NO, G1-PE 73-NO, G1-PE 55-NO, G1-PE 37-NO, and G1-ED-NO 
dendrimers, respectively. Of the dendrimers evaluated, G1-PE 37-NO exhibited the 
greatest anti-biofilm efficacy (i.e., lowest MBC). To determine if the enhanced G1-PE-
37-NO antibacterial activity was due to more thorough diffusion within the biofilm, the 
association of G1-PE 73-NO, G1-PE 37-NO, and G1-ED-NO dendrimers and P. 
aeruginosa biofilms was characterized using confocal microscopy. As shown in Figure 
3.5, a greater number of bacteria in the biofilms exhibited red fluorescence upon 
incubation with RITC-labeled G1-PE 37-NO compared to the biofilm incubated with G1-
PE 73-NO. Hydrophobic dendrimers generally exhibit improved bacteria association due 
to favorable electrostatic effects. However, the more hydrophobic G1-ED-NO dendrimer 
was not as effective in associating with the bacterial biofilm, likely due to less efficient 
penetration through the EPS.51  
 The G1-PE 37-NO dendrimer proved to be the most effective in eradicating the 
P. aeruginosa biofilm due to its improved association with bacterial cells and diffusion 
within the biofilm. Of note, dendrimer size did not appear to significantly impact 
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Figure   3.5  Confocal  microscopy   images   of  P.   aeruginosa   biofilms   incubated  with   (A)  
G1-PE-37-NO,  (B)  G1-ED-NO,  (C)  G1-PE  73-NO,  and  (D)  G3-PE  73-NO  RITC-labeled  
dendrimers   for   1   h   (50   µg/mL).   Increased   red   fluorescence   indicates   more   efficient  
dendrimer–bacteria  association  and  improved  diffusion.  Scale  bar  is  300  µm. 
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 bacterial association with the P. aeruginosa biofilm. Although G3-PE 73-NO exhibited 
similar association with the biofilm compared to G1-PE 73-NO, greater intracellular NO 
levels (DAF-2 fluorescence) were observed for biofilms incubated with the larger G3 
dendrimers, indicating enhanced NO delivery efficiency (Figure 3.6). The increased 
concentration of N-diazeniumdiolates at the G3 dendrimer surface may facilitate more 
localized NO delivery, thus improving bactericidal efficacy even if the dendrimer–
bacteria association is similar to the smaller G1 systems.  
3.3.2.3 In vitro cytotoxicity 
Both control and NO-releasing dendrimers were evaluated for cytotoxicity toward 
L929 mouse fibroblasts at concentrations necessary for P. aeruginosa biofilm 
eradication. As expected, the more hydrophobic dendrimers (e.g., G1-ED-NO and G1-PE 
37-NO) exhibited greater cytotoxicity (i.e., ~70% cell viability reduction) after 24 h. 
Dendrimers with intermediate ratios of PO/ED (e.g., G1-PE 55-NO and G1-PE 73-NO) 
were non-cytotoxic at the biofilm MBCs, supporting their potential future therapeutic use 
compared to other scaffolds. 
3.3.2.4 Conclusions  
The bactericidal efficacy of NO-releasing amphiphilic dendrimers was 
demonstrated to be a function of dendrimer exterior functionality (i.e., hydrophobicity) 
and dendrimer size (i.e., generation). The dendrimer hydrophobicity significantly 
influenced association and diffusion within the biofilm, as well as the efficiency of 
intracellular NO delivery. Dendrimers modified with approximately equal ratios of the 
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Figure   3.6      Confocal   microscopy   images   of   intracellular   DAF-2   fluorescence   in   P.  
aeruginosa  biofilms  incubated  with  (A)  G1-  and  (B)  G3-PE  73-NO  for  1  h  (20  µg/mL)  
Green  DAF-2   fluorescence   indicates      increased   intracellular  NO   levels.  Scale  bar   is  50  
µm.   
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hydrophilic PO and hydrophobic ED groups were found to successfully eradicate the P. 
aeruginosa biofilms at concentrations that were also non-toxic to healthy host cells. 
3.3.3 Nitric oxide-releasing chitosan oligosaccharides 
Chitosan has been widely used in antibacterial and wound healing applications 
due to its non-toxic, biodegradable scaffold.52-55 In Chapter 2, the synthesis of NO-
releasing chitosan oligosaccharides for use as antibacterial agents was presented. The 
Chitosan 1/NO, Chitosan 2/NO, and Chitosan 3/NO scaffolds were evaluated for any 
molecular weight and exterior functionality dependence on killing of P. aeruginosa 
biofilms in addition to the previous results obtained for planktonic cells. 
3.3.3.1 Bactericidal efficacy against planktonic bacteria as a function of exterior 
functionality and molecular weight 
As discussed in Chapter 2, planktonic P. aeruginosa cells were exposed to a range 
of concentrations of NO-releasing chitosan oligosaccharides (e.g., Chitosan 1/NO -5k, 
Chitosan 2/NO-5k, Chitosan 3/NO -5k) to evaluate their ability to kill bacteria. The 
neutral PEG-modified chitosans were less effective in killing due to poor association with 
the bacteria. Molecular weight did not play a role in the bactericidal efficacy of Chitosan 
2-2.5k, 5k, or 10k, however it was hypothesized that a greater dependence may be 
observed against biofilms. 
3.3.3.2 Biofilm killing assays as a function of nitric oxide-releasing chitosan exterior 
functionality and molecular weight 
Pseudomonas aeruginosa biofilms were exposed to a range of concentrations of 
NO-releasing chitosan oligosaccharides (0.2–1.3 mg/mL) for 24 h. After 24 h, the 
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biofilms were disrupted and cell/chitosan suspensions were diluted and plated to 
determine bacterial viability.56565656 The biofilm MBC (5-log reduction) was 400, 700, 
and 1000 µg/mL for Chitosan 2/NO-5k, Chitosan 1/NO-5k, and Chitosan 3/NO-5k, 
respectively. Chitosan 2/NO-5k exhibited the greatest anti-biofilm efficacy, attributed to 
its increased NO storage and rapid association with the negatively-charged bacteria 
(Chapter 2, Figure 2.8). Chitosan 1/NO-5k and Chitosan 3/NO-5k stored similar amounts 
of NO (~0.3 µmol/mg); however, less Chitosan 1/NO-5k was necessary (700 µg/mL) to 
completely eradicate the biofilm compared to Chitosan 3/NO-5k (1000 µg/mL). Reduced 
efficacy of Chitosan 3/NO-5k was likely due to less association between the neutral PEG 
chains and the bacterial membrane. To confirm this hypothesis, the association of RITC-
Chitosan 2/NO-5k and RITC-Chitosan 3/NO-5k with the P. aeruginosa biofilm was 
evaluated using confocal microscopy. As shown in Figure 3.8, biofilms incubated with 
RITC-Chitosan 2/NO-5k exhibited more intense red fluorescence compared to RITC-
Chitosan 3/NO-5k, thus confirming the lessened association of the chitosan modified 
with the neutral PEG chain.  
Although chitosan molecular weight did not play a significant role in planktonic 
killing of P. aeruginosa, reduced bactericidal efficacy was observed for Chitosan 2/NO-
10k compared to Chitosan 2/NO-2.5k (600 µg/mL vs. 400 µg/mL for Chitosan 2/NO-10k 
and Chitosan 2/NO-2.5k, respectively) against biofilms. The exopolysaccharide (EPS) 
matrix of the bacterial biofilm likely slows the diffusion of the Chitosan 2/NO-10k into 
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Figure   3.7   Confocal   fluorescence   images   of   RITC-labeled   chitosan   oligosaccharide  
association  with  P.  aeruginosa  biofilms:  A)  Chitosan  2/NO-5k,  B)  Chitosan  3/NO-5k,  C)  
Chitosan  2-10k)  and  images  of  Syto  9  labeled  biofilms  incubated  with  D)  Chitosan  2/NO-
5k,   E)  Chitosan   3/NO-5k   and   F)  Chitosan   2/NO-10k.   Scale   bar   is   40   µm.  The   Syto   9  
(green)   fluorescence   shows   biofilm   cells.   Increased   RITC   (red)   fluorescence   indicates  
more  efficient  chitosan  diffusion  within  the  biofilm.   
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the biofilm, thus reducing antibacterial activity. Previous studies have observed less 
efficient EPS penetration of high-molecular weight dextran compared to the low-
molecular weight polymer.57 This hypothesis was further confirmed with confocal 
microscopy by comparing chitosan–bacteria association as a function of molecular 
weight. Indeed, when P. aeruginosa biofilms were exposed to both RITC-Chitosan 
2/NO-2.5k and RITC-Chitosan 2/NO-10k, increased red fluorescence and diffusion 
within the biofilm was observed for the lower molecular weight scaffold (Figure 3.8). 
3.3.3.3 In vitro cytotoxicity  
Control and NO-releasing chitosan oligosaccharides were evaluated for 
cytotoxicity using L929 mouse fibroblasts and found to be non-toxic, even at the MBCs 
necessary for biofilm eradication. Similar to cytotoxicity results evaluated at the 
planktonic MBC concentrations, fibroblast proliferation was observed for some NO-
releasing chitosans.58 The potent antibacterial activity and minimal toxicity of the NO-
releasing chitosan oligosaccharides warrants further examination into their use as 
antibacterial therapeutics.  
3.3.3.4 Conclusions 
The NO-releasing chitosan oligosaccharides presented herein allowed for 
diffusion into P. aeruginosa biofilms and association with bacteria cells, resulting in 
complete biofilm eradication at concentrations eliciting no significant toxicity against 
healthy host cells. This study demonstrated the great potential of NO-releasing chitosan 
oligosaccharides as future therapeutics. 
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CHAPTER 4: ROLE OF DENDRIMER NITRIC OXIDE-RELEASE KINETICS 
IN ERADICATION OF PLANKTONIC BACTERIA AND BIOFILMS 
4.1 Introduction 
The ubiquitous presence of bacteria in clinical settings has necessitated the 
development of antibacterial agents to combat infections associated with open wounds 
and implanted medical devices,1-3 as well as infections resulting from persistent 
conditions such as diabetes mellitus4 and cystic fibrosis.1, 5-7 Although many antibacterial 
agents have proven effective against planktonic (i.e., free-floating) bacteria, medically-
relevant infections generally arise from the formation of complex bacterial biofilm 
communities.6 Several factors contribute to the observed antibacterial resistance of 
biofilms compared to planktonic suspensions, including slow antibacterial penetration 
through the layers of self-secreted extracellular polymeric substances (EPS), 
differentiation of biofilm cells into a resistant phenotype, and reduced antibacterial action 
in altered microenvironments (e.g., regions of nutrient depletion).7-12 Strategies for 
preventing bacterial biofilm formation and eradicating established biofilms while 
minimizing the development of resistance are thus warranted. 
 While antibiotics (e.g., vancomycin and ciprofloxacin),13 antimicrobial 
peptides,14 silver ions,15, 16 and dendrimers17 have proven effective against biofilms, 
recent research has focused on the importance of tailoring antibacterial 
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pharmacodynamics for maximum eradication and prevention of bacteria re-growth.18-23 
As such, several labs have evaluated bacterial biofilm formation and eradication as a 
function of antibacterial-release kinetics.23-28 For example, Cheow et al. studied the 
influence of levofloxacin-release rate from nanoparticles against E. coli biofilms.19 The 
antibiotic-release profile was deemed to be equally as important as total dosage in biofilm 
eradication, suggesting that a biphasic release profile is optimal for maximum killing and 
prevention of biofilm re-growth while minimizing the potential for antibiotic tolerance. 
Similarly, antimicrobial peptide (i.e., ponericin G1) release from polyelectrolyte 
multilayer films with both burst- and linear-release profiles was investigated against S. 
aureus biofilms.27 Biphasic release was again preferential where a large initial bolus 
rapidly eradicated cells, and subsequent smaller doses eliminated any residual bacteria. 
Despite the demonstrated killing potential of these antibacterials, continued concerns 
over resistance preclude their long-term therapeutic utility.29 Bacteria have developed 
resistance to antibiotics and antimicrobial peptides through a myriad of mutations29 and 
modification of cell surface charge.30, 31 Therefore, even if antibacterial 
pharmacodynamics can be controlled, complete eradication of planktonic bacteria and 
biofilms is complex and new antibacterials that do not foster resistance are urgently 
needed.1, 32, 33  
Nitric oxide (NO), an endogenously-produced radical, is a broad-spectrum 
antibacterial generated by the immune system to exert bacterial membrane damage 
through both oxidative and nitrosative stresses.34-36 Bacterial resistance to NO is unlikely 
given its dual-mechanistic action and small structure. Privett et al. observed no increase 
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in resistance to exogenous NO treatment for S. aureus, methicillin-resistant S. aureus, S. 
epidermidis, E. coli, or P. aeruginosa cells after exposure to sub-inhibitory 
concentrations through 20 d.37 As noted in Chapter 3, the effects of NO release on 
bacterial biofilms are concentration dependent, with low NO concentrations (~nM) 
resulting in biofilm dispersal and higher concentrations (~µM) killing the embedded 
bacteria.38-40 Due to the reactive nature of NO, macromolecular NO donors including 
silica, metallic nanoparticles, and dendrimers have been designed to enhance localized 
delivery to the site of infection.41 For example, N-diazeniumdiolate-modified silica 
nanoparticles and dendrimers that store large NO payloads have demonstrated efficacy 
against both planktonic bacteria and biofilms.40, 42, 43 Selective tuning of NO-release 
kinetics for bacterial eradication has not yet been investigated, although initial work 
indicates the importance of NO-release profiles in bactericidal efficacy.40 Hetrick et al. 
observed increased efficacy of NO-releasing N-methylaminopropyltrimethoxysilane 
(MAP3) silica particles (~6 min half-life) against P. aeruginosa biofilms compared to N-
(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3) particles (~18 min half-life). The 
increased anti-biofilm efficacy for the more rapid NO-releasing MAP3 particles may 
suggest that large initial bursts of NO are preferred; however, the MAP3 and AHAP3 
systems exhibited varied total NO storage (~7.6 and 3.8 µmol/mg, respectively), and thus 
bacterial killing as a function of NO-release kinetics cannot be directly determined using 
these systems. 
Ideal systems for determining the effects of NO-release kinetics on bactericidal 
efficacy would exhibit a range of half-lives while maintaining similar total NO storage. 
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As such, four NO-releasing poly(amidoamine) (PAMAM) dendrimer scaffolds with 
varied half-lives (~0.9–3.5 h) and similar 24 h NO storage (~1.8 µmol/mg) were utilized 
to evaluate the role of NO-release kinetics on bacterial killing. The goal was to evaluate 
the optimal NO-release profile (i.e., burst or sustained release) for eradication of 
planktonic and biofilm-based Gram-negative Pseudomonas aeruginosa and Gram-
positive Staphylococcus aureus bacteria.  
4.2 Materials and Methods 
Note: Dendrimer synthesis, characterization, and cytotoxicity evaluation were 
supported by other members of the Schoenfisch lab 
Sodium methoxide (5.4 M in methanol), rhodamine B isothiocyanate  (RITC), 
propidium iodide (PI), fetal bovine serum (FBS), Dulbecco's Modified Eagle's Medium 
(DMEM), phenazine methosulfate (PMS), 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium inner salt (MTS), trypsin, 
phosphate buffered saline (PBS) used for cell culture, and Pen Strep solution (10,000 
u/mL penicillin, 10,000 µg/mL streptomycin) were purchased from the Sigma Aldrich 
Corp. (St. Louis, MO). Propylene oxide (PO) and acrylonitrile (ACN) were obtained 
from Acros Organics (Geel, Belgium). Spectra/Por Float-A-Lyzers for dialysis of the 
dendrimers were purchased from Spectrum Laboratories, Inc. (Rancho Dominguez, CA). 
Tryptic soy broth (TSB) and tryptic soy agar (TSA) were obtained from Becton, 
Dickinson, and Company (Franklin Lakes, NJ). Pseudomonas aeruginosa (ATCC 
#19143) and Staphylococcus aureus (ATCC# 29231) were obtained from the American 
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Type Culture Collection (Manassas, VA). The Centers for Disease Control and 
Prevention (CDC) bioreactor was purchased from BioSurface Technologies Corporation 
(Bozeman, Montana). Medical grade silicone rubber (1.45 mm thick) was purchased from 
McMaster-Carr (Atlanta, GA) and doubled in thickness using Superflex Clear RTV 
silicone adhesive sealant (Loctite, Westlake, OH) to fabricate coupons to fit the CDC 
reactor (thickness ~4 mm and diameter ~12.7 mm). L929 mouse fibroblasts (ATCC 
#CCL-1) were purchased from the University of North Carolina Tissue Culture Facility 
(Chapel Hill, NC). Syto 9 green fluorescent nucleic acid stain was purchased from Life 
Technologies (Grand Island, NY). 4,5-Diaminofluorescein diacetate (DAF-2 DA) was 
purchased from Calbiochem (San Diego, CA). Nitric oxide (NO) was purchased from 
Praxair (Bethlehem, PA). Argon (Ar) gas was obtained from Airgas National Welders 
(Raleigh, NC). A Millipore Milli-Q UV Gradient A10 System (Bedford, MA) was used 
to purify distilled water to a final resistivity of 18.2 MΩ·cm  and  a  total  organic  content  of  
≤6   parts   per   billion   (ppb). Other solvents and chemicals were analytical-reagent grade 
and used as received. 
4.2.1 Synthesis of secondary amine-functionalized PAMAM dendrimers  
Secondary amine-functionalized PAMAM dendrimers (generation 3 or G3) were 
synthesized as described previously.44 Briefly, primary amine-functionalized G3-
PAMAM dendrimers (100 mg) were dissolved in methanol (1 mL). One molar equivalent 
of PO, ACN, or a mixture of PO and ACN relative to the primary amines was then added 
to the G3-PAMAM-NH2 solution under constant stirring at room temperature for 3 d to 
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yield the secondary amine-functionalized G3-PAMAM conjugates. Solvent and 
unreacted PO or ACN were removed under reduced pressure. The resulting secondary 
amine-functionalized dendrimers were characterized by nuclear magnetic resonance 
(NMR) spectroscopy in deuterated methanol (data not shown). 
4.2.2 N-diazeniumdiolation of secondary-amine functionalized PAMAM dendrimers  
N-diazeniumdiolate-functionalized PAMAM dendrimers were synthesized by 
adding one equivalent of 5.4 M sodium methoxide solution in methanol (with respect to 
the molar amount of primary amine functionality in PAMAM-NH2 used to synthesize 
dendrimers) to a vial containing dendrimers (100 mg) in methanol (1 mL). The glass vials 
were then inserted into a stainless steel reactor, and the headspace of the reactor was 
subsequently flushed with Ar three times followed by three longer purges with Ar (3 x 10 
min) to remove oxygen from the stirred solution. The reactor was filled with purified 
gaseous NO to 10 atm for 3 d. Unreacted NO was then removed using the same Ar 
flushing procedure described above prior to removing the vials from the vessel. The 
resulting N-diazeniumdiolate-modified PAMAM dendrimers were stored at -20 °C until 
use. 
4.2.3 NO-release measurements 
Real-time NO-release from the dendrimers was measured using a Sievers 280i 
Chemiluminesence Nitric Oxide Analyzer (NOA; Boulder, CO). The NO-releasing 
dendrimers (1 mg) were added to a sample vessel containing 30 mL deoxygenated PBS 
(pH 7.4, 37 °C). Liberated NO was carried from the sample vessel to the NOA at a flow 
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rate of 70 mL/min. Additional nitrogen flow was supplied to the sample vessel to match 
the collection rate of the NOA (200 mL/min). Nitric oxide-release measurements were 
terminated when the levels fell below 10 ppb NO/mg dendrimer. The real-time NO-
release measurements were used to determine the total NO-release duration (t[NO]), total 
NO-release after 24 h (t[NO]24h, maximum NO flux ([NO]max), and half-life (t1/2).  
4.2.4 Planktonic bactericidal assays 
Pseudomonas aeruginosa and Staphylococcus aureus bacterial cultures were 
grown from frozen stock (-80 °C) in TSB overnight at 37 °C. An aliquot of the 
suspension (0.5 mL) was added to fresh TSB (50 mL) and incubated at 37 °C until the 
bacteria reached mid-exponential phase (~1 × 108 colony forming units (cfu)/mL) as 
determined by the optical density at 600 nm (OD600). The relationship between the 
concentration of the bacteria in suspension and the OD600 was calibrated for each strain 
using an Eppendorf BioPhotometer Plus Spectrophotometer (Hamburg, Germany). 
Colony forming units were enumerated from culture dilutions grown on TSA plates. The 
bacterial suspension was then centrifuged (3645 g for 10 min, 25 °C), resuspended in 
PBS, and diluted to ~1 × 106 cfu/mL in PBS supplemented with 1% (w/w) glucose and 
0.5% (v/v) TSB for planktonic bactericidal assays. 
The minimum bactericidal concentration (MBC) of the NO-releasing PAMAM 
dendrimers for planktonic P. aeruginosa and S. aureus was defined as the concentration 
that resulted in a 3-log reduction in viability versus untreated cells after 24 h. The 
bacterial suspensions (106 cfu/mL) were incubated with the NO-releasing dendrimers for 
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24 h over a range of dendrimer concentrations that were tested in triplicate. After 
exposure, the samples were diluted, plated on TSA, with counting of resulting colonies to 
determine viability. 
4.2.5 Biofilm bacterial assays 
A CDC bioreactor was used to grow P. aeruginosa and S. aureus biofilms over 48 
h. Growth conditions (e.g., nutrient concentrations, additives, flow rate) were optimized 
for both the P. aeruginosa and S. aureus biofilms. Briefly, medical grade silicone rubber 
substrates were mounted in the coupon holders within the CDC reactor. After 
autoclaving, the reactor effluent line was clamped and 500 mL sterile 1% (w/v) TSB (P. 
aeruginosa growth) or 10% (w/v) TSB and 0.1% (w/v) glucose (S. aureus growth) was 
added aseptically. Similar to planktonic experiments, P. aeruginosa and S. aureus 
bacterial cultures were grown from frozen stock (-80 °C) overnight in TSB at 37 °C, 
reinoculated, and grown to mid-exponential phase. The reactor was then inoculated with 
an aliquot (1 mL) of the resulting 1 × 108 cfu/mL bacterial suspension (final 
concentration ~2 × 105 cfu/mL). The completed assembly was incubated at 37 °C for 24 h 
with   stirring   (150   rpm).   Following   this   “batch   phase”   growth,   the   effluent   line   was  
opened and the reactor media was refreshed continuously with 0.33% (v/v) TSB at 6 
mL/min (P. aeruginosa growth) or 1% (v/v) TSB at 2.7 mL/min (S. aureus growth) for 
another 24 h to complete growth of the biofilms.  
The MBC for biofilm eradication was determined as the concentration of NO-
releasing PAMAM dendrimers that resulted in bacterial viability below the limit of 
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detection for the plate counting method (2.5 x 103 cfu/mL).45 Each strain of bacteria was 
tested in triplicate over an optimized concentration range. P. aeruginosa and S. aureus 
biofilms grown on silicone rubber substrates were exposed to different concentrations of 
NO-releasing dendrimers in 3 mL PBS supplemented with 1% (w/w) glucose and 0.5% 
(v/v) TSB at 37 °C with slight agitation for 24 h. After 24 h of incubation, the samples 
were sonicated and vortexed to disrupt the biofilm. Aliquots of the cell/nanoparticle 
suspensions were diluted in PBS, plated on TSA, and incubated at 37 °C overnight. 
Bacterial viability was then determined by counting the observed colonies.  
4.2.6 Confocal microscopy 
Fluorescently-labeled control (i.e., non-NO-releasing) PAMAM dendrimers were 
prepared following a previously reported procedure.43 Briefly, G3-PAMAM-NH2 (100 
mg) and rhodamine B isothiocyanate (RITC) (3 mg) were dissolved in methanol (2 mL). 
The solution was stirred for 3 d in the dark and the resulting product solution was 
dialyzed against 0.1 M NaCl (2 L) for 24 h, and ultrapure Milli-Q water for 3 d (3 × 2 L). 
Subsequent lyophilization yielded RITC-labeled G3-PAMAM-NH2. The fluorescently-
labeled G3-PAMAM-NH2 dendrimers were then modified with one molar equivalent of 
PO, ACN, or a PO/ACN mixture to yield the RITC-labeled secondary-amine-
functionalized dendrimers for dendrimer–bacteria association studies.  
P. aeruginosa biofilms were grown on glass substrates (Biosurface Technologies) 
and subsequently exposed to NO-releasing dendrimers (200 µg/mL) in PBS 
supplemented with DAF-2 DA (10 µM) and PI (30 µM) for 1 and 4 h or RITC-labeled 
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control dendrimers (200 µg/mL) in PBS for 1 h followed by staining with PBS 
supplemented with Syto 9 (10 µM) for 20 min. Before imaging, the substrates were 
dipped in PBS to remove excess dye and loosely adhered cells. A Zeiss 510 Meta 
inverted laser scanning confocal microscope (Carl Zeiss, Thornwood, NY) with a 488 nm 
Ar excitation laser (2.0% intensity) and a BP 505–530 nm filter was used to obtain DAF-
2 and Syto 9 (green) fluorescence images. A 543 nm HeNe excitation laser (25.3% 
intensity) with a BP 560–615 nm filter was used to obtain PI and RITC (red) fluorescence 
images. The images were collected using a Zeiss C-apochromat lens (10x, 1.2 numerical 
aperture).  
4.2.7 In vitro cytotoxicity 
L929 mouse fibroblasts were cultured in DMEM supplemented with 10% (v/v) 
FBS and 1 wt% Pen Strep solution, and incubated in 5% (v/v) CO2 under humidified 
conditions at 37 oC. After reaching 80% confluency, the cells were trypsinized, seeded 
onto tissue culture-treated polystyrene 96-well plates at a density of 3 × 104 cells/mL and 
further incubated at 37 oC for 48 h. The supernatant was subsequently aspirated prior to 
adding fresh DMEM (200   μL) with control (i.e., non-NO-releasing) or NO-releasing 
dendrimers to each well. After incubation at 37 oC for 24 h, the supernatant was aspirated 
and the cells rinsed 3x with PBS. A mixture of DMEM/MTS/PMS (105/20/1, v/v/v) (120 
μL) was then added to each well. The absorbance of the resulting colored solution after 
1.5 h incubation at 37 oC was quantified at 490 nm using a Thermo Scientific Multiskan 
EX plate reader (Thermo Fisher Scientific, Inc., Waltham, MA). The mixture of 
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DMEM/MTS/PMS and untreated cells were used as the blank and control, respectively. 
Cell viability was calculated by taking the ratio of the absorbance of treated to untreated 
cells after subtracting the absorbance of the blank from each.  
4.3 Results and Discussion 
Although many reports on the bactericidal action of NO have appeared in the 
literature,42, 46 the effects of NO-release kinetics on planktonic bacteria and biofilm 
eradication, and how these release profiles impact healthy cells have not yet been 
investigated. Thus, the goal of this study was to evaluate NO-induced killing of 
planktonic and biofilm-based P. aeruginosa and S. aureus bacteria as a function of NO-
release kinetics (i.e., burst versus sustained release). Poly(amidoamine) dendrimers were 
functionalized with PO, ACN, or a PO/ACN mixture (i.e., 1:1 or 1:7 PO/ACN) to vary 
the maximum NO flux and half-life while maintaining the same total NO storage over 24 
h. As shown in Table 4.1, the dendrimers exhibited a range of NO-release kinetics with 
half –lives ranging from 0.9 to 3.5 h. Importantly, the four scaffolds had similar total NO 
storage over 24 h (1.89 ± 0.11, 1.70 ± 0.16, 1.56 ± 0.08, and 1.89 ± 0.10 µmol/mg for the 
PO, 1:1, 1:7, and ACN NO-releasing dendrimers, respectively). The PO-modified 
dendrimer exhibited an initial burst of NO release ([NO]max = 6500 ± 675 ppb/mg), while 
a lower maximum flux and more sustained release was observed for the ACN-modified 
dendrimer (NO]max = 3815 ± 875 ppb/mg). Hydrophobic ACN functional groups likely 
slow the proton-initiated N-diazeniumdiolate decomposition compared to hydrophilic PO 
functional groups, thus delaying NO release. As expected, the NO-release profiles for the 
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1:1 and 1:7 PO/ACN-modified dendrimers exhibited a combination of the PO and ACN 
release profiles ([NO]max = 5150 ± 890 and 4800 ± 1065 ppb/mg, respectively). 
Table  4.1  Nitric  oxide  release  properties  of  N-diazeniumdiolate-modified  PAMAM  
dendrimers  as  measured  by  NOA.  All  values  are  n≥3  measurements.   
  
Dendrimer Feed Ratio
t[NO] 
(µmol/mg)
t[NO]24h
(µmol/mg)
[NO]max
(ppb/mg)
t1/2 (h)
PO ̶ 1.89 ± 0.11 1.89 ± 0.11 6500 ± 675 0.9 ± 0.3
PO/ACN 1:1 70:30 1.90 ± 0.20 1.70 ± 0.16 5150 ± 890 1.8 ± 0.4
PO/ACN 1:7 30:70 1.75 ± 0.12 1.56 ± 0.08 4800 ± 1065 2.4 ± 0.3
ACN ̶ 2.06 ± 0.19 1.89 ± 0.10 3815 ± 875 3.5 ± 0.4
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4.3.1 Bactericidal efficacy against planktonic bacteria 
Prior to evaluating the effects of NO-release kinetics on clinically-relevant 
bacterial biofilms, we sought to determine any relation between NO-release profile and 
eradication of planktonic bacteria. Indeed, the bactericidal efficacy of the NO-releasing 
dendrimers against P. aeruginosa was dependent on the NO-release kinetics, with the 
PO-modified dendrimers proving the most effective (MBC24h = 0.05 mg/mL), followed 
by the 1:1 PO/ACN, 1:7 PO/ACN, and ACN-modified dendrimers with 24 h MBCs of 
0.10, 0.20, and 0.20 mg/mL, respectively (Table 4.2). The killing of planktonic S. aureus 
followed a similar trend (MBC values of 0.20, 0.60, 0.60, and 0.60 mg/mL for the PO, 
1:1 PO/ACN, 1:7 PO/ACN, and ACN-modified dendrimers, respectively), although 
increased doses of NO (~3–4x) were required to exhibit 3-log viability reductions. The 
increased NO dose required for Gram-positive S. aureus killing compared to Gram-
negative P. aeruginosa has been observed previously.43, 47 Such disparity is likely the 
result of multiple factors including differential peptidoglycan thicknesses,48 varied 
production of antioxidant enzymes (e.g., superoxide dismutase) to mitigate the effects of 
NO,49 and S. aureus’  use of NO as a cytoprotection agent.50  
The NO-release profiles of the dendrimer scaffolds influenced planktonic 
bacterial killing, with the PO-modified dendrimer (i.e., burst release) being the most 
effective (~0.09 µmol NO/mL) and the ACN-modified dendrimer (i.e., lower, sustained 
release) being the least effective (~0.38 µmol NO/mL). The large initial burst of NO from 
the PO-modified dendrimers is sufficient to quickly kill the planktonic bacteria, releasing 
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P. aeruginosa S. aureus
Dendrimer
Planktonic
MBC24h
(mg/mL)a
Biofilm
MBC24h
(mg/mL)b
Planktonic
NO 
Dose
(µmol/mL)
Biofilm
NO 
Dose
(µmol/mL)
Planktonic
MBC24h
(mg/mL)a
Biofilm
MBC24h
(mg/mL)b
Planktonic
NO
Dose
(µmol/mL)
Biofilm
NO
Dose
(µmol/mL)
PO 0.05 5.0 0.09 ± 0.01 9.45 ± 0.55 0.2 5.0 0.38 ± 0.02 9.45 ± 0.55
PO/ACN 1:1 0.10 3.0 0.17 ± 0.02 5.10 ± 0.50 0.6 3.0 1.02 ± 0.10 5.10 ± 0.50
PO/ACN 1:7 0.20 3.0 0.31 ± 0.02 4.68 ± 0.24 0.6 3.0 0.94 ± 0.05 4.68 ± 0.24
ACN 0.20 1.0 0.38 ± 0.02 1.89 ± 0.19 0.6 3.0 0.94 ± 0.06 5.67 ± 0.57
bMBC: Minimum Bactericidal Concentration resulting in bacterial viability below the limit of detection for the plating method (2.5 x 103 cfu/mL).
aMBC: Minimum Bactericidal Concentration resulting in 3-log reduction in bacterial viability.
Table  4.2  Determination  of  planktonic  and  biofilm  MBCs
  
and  bactericidal  NO  doses  for  
NO-releasing  PAMAM  dendrimers  against  P.  aeruginosa    and  S.  aureus  bacteria. 
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~0.95 µmol NO/mg in the first hour of exposure. In contrast, the ACN-modified 
dendrimers released a more sustained level of NO that would not reach ~0.95 µmol 
NO/mg until 4 h after exposure. The levels of NO generated from the ACN-modified 
dendrimers are likely insufficient for complete killing of the metabolically active 
planktonic cells. As such, more NO (~4x) is required for the same 3-log reduction in 
viability.51 Of note, the control dendrimers were not toxic at planktonic P. aeruginosa 
MBCs, but were significantly toxic (~3-log reduction in bacterial viability) at MBCs for 
the eradication of planktonic S. aureus, likely due to the increased amount of scaffold.  
4.3.2 Bactericidal efficacy against biofilm bacteria 
In addition to exhibiting bactericidal action against planktonic bacteria, the NO-
releasing PAMAM dendrimers also proved effective against P. aeruginosa and S. aureus 
biofilms. Interestingly, the NO-releasing dendrimer MBCs for eradication of the biofilms 
followed the opposite trend of that observed for planktonic cells, with the ACN-modified 
dendrimer exhibiting the greatest efficacy (Table 4.2). The MBC for the NO-releasing 
ACN-modified dendrimers against P. aeruginosa biofilms was 1.0 mg/mL (~1.89 µmol 
NO/mL), compared to MBCs of 3.0, 3.0, and 5.0 mg/mL for the 1:7 PO/ACN, 1:1 
PO/ACN, and PO-modified dendrimers, respectively. S. aureus biofilms exhibited similar 
susceptibility to the NO-releasing dendrimers with MBCs of 3.0, 3.0, 3.0 and 5.0 mg/mL 
for the ACN, 1:7 PO/ACN, 1:1 PO/ACN, and PO-modified dendrimers, respectively. 
Unlike planktonic assays, the concentrations of NO-releasing dendrimers needed to 
eradicate S. aureus biofilms compared to P. aeruginosa biofilms were not significantly 
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different. Dendrimers are effective at penetrating biofilms.52, 53 At high concentrations ( 
≥3.0  mg/mL), dendrimer diffusion and subsequent NO-delivery may be so similar that 
other factors such as varying levels of antioxidant enzymes and NO cytoprotection 
mechanisms play a lesser role. 
To further confirm that the observed biofilm eradication was a function of NO-
release kinetics and not simply increased control scaffold concentration, biofilm viability 
was evaluated for the control ACN, 1:7 PO/ACN, 1:1 PO/ACN, and PO-modified 
dendrimers at the highest MBC concentration (5.0 mg/mL) for both P. aeruginosa and S. 
aureus (Figure 4.3). Similar killing (~1–2 logs for controls versus 4–5 logs for NO-
releasing) of the biofilm bacteria was observed for the four control dendrimer scaffolds, 
confirming that biofilm eradication was a function of NO-release kinetics and not the 
control scaffold. 
In comparing the eradication of planktonic bacteria to biofilms, the biofilms 
required ~5–100x more NO and exhibited increased susceptibility to lower, sustained NO 
levels over burst-release profiles. The initial NO burst from the PO dendrimers likely 
resulted in residual bacteria remaining embedded within the biofilm. However, the more 
sustained NO release from the ACN-modified dendrimers may have continued to exert 
both oxidative and nitrosative stresses against the bacteria throughout the duration of the 
assay, thus requiring less NO for complete eradication (~1.89–5.67 versus 9.45 µmol 
NO/mL for NO-releasing ACN- and PO-modified dendrimers, respectively). 
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Figure  4.1  Determination  of  bacterial  viability
  
for    (A)  P.  aeruginosa    and  (B)  S.  aureus  
biofilms  exposed  to  control  (i.e.,  non-NO-releasing)  PAMAM  dendrimers  at  5.0  mg/mL.  
Viability  is  similar  for  the  four  control  scaffolds  at  the  highest  MBC.   
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4.3.3 Confocal microscopy 
 Confocal microscopy was utilized to further support the results of the bactericidal 
assays. The eradication of both P. aeruginosa and S. aureus biofilms was most effective 
using scaffolds with sustained NO-release profiles. To confirm that the observed 
differences in scaffold efficacy were due to NO release and not scaffold penetration 
within the biofilm, we monitored the diffusion of RITC-labeled ACN, 1:7 PO/ACN, 1:1 
PO/ACN, and PO-modified dendrimers within the P. aeruginosa biofilm. Microscopy 
studies were not conducted with S. aureus biofilms since the observed trends in killing 
were similar to P. aeruginosa. For evaluation of dendrimer diffusion, P. aeruginosa 
biofilms were incubated with the control RITC-labeled dendrimers (200 µg/mL) for 1 h. 
The biofilm cells were then stained with green nucleic acid stain (Syto 9). As shown in 
Figure 4.4, the P. aeruginosa biofilms exposed to control ACN, 1:7 PO/ACN, 1:1 
PO/ACN, or PO-modified dendrimers exhibited similar red RITC fluorescence, 
indicating similar scaffold diffusion through the biofilm independent of the ACN or PO 
surface functionality. The improved anti-biofilm efficacy of the NO-releasing ACN 
dendrimers compared to the PO dendrimers may thus be attributed to NO-release kinetics 
and not differences in dendrimer association and diffusion through the biofilm. 
 Intracellular NO concentrations and bacterial killing in P. aeruginosa biofilms 
were also visualized with confocal microscopy. Based on results from the biofilm 
eradication assays, we hypothesized that greater intracellular NO concentrations (green 
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Syto 9RITC
A
B
C
D
Figure  4.2   Fluorescent   images  of  RITC-modified   (A)  PO,   (B)  1:1,   (C)  1:7,   and   (D)  ACN  
control   PAMAM   dendrimers   (200   µg/mL)   diffusion   in   P.   aeruginosa   biofilm   1   h   after  
dendrimer   addition.   Green   Syto   9   fluorescence   shows   biofilm   cells.   Similar   RITC   red  
fluorescence  indicates  similar  association  and  diffusion  within  biofilm  for  each  scaffold. 
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 DAF fluorescence) would likely be observed for the NO-releasing PO-modified 
dendrimers, but that the biofilms exposed to NO-releasing ACN-modified dendrimers 
would exhibit enhanced bacterial cell death (red PI fluorescence) after prolonged 
exposure. P. aeruginosa biofilms were exposed to the NO-releasing PO, 1:1, 1:7, and 
ACN dendrimers (200 µg/mL) for periods of 1 and 4 h. Exposure times of 1 and 4 h were 
selected to evaluate intracellular NO concentrations and bacterial cell death at the t1/2 for 
the PO and ACN systems, respectively. As expected, the biofilms exposed to the NO-
releasing PO dendrimers exhibited increased green intracellular NO and red PI 
fluorescence at 1 h (Figure 4.5). At this time no DAF or PI fluorescence was readily 
visible within the biofilms exposed to the NO-releasing 1:1 PO/ACN, 1:7 PO/ACN, or 
ACN-modified dendrimers since the NO-release levels were likely low and the 
fluorescence concomitantly below the limit of detection. After 4 h, red PI fluorescence 
was observed for bifiolms exposed to the NO-releasing 1:1, 1:7, and ACN-modified 
dendrimers in addition to the PO-modified scaffolds. However, significant DAF 
fluorescence was not observed for the 1:1 PO/ACN, 1:7 PO/ACN, or ACN-modified 
dendrimers, suggesting that NO-release amount remained below the limit of detection or 
that the DAF dye diffused into solution upon destruction of the bacterial cell membrane. 
Overall, the visualization of PI fluorescence over time confirmed that the NO-releasing 
ACN dendrimers exerted similar, if not better killing of P. aeruginosa biofilms at 
prolonged exposure (i.e., 4 h), even though the NO-releasing PO dendrimers disrupted 
some of the bacterial cell membranes within 1 h. 
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Figure  4.3.  Fluorescent  images  of  P.  aeruginosa  biofilm  exposed  to  the  same  dendrimer  
concentration   (200   µg/mL)   of   NO-releasing   (A)   PO,   (B)   1:1,   (C)   1:7,   or   (D)   ACN  
dendrimers  for  1  or  4  h.  DAF-2  green  fluorescence  indicates  increased  intracellular  NO  
and  PI  red  fluorescence  indicates  compromised  cell  membranes  (i.e.,  cell  death). 
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4.3.4 Cytotoxicity of PAMAM dendrimers at therapeutic concentrations 
 Given the bactericidal efficacy of the NO-releasing PAMAM dendrimers 
presented herein, the PO, 1:1 PO/ACN, 1:7 PO/ACN, and ACN-modified scaffolds were 
evaluated against healthy host cells to further determine potential therapeutic utility. 
L929 mouse fibroblasts, which are ubiquitous in connective tissue,54 were incubated with 
both control and NO-releasing dendrimers for 24 h at their respective planktonic and 
biofilm MBCs. Fibroblasts exposed to the dendrimers at planktonic MBCs (0.05–0.6 
mg/mL) exhibited no reduction in cell viability for either the control or NO-releasing 
systems (Figure 4.6). Significant viability reductions (~55–84%) were observed for 
fibroblasts exposed to NO-releasing dendrimers at biofilm MBCs (1.0–5.0 mg/mL) even 
though the controls remained relatively non-toxic (~1–18% viability reduction) (Figure 
4.7).  
The aforementioned cytotoxicity studies demonstrate the utility of NO-releasing 
PO, 1:1PO/ACN, 1:7 PO/ACN, and ACN PAMAM dendrimers as antibacterial agents 
against planktonic bacteria, due to their potent biodical action and minimal effects toward 
healthy host cells. However, >99% of bacteria exist in a biofilm state and the cytotoxicity 
of potential therapeutics must be evaluated with these conditions in mind.55 The control 
PAMAM dendrimers were not significantly cytotoxic to L929 fibroblasts regardless of 
the concentration tested (0.05–5.0 mg/mL). In contrast, larger NO concentrations (≥5.67  
µmol NO/mL) resulted in elevated cytotoxicity (Figure 4.7 A and B). Of note, NO-
releasing ACN-PAMAM dendrimers exhibited only ~3% reduction in cell viability 
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Figure   4.4   Cytotoxicity   of   NO-releasing   (white)   and   control   (gray)   PAMAM   dendrimers  
against  L929  mouse  fibroblasts  at  MBC  concentrations  required  for  killing  of  planktonic  (A)  
P.  aeruginosa  and  (B)  S.  aureus  as  listed  in  Table  4.2. 
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Figure   4.5   Cytotoxicity   of   NO-releasing   (white)   and   control   (gray)   PAMAM   dendrimers  
against  L929  mouse  fibroblasts  at  MBC  concentrations  required  for  (A)  P.  aeruginosa  and  (B)  
S.  aureus    biofilm  killing  as  listed  in  Table  4.2. 
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 at the MBC (1.0 mg/mL or ~1.89 µmol NO/mL) for P. aeruginosa biofilm eradication, 
making them a desirable therapeutic for anti-biofilm applications. 
4.3.5 Cytotoxicity of PAMAM dendrimers as a function of NO-release kinetics 
In addition to evaluating cytotoxicity at the dendrimer MBC concentrations, we 
sought to determine if NO-induced cytotoxicity was a function of NO-release kinetics.  
L929 mouse fibroblasts were incubated with varying concentrations (i.e., 0.2, 1.0, 3.0, 
and 5.0 mg/mL) of control and NO-releasing PO, 1:1 PO/ACN, 1:7 PO/ACN, and ACN-
PAMAM dendrimers for 24 h. As shown in Figure 4.8B, the four control PAMAM 
dendrimers were minimally toxic over the entire concentration range tested (0.2–5.0 
mg/mL). In contrast, the effects of NO on L929 cell viability proved to be concentration 
dependent (Figure 4.8A). Low levels of NO (≤1.89 µmol NO/mL) actually promoted 
fibroblast proliferation,56 while larger doses (≥5.67  µmol NO/mL) resulted in significant 
reductions in viability. Determination of fibroblast cytotoxicity as a function of NO-
release kinetics was not definitive for the systems and concentrations tested. At low 
concentrations of NO-releasing dendrimers (≤1.0   mg/mL), little dependence on NO-
release kinetics was noted as the cell viabilities for the fibroblasts exposed to NO-
releasing PO and ACN dendrimers proved similar. At 5.0 mg/mL, the burst-release 
profile of the NO-releasing PO dendrimers resulted in a greater reduction in cell viability 
(~84% reduction) compared to the lower but sustained NO release from the ACN 
dendrimers (~51% reduction). At larger NO concentrations, it is likely that the 
antioxidant enzymes (e.g., superoxide dismutase) employed by mammalian cells are  
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Figure  4.6  Cytotoxicity  of      (A)  NO-releasing  and  (B)  control  PAMAM  dendrimers  against  
L929  mouse   fibroblasts   at   concentrations  of  0.2   (dashed),   1.0   (light   gray),  3.0   (dark  gray),  
and  5.0  (white)  mg/mL. 
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unable to adequately mitigate the effects of NO. Thus, scaffolds delivering large bursts of 
NO exhibit slightly greater cytotoxicity compared to sustained release systems. 
4.4 Conclusions 
The importance of NO-release kinetics in the eradication of planktonic and 
biofilm-based P. aeruginosa and S. aureus bacteria was demonstrated using NO-releasing 
PAMAM dendrimers functionalized with PO, ACN, or both PO/ACN. Although Hetrick 
et al. noted improved biofilm eradication for the NO-releasing MAP3 silica particles with 
faster release (i.e., lower t1/2) compared to the slower-releasing AHAP3 particles, the total 
NO storage between the two scaffolds was so varied (~7.6 versus 3.8 µmol/mg, 
respectively) that killing differences could not be due to NO-release kinetics alone.40 
While our results indicate that slower, sustained NO-release profiles are preferred for 
biofilm eradication, increasing total NO storage (>1.89 µmol/mg) may improve the 
efficacy of faster-releasing dendrimer scaffolds since fewer residual bacteria would likely 
remain after delivery of the intial NO burst. However, an increased NO storage may also 
influence cytotoxicity to healthy host cells. Previous literature has observed that scaffolds 
delivering sustained levels of an antibacterial over time were ultimately more effective 
against biofilms, with biphasic release profiles being the most ideal,19, 27 although these 
systems may result in increased antibiotic resistance over time.29 The slower NO-
releasing ACN-PAMAM dendrimers presented here show therapeutic potential due to 
their ability to effectively eradicate P. aeruginosa biofilms at concentrations with 
minimal cytotoxicity. Eradication of S. aureus biofilms could be improved by further 
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tuning of both the NO-release profile and total NO storage, and perhaps even co-
administering NO-releasing PO- and ACN- modified dendrimers.  
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CHAPTER 5: SIZE- AND SHAPE-DEPENDENT SILICA NANOPARTICLE 
PHYTOTOXICITY AND UPTAKE IN ARABIDOPSIS THALIANA 
5.1 Introduction 
The evolution of nanotechnology is proceeding rapidly as researchers work to 
engineer nanomaterials with unique molecular organization, properties, and functions 
relative to bulk materials.1 Indeed, engineered nanoparticles (ENPs) have already proven 
to be useful for drug delivery and environmental remediation.2, 3 Engineered 
nanoparticles incorporated into consumer goods are now making their way into 
atmospheric, aquatic, and terrestrial environments due to incidental and direct 
release/disposal.2, 4, 5 A better understanding of particle fate, behavior, and potential 
toxicity in these environments is thus warranted.  
Studies have assessed the toxicity of ENPs toward mammalian cells, bacteria, 
aquatic invertebrates, and other terrestrial organisms. To date, plant toxicity due to 
nanoparticle exposure has received less attention.6, 7 Prior work with plants has evaluated 
the toxicity of silica (SiO2), zinc oxide (ZnO), nickel hydroxide (Ni(OH)2), copper (Cu), 
cerium oxide (CeO2), titanium dioxide (TiO2), iron oxide  (Fe3O4), gold (Au), silver (Ag), 
iron (Fe), and CdSe/ZnS quantum dot nanoparticles to Arabidopsis thaliana,4, 8 rye 
grass,9, 10  mesquite,11 and select edible plant species including wheat and mung bean,5 
alfalfa, tomato, corn, and cucumber.12, 13  
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Silica nanoparticles (SiNPs) have received special interest due to their 
prominence in cosmetic and biomedical applications.14-16 In one study, the toxicity of 
12.5 and 27.0 nm SiNPs (20.0 and 28.8 mg L-1, respectively) to green alga was shown to 
reduce growth by 20% after 72 h.17 Silica particles (10–20 nm) were also shown to 
exhibit toxicity to Scenedesmus obliquus (green algae) after 72 and 96 h, as evidenced by 
a 20% reduction in growth (388.1 and 216.5 mg L-1, respectively) and decreased 
chlorophyll content.18 In contrast, phytotoxicity assays with Cucurbita pepo (zucchini) 
showed no significant difference in germination percent, root elongation, or biomass after 
exposure to 1000 mg L-1 bulk silicon powder and SiNPs (< 100 nm) for 5–14 d.19 Lee et 
al. found that 42.8 nm SiNPs promoted Arabidopsis thaliana root elongation at a low 
concentration (400 mg L-1),  but  resulted  in  toxicity  at  higher  concentrations  (≥  2000  mg  
L-1).4 Likewise, an increase in shoot/root ratio has been reported in Lactuca sativa 
(lettuce) plants after 15 d exposure to 0.066% (w/w) SiNPs (~100 nm).20 Nair and 
coworkers examined the use of SiNPs (~25 nm) labeled with fluorescein isothiocyanate 
(FITC) as potential biolabels in plants.21 They confirmed uptake of the SiNPs into rice 
seedlings and determined that the particles had no effect on germination up to 50 mg L-1. 
The importance of nanoparticle shape and surface charge in phytotoxicity have also been 
noted, but studies systematically investigating these parameters are not currently 
available.22 While work thus far on the phytotoxicity of SiNPs to higher plants has 
established a strong foundation, we sought to examine toxicity over an increased SiNP 
size range (i.e., < 42.8 nm and > 100 nm) and growth duration (i.e., 6 weeks), with 
evaluation of particle surface charge and shape. In addition, the literature currently lacks 
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visualization of SiNPs in A. thaliana cells and information about where SiNPs are 
uptaken (i.e., roots, rosette, and stem).  
Herein, the phytotoxicity of 14, 50, and 200 nm SiNPs at concentrations of 250 
and 1000 mg L-1 (ppm) to Arabidopsis thaliana over 3 and 6 weeks in a hydroponic 
growth medium was evaluated. Additionally, SiNPs of various shape (i.e., aspect ratios 1 
and 3) were examined for phytotoxic effects and uptake. The objective was to determine 
how size, surface charge, composition, and shape play a role in SiNP phytotoxicity while 
assessing particle uptake in the roots, rosette, and stems. A. thaliana is a universal model 
plant due primarily to its rapid life-cycle and relevance for toxicity implications on edible 
food crops.4, 13 Multiple plant growth parameters were evaluated including rosette 
diameter, biomass, and length of the main stem. Transmission electron microscopy 
(TEM) and inductively coupled plasma-optical emission spectroscopy (ICP-OES) were 
used to visualize SiNP localization and quantify uptake. 
5.2 Materials and Methods 
Note: Silica particle synthesis and characterization (AR1 and AR3) were 
supported by other members of the Schoenfisch lab 
Tetraethylorthosilicate (TEOS) was purchased from Gelest (Morrisville, PA). 
Ethanol (EtOH), ammonium hydroxide (28 wt%), and a silicon reference standard 
solution (1000 ppm) were purchased from Fisher Scientific (Fair Lawn, NJ). 
Cetyltrimethylammonium bromide (CTAB) was obtained from Acros Organics (Geel, 
Belgium). Organosilicasol MT-ST silica particles (14 nm) in methanol were obtained 
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from Nissan Chemical Corp. (Houston, TX). Wild-type Arabidopsis thaliana (Col-0) 
seeds were purchased from Carolina Biological Supply Company (Burlington, NC).  
Triton X-100,   agar,   Hoagland’s   No.   2   Basal   Salt   Mixture, triethanolamine, and 
glutaraldehyde (50% v/v in water) were purchased from Sigma-Aldrich (St. Louis, MO). 
A hydroponic plant growth system was acquired from Araponics (Liège, Belgium). 
Hydrofluoric acid (48–51 wt%) and osmium tetroxide (2.5 wt% in t-butanol) were 
purchased from Acros Organics (Morris Plains, NJ). Cacodylate buffer was purchased 
from Electron Microscopy Sciences (Hatfield, PA). LR White Resin was purchased from 
Polysciences, Inc. (Warrington, PA). Argon (Ar) gas was obtained from Airgas National 
Welders (Raleigh, NC). Other solvents and chemicals were analytical-reagent grade and 
used as received. A Millipore Milli-Q UV Gradient A10 System (Bedford, MA) was used 
to  purify  distilled  water  to  a  final  resistivity  of  18.2  MΩ·cm  and  a  total organic content of 
≤6  parts  per  billion  (ppb).   
5.2.1 Silica nanoparticle synthesis and characterization  
Organosilicasol MT-ST particles (14 nm) were dried under vacuum before use. 
Tetraethylorthosilicate SiNPs (50 and 200 nm) were synthesized by the Stöber method 
following conditions reported by Bogush et al.23 Briefly, 50 nm SiNPs were made by 
adding TEOS (3.792 mL) to a stirred solution of EtOH (91.378 mL),ammonium 
hydroxide (3.378 mL), and water (1.452 mL). After 5 h, the particles were collected by 
adding hexane to the solution in a 2:1 ratio (v/v) and centrifugation (3645g for 5 min). 
The particles were resuspended in EtOH via sonication and collected again by 
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centrifugation (3645g for 5 min). This washing procedure was repeated and the particles 
were then dried under vacuum. The 200 nm SiNPs were made by adding TEOS (3.792 
mL) to a stirred solution of EtOH (88.351 mL), ammonium hydroxide (6.757 mL), and 
water (1.101 mL). These particles were collected, washed, and dried after 2 h using the 
aforementioned procedure. For select studies, the silica particles were calcined at 1000 °C 
for 24 h in a muffle furnace. 
Silica particles of two distinct aspect ratios (AR1 and AR3) were synthesized via 
a surfactant-templated approach as previously described by varying reaction temperature 
and ammonia concentration.24  Elevated temperature (50 vs. 20 °C) was used to increase 
the aspect ratio of the particles (AR3), while a greater ammonia concentration (1.0 vs. 0.5 
M) allowed for the synthesis of a more spherical particle (AR1). Tuning these reaction 
parameters, silica particles with aspect ratios of 1 (62 ± 8 nm) and 3 (241 ± 32 nm length 
and 78 ± 6 nm width), but similar particle volume (~106 nm3) were achieved. Of note, 
cetyltrimethylammonium bromide (CTAB) removal was confirmed via CHN analysis 
prior to surface grafting.  
 Particle size, shape, and morphology were characterized with a JEOL 100 CX II 
transmission electron microscope (TEM) at 80 kV or Hitachi S-4700 scanning electron 
microscope (Tokyo, Japan).  Hydrodynamic diameters and zeta potentials were 
determined by dynamic light scattering (DLS) using a Malvern Zetasizer Nano ZS 
(Worcestershire, UK). Measurements were performed in solutions of the plant growth 
medium at pH 5.8. To assess the relative amount of silanols and/or unreacted silane on 
the particle surface, CHN elemental analysis was performed using a 2400 Series II 
166 
CHNS/O analyzer from Perkin Elmer to determine both wt% H and C for each particle 
size. 
5.2.2. Plant growth  
A. thaliana seeds were sterilized prior to use with a solution of 95% (v/v) EtOH 
(73.7 mL), water (26 mL), and Triton X-100   (50  μL)   for  10  min,  and  rinsed  with  95%  
(v/v) EtOH twice. Seeds were pretreated via dispersal on filter paper moistened with 
water,   then   “incubating”   at   4   °C   for   6   d   in   the   dark   to   simulate  winter   and   encourage  
germination.25 The hydroponic system, including seed holders, was sterilized with a 10% 
(v/v) sodium hypochlorite solution and rinsed copiously with water. The seed holders 
were filled with 0.65 wt% agar support, and seeds sown by dropping one seed (in a 
suspension of 0.2 wt% agar) into each holder.25 The SiNPs 14, 50, and 200 nm SiNPs 
were dispersed in the hydroponic troughs at concentrations of 250 or 1000 ppm with 
Hoagland’s  No.   2  Basal   Salt  Mixture   (400  mg   L-1), while the AR1 and AR3 particles 
were dispersed at 250 ppm.  Control  plants  were  grown  in  blank  solutions  of  Hoagland’s  
No. 2 Basal Salt Mixture (400 mg L-1). Studies were carried out by either allowing the pH 
of the hydroponic solution to fluctuate naturally or maintaining the pH at pH 5.8 via 
addition of dilute hydrochloric acid or sodium hydroxide. Seeds were grown at room 
temperature under fluorescent light (GE Pro-Line Watt-Miser F40T12) with a 12 h 
photoperiod and 78–91 µmolm-2s-1 photosynthetically active radiation for 3 or 6 weeks. 
During the first two weeks of germination and growth, transparent lids were used to 
increase the relative humidity (~50–60%) surrounding the seedlings and establish 
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plantlets.26 For each experiment, at least 6 separate plants were harvested and examined. 
Significant   differences   in   growth  were   determined   based   on   the   Student’s   t-test at the 
95% confidence level. 
5.2.3 Transmission electron microscopy  
Plant samples were fixed with 4% (v/v) glutaraldehyde in 0.1 M cacodylate buffer 
for 3 h at room temperature.9 Specimens were then rinsed with 0.1 M cacodylate buffer 
for 10 min and post-fixed with 1% (v/v) osmium tetroxide in 0.1 M cacodylate buffer for 
2 h. After two additional 10 min rinses in 0.1 M cacodylate buffer, samples were 
dehydrated in a series of graded ethanol solutions (30, 50, 70, 95, and 100% v/v), with 10 
min incubation per solution. LR White Resin was used to infiltrate the plant tissue with a 
series of resin solutions (25, 50, 75, 100, and 100% v/v in EtOH), with 1 h incubation per 
solution. Plant samples were then embedded in 100% LR White Resin in gelatin capsules 
at 60 °C for 40 h. An ultramicrotome was used to cut thin sections (~100 nm) that were 
post-stained with 2% (v/v) uranyl acetate and 0.5–1% (v/v) lead citrate. Samples were 
then characterized using a JEOL 100 CX II TEM at 80 kV.  
5.2.4 Silicon elemental analysis  
Several plant samples from the same exposure group (6 weeks) were 
homogenized by grinding with a mortar and pestle, digested with acid, and analyzed via 
ICP-OES to determine Si content. Briefly, plant samples were digested with 10% (v/v) 
HNO3 (10 mL) in a microwave accelerated reaction system (CEM Corporation; 
Matthews, NC) for 15 min at 200 °C. Following digestion, samples were prepared further 
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for Si elemental analysis by adding aqua regia (2.5 mL) and hydrofluoric acid (1 mL) to 
dissolve any remaining material. Triethanolamine (3.575 mL of 40% v/v) was used to 
neutralize this solution. The solution was then diluted to 50 mL with water. CAUTION: 
hydrofluoric acid is extremely corrosive and requires special handling. Silicon elemental 
analysis was carried out in triplicate using a Prodigy ICP-OES (Teledyne Leeman Labs; 
Hudson, NH). The instrument was calibrated from 0.1–10 ppm in the axial configuration 
at 251.611 nm using a silicon reference standard solution. 
5.3 Results and Discussion 
5.3.1 Size-dependent phytotoxicity and uptake 
5.3.1.1 Synthesis and characterization of silica nanoparticles with varied size 
The physicochemistry of nanoparticles in the environment is influenced by their 
shape, size, surface area, degree of aggregation, adsorption, and local pH and ionic 
strength.7 To enable the study of particle phytotoxicity over a range of sizes spanning ~2 
orders of magnitude and compare results to previous work, we purchased 14 nm SiNPs 
and synthesized both 50 and 200 nm SiNPs via the Stöber process.4, 17, 19, 20 Particle size 
of the SiNPs (50 and 200 nm) is easily tuned in the Stöber process by varying water and 
ammonia concentrations and/or overall reaction time.23 
Prior to studying phytotoxicity, we sought to understand the shape and 
morphology of the native SiNPs. As expected, the silica particles were spherical and 
monodisperse upon TEM analysis (14.8 ± 2.4, 51.4 ± 5.3, and 211.5 ± 24.3 nm for the 14, 
50, and 200 nm SiNPs, respectively) while the hydrodynamic diameters of the particles in 
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the hydroponic growth medium were larger due to solvation (Figure 5.1 and Table 5.1).27 
Of note, the particles remained monodisperse in the growth medium, indicating their 
suitability for evaluating size-dependent phytotoxicity.  
Surface charge, a parameter that influences particle stability, was evaluated by 
measuring the zeta potential in the plant growth medium at pH 5.8. Interestingly, the zeta 
potentials for the 50 and 200 nm SiNPs synthesized in-house with the Stöber method 
were highly negative in magnitude at -20.3 ± 0.4 and -31.9 ± 0.9 mV, respectively, while 
the zeta potential for the 14 nm MT-ST SiNPs was less negative (Table 5.1). The 
difference in measured surface charge is attributed to the synthesis and drying conditions 
employed during particle preparation (e.g., in-house vs. commercial). Elemental analysis 
(CHN) was performed to elucidate any relationship between zeta potential variation and 
surface composition of the particles. The 14 nm particles were characterized with a lower 
wt% H and C than the 50 and 200 nm SiNPs (Table 5.2). Unreacted but stable silane and 
silanol groups on the particle surfaces are suspected contributors to the highly negative 
zeta potential of the 50 and 200 nm SiNPs. 
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B
C
Figure  5.1  TEM  of  SiNPs  with  sizes  of  14.8  ±  2  nm  (A),  51.4  ±  5  nm  (B),  and  211.5 
  ±  24  nm  (C).  Scale  bar  is  100  nm  (A)  or  200  nm  (B  and  C). 
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Table   5.1   Size   and   charge   characterization   of   SiNPs   via   TEM,   DLS,   and   zeta   potential.  
Measurements   were   made   in   Hoagland’s   #2   nutrient   solution   (400   mg   L
-1
)   with   SiNP  
concentration  of  250  ppm  unless  noted.  Measurement  of  14  nm  SiNPs  made  in  ethanol.a 
TEM Size
(nm)
DLS Size
(nm)
Zeta Potential
(mV)
14 nm 14.8 ± 2 139.4 ± 9.6
12.4 ± 0.1a
-15.3 ± 1.1
50 nm 51.4 ± 5 135.2 ± 1.1 -20.3 ± 0.4
200 nm 211.5 ± 24 291.6  ± 2.3 -31.9 ± 0.9
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14 nm 50 nm 200 nm
Unmodified Calcined Unmodified Calcined Unmodified Calcined
% C 1.18 -0.03 3.46 -0.03 3.08 -0.05
% H 0.40 -0.05 1.28 -0.05 1.45 -0.06
Table  5.2  Carbon  and  hydrogen  weight  percents   for  unmodified  and  calcined  SiNPs  as  
determined  by  CHN  analysis. 
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5.3.1.2 Plant growth  
In initial experiments, A. thaliana seeds were grown in solutions of 250 and 1000 
ppm SiNPs (i.e., 14, 50, and 200 nm) without adjusting the pH of the growth medium. 
These experiments were intended to mimic an environment where the pH is not 
maintained at a given level. Of note, terrestrial environments often do contain buffers that 
influence pH of the bulk soil and root-mediated pH changes in the rhizosphere.28, 29 In our 
studies, 50 and 200 nm SiNPs at 250 and 1000 ppm over 3 weeks (Figure 5.2) and 6 
weeks (Figure 5.3) resulted in reduced plant development with respect to rosette 
diameter, biomass, and stem length. Plants exposed to 50 and 200 nm SiNPs were also 
chlorotic, exhibiting a yellowish color due to insufficient production of chlorophyll 
(Figure 5.4).30 Compared to the larger particles, no chlorosis or reduction in growth was 
observed for the 14 nm SiNPs at 3 or 6 weeks for the concentrations studied. The lack of 
phytotoxicity for the 14 nm SiNPs may be attributed to the particles not significantly 
altering the pH of the growth medium, whereas the 50 and 200 nm SiNPs raised the pH 
over 3 units (e.g., pH 5.24, 5.98, 8.31, and 8.59 for the blank, 14, 50, and 200 nm SiNP 
solutions at 1000 ppm, respectively). The variation in pH over the 6 weeks for these 
exposure groups is provided in Supporting Information (Table 5.3). The wt% H values 
for the 14, 50, and 200 nm SiNPs were 0.4, 1.28, and 1.45%, respectively, corresponding 
to fewer silanols on the particle surface for the 14 nm SiNPs and thus a lessened capacity 
to alter solution pH (Table 5.2). As has been reported previously, a more basic  
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Figure  5.2  Growth  data  for  plants  harvested  at  3  weeks  with  (A,  C)  pH  5.8  and  (B,  D)  pH  
unadjusted  after  exposure  to  250  ppm  (white),  1000  ppm  (light  gray),  or  calcined  (dark  gray)  
SiNPs.  Values  are  normalized  to  plants  grown  in  blank  solution.  *Significant  difference  at  
95%  relative  to  blank.  Of  note,  stems  were  not  developed  by  3  week  harvest  for  
measurement. 
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Figure  5.3  Growth  data  for  plants  harvested  at  6  weeks  with  (A,  C,  E)  pH  5.8  and  (B,  D,  F)  
pH  unadjusted  after  exposure  to  250  ppm  (white),  1000  ppm  (light  gray),  or  calcined  (dark  
gray)  SiNPs.  Values  are  normalized  to  plants  grown  in  blank  solution.  *Significant  
difference  at  95%  relative  to  blank. 
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A B
Figure  5.4  Growth  after  6  weeks  in  (A)  blank  nutrient  solution  with  no  pH  adjustment  and  
(B)   after   exposure   to   250   ppm   of   200   nm   SiNPs   with   no   pH   adjustment.   Seed   holder  
diameter  is  2  cm. 
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 Initial 1 Week 3 Weeks 6 Weeks
250 ppm
Blank 5.24 5.27 5.38 7.11
14 nm 5.67 5.51 5.26 7.4
50 nm 6.99 6.76 6.70 5.64
200 nm 7.26 7.12 6.98 6.6
1000 ppm
Blank 5.24 4.88 5.34 6.49
14 nm 5.98 4.91 5.40 7.05
50 nm 8.31 7.30 7.48 7.27
200 nm 8.59 7.89 7.75 7.25
Calcined
Blank 5.39 5.68 5.52 6.81
14 nm 6.78 6.91 6.98 7.15
50 nm 4.69 4.72 6.23 7.03
200 nm 5.19 4.41 5.32 6.38
Table5.3 Variation in pH for exposure groups where pH was not adjusted over 6 weeks. 
Blank  exposure  groups  were  grown  in  a  solution  of  Hoagland’s  #2  Basal  Salt  Mixture  
(400 mg L-1). 
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pH may limit the availability of nutrients and result in growth deficiencies.31 Indeed, A. 
thaliana plants grow optimally at pH 5.8 where the necessary nutrients are more 
biologically available for uptake.4 To understand the role of pH on nanoparticle 
phytotoxicity, plants were grown at pH 8 in absence of the SiNPs. A. thaliana plant 
growth (i.e., rosette number, biomass, and length of main stem) was reduced by the more 
basic medium relative to the control (pH 5.8) at 3 or 6 weeks (Figure 5.5), but not to the 
same degree as with 50 and 200 nm SiNPs and concomitant greater pH medium.  Indeed, 
previous  reports  have  noted  that  alkaline  stress  (pH  ≥  8.0)  in  Arabidopsis can reduce root 
growth and begin de-polymerization of microfilaments.30 Thus, the question was raised 
as to whether the observed reduction in growth for the highly negative 50 and 200 nm 
SiNPs could be reversed if their surface charge was mitigated by maintaining the growth 
medium at pH 5.8. 
  Arabidopsis seeds were then exposed to the same concentrations of SiNPs while 
maintaining the solution pH at 5.8 and we hypothesized that by holding the growth 
medium pH constant, plant development would be less affected due to protonation of the 
silanol groups on the SiNP surface. As expected, phytotoxic effects at 3 (Figure 5.2) or 6 
(Figure 5.3) weeks were not observed relative to plants grown in the blank solution 
regardless of particle size. Furthermore, neither the rosette diameter, biomass, nor length 
of the main stem was reduced compared to blanks. In fact, plants showed similar 
flowering behavior upon maturation relative to the blanks. In some cases, the presence of 
the SiNPs even aided growth. At 6 weeks at pH 5.8, several of the 14, 50, and 200 nm 
SiNP exposure groups exhibited increased development relative to the blank.  
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A B
Figure 5.5 Plants grown for 6 weeks in (A) pH 5.8 nutrient solution and (B) nutrient 
solution adjusted to pH 8. Scale bar is 15 cm. 
 
180 
For example, the normalized biomass of 50 nm SiNPs at 250 ppm was 168.8 ± 59.7%. 
The role of silicon in plant nutrition and alleviating stress has been argued as essential, 
increasing the plausibility that exposure to the SiNPs strengthens plant structure.31, 32 In 
total, the data suggest that allowing the pH to naturally fluctuate leads to nanoparticle 
phytotoxicity at 250 ppm over 3 weeks for the 50 and 200 nm SiNPs. Conversely, no 
toxicity is noted for even the 1000 ppm exposure groups regardless of size when pH is 
maintained at 5.8. 
 The particles were also calcined to validate that the surface charge of the 50 and 
200 nm particles, rather than the SiNP scaffold itself, resulted in the observed 
phytotoxicity. In this method, the silica surface was dehydrated by prolonged heating at 
1000 °C resulting in the removal of unreacted alkoxy silane groups and silanols while 
maintaining particle composition, size, and morphology.33 To confirm that calcining the 
particles resulted in surface modification, the pH of each particle solution (calcined and 
unmodified) was measured in the growth medium at a concentration of 1000 ppm SiNPs. 
The pH of the calcined 14, 50, and 200 nm SiNPs was 5.74, 5.40, and 5.35, respectively, 
versus 5.98, 8.31, and 8.59 for the unmodified particles. As expected, calcining the SiNPs 
reduced pH values to within 0.2 pH units of the blank for 50 and 200 nm SiNP solutions. 
Removal of unreacted silane and silanol groups from the calcined SiNPs was confirmed 
with CHN where the wt% H and C values decreased for the calcined particles (Table 
5.2). 
  Arabidopsis seeds were exposed to the resulting calcined SiNPs at 1000 ppm with 
the assumption that if no phytotoxicity were observed at the higher concentration of 1000 
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ppm, growth reductions would not be observed at 250 ppm.  In this case, the pH of the 
growth medium was not adjusted to allow for comparison to the phytotoxicity of the 
unmodified SiNPs (50 and 200 nm) without pH adjustment. At both 3 and 6 weeks, no 
reduction in plant development was observed for the any of the calcined SiNP exposure 
groups, supporting our hypothesis that the SiNPs alone are not phytotoxic at 
concentrations up to 1000 ppm. Maintaining the growth medium pH at 5.8 or removing 
the surface charge of the SiNPs thus eliminated the SiNP toxicity (Figure 5.6). 
 To further confirm that the 14, 50, and 200 nm silica scaffolds themselves are not 
phytotoxic even in cases where high pH growth medium resulted, Arabidopsis plants 
were grown in the presence of the calcined SiNPs at 1000 ppm with the growth medium 
maintained at pH 8. As noted above, some reduced development for plants grown in the 
blank pH 8 medium was noted at 3 and 6 weeks, but the plants exposed to 1000 ppm 
calcined 14, 50, and 200 nm SiNPs were not significantly different from these blanks 
(Figure 5.7). The presence of the calcined SiNPs in the higher pH medium did not further 
reduce plant growth and development, validating that the SiNP scaffold is not toxic up to 
1000 ppm.  
We hypothesize that the observed phytotoxicity arises from a combination of the 
high pH of the growth medium and the ability of the negative SiNPs (i.e., 50 and 200 nm) 
to adsorb nutrients, making them unavailable for plant uptake.34 Plant development 
problems (e.g., reduced growth and chlorosis) resulting from deficiencies of macro- (e.g., 
nitrogen, phosphorus, and potassium) and micro-nutrients (e.g., iron, zinc, and 
manganese) are well-known.31 Silica particles with a greater number of silanols on the  
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C
Figure 5.6 Growth of plants exposed to 1000 ppm SiNPs after 6 weeks showing 
development with (A) no pH adjustment; (B) pH 5.8; and (C) pH unadjusted with calcined 
SiNPs. Scale bar is 15 cm. 
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pH 8
Blank
pH 8
14 nm
Calcined
pH 8
50 nm
Calcined
pH 8
200 nm
Calcined
Figure 5.7 Growth of plants after 6 week exposure to 1000 ppm calcined 
SiNPs with growth medium maintained at pH 8. Scale bar is 15 cm. 
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particle surface adsorb these nutrients and restrict plant uptake, thus resulting in reduced 
plant growth and chlorosis.29, 34-36 Upon adjusting the pH of the growth medium to 5.8, 
the nutrients adsorbed to silanols on the 50 and 200 nm particles are likely displaced by 
H+ ions, making them available for uptake.36 Likewise, the SiNPs no longer adsorb 
nutrients and the toxicity is eliminated when the surface charge is removed through 
calcination. 
The results presented herein build upon prior work evaluating SiNP phytotoxicity. 
Characterization of the SiNP surface charge proved important since phytotoxicity, likely 
due to nutrient adsorption, was observed for the highly negative 50 and 200 nm SiNPs. 
When the silanols on the SiNPs are capable of altering the growth medium pH and/or 
nutrient availability, phytotoxicity may be observed at concentrations even as low as 250 
ppm, a marked difference from previous work showing no reduction in A. thaliana 
growth at SiNP concentrations below 400 ppm.4 Modifying the charge of the 50 and 200 
nm SiNPs or adjusting the pH of the medium to that for favorable growth conditions 
resulted in no phytotoxic effects, even at exposure concentrations of 1000 ppm. Similar 
to   Lee   and   Shah’s   report,4, 20 we also noted cases of increased plant growth and 
development after exposure to 14, 50, and 200 nm SiNPs when pH effects were not a 
factor. 
5.3.1.3 Transmission electron microscopy  
Transmission electron microscopy was used to determine SiNP localization 
within the plant cells. Samples were exposed to the SiNPs at 1000 ppm with the growth 
medium maintained at pH 5.8 for a period of 6 weeks to simulate high exposure levels 
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and assess particle uptake for experiments that did not result in phytotoxicity. The 
resulting TEM images revealed that the 14, 50, and 200 nm SiNPs each were taken up 
into the roots of A. thaliana (Figures 5.8 and 5.9). Within the root cells, the SiNPs were 
localized in the cytoplasm of the cell surrounding organelles. Fewer particles were 
observed with increasing particle size as a result of fewer particles and/or the inability of 
the larger particles to enter the cells as readily. Of note, the TEM sizes of the particles in 
the roots (11.7 ± 1.4, 52.9 ± 15.7, and 162.9 ± 19.0 nm for the 14, 50, and 200 nm SiNPs, 
respectively) differed slightly from sizes observed in TEM micrographs taken before the 
exposure experiments (14.8 ± 2.4, 51.4 ± 5.3, and 211.5 ± 24.3 nm for the 14, 50, and 
200 nm SiNPs, respectively; Figure 5.1). We attribute this disparity to degradation of the 
particles in solution (or plant) over the 6-week period. Indeed, particle sizes determined 
by DLS were reduced by 46.2, 23.6, and 22.3% for the 14, 50, and 200 nm SiNPs, 
respectively, after 6 weeks immersion in the plant nutrient solution (pH 5.8), likely 
indicating some SiNP dissolution. This corroborates previous results by Zhang et al. in 
which small NPs were found to dissolve more readily than their larger counterparts.37 
Although dissolution has been shown to increase with pH,38 we do not believe Si 
dissolution to be the cause of observed phytotoxicity with the highly negative 50 and 200 
nm SiNPs because the toxicity was mitigated by adjusting the pH to 5.8 or calcination. If 
the toxicity resulted from dissolved silicon species, a significant reduction in 
development would have been noted in the treatment of the Arabidopsis plants at pH 8 
with the caclined SiNPs.  In addition, Stampoulis and coworkers previously reported that 
bulk Si powder (1000 ppm) was non-toxic to Cucurbita pepo (zucchini).19  
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Figure   5.8   Transmission   electron  microscopy   images   of   roots   from   (A)   blank   solution  
and   from   1000   ppm   exposure   after   6   weeks   with   SiNP   sizes   of   (B)   14   nm;;   14   kx  
magnification;;  (C)  50  nm;;  29  kx;;  and  (D)  200  nm;;  14  kx.  Arrows  point  to  SiNPs  in  each  
image. 
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Figure  5.9  Transmission  electron  microscopy  image  of  roots  from  1000  ppm  exposure  to  
14  nm  SiNPs  after  6  weeks.  Magnification  is  72  kx  and  scale  bar  is  0.2  µm. 
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  Lastly, sections of the leaves and stems exposed to SiNPs during plant growth 
were examined with TEM to ascertain particle localization. No nanoparticles were visible 
in the leaves and stems examined, a potentially anticipated result since the leaves and 
stems do not come into direct contact with the nanoparticle solution and should therefore 
have a lower distribution of the SiNPs than the roots.  
5.3.1.4 Silicon elemental analysis  
Silicon (Si) elemental analysis was carried out to provide a more quantitative 
understanding of particle uptake and interaction with A. thaliana. Silicon content was 
expected to be greatest in the roots since they were directly exposed to the SiNP solution. 
If possible, the SiNPs would then translocate to the leaves of the rosette and finally into 
the stem. 
 Prior to analysis, the optimal conditions for complete digestion of the plants and 
SiNPs were determined. Plant tissue was first digested with 10% (v/v) HNO3 in a 
microwave accelerated reaction system.39 Initial ICP-OES experiments showed that 
concentrated HNO3 alone did not completely dissolve the SiNPs and as a result, we 
explored other digestion protocols. The combination of aqua regia and hydrofluoric acid 
(HF) has been used previously to dissolve coal fly ash, a material with high silica 
content.40 However, we observed surprisingly large Si readings for our blank calibration 
sample (a solution of HNO3, aqua regia, and HF in water) under these acidic conditions, 
which we could only attribute to the hydrofluoric acid. The large Si readings from the 
calibration blank result from HF reaction with the quartz ICP torch, necessitating a 
neutralization step to remove excess HF.41 Triethanolamine, an organic base, was used to 
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neutralize the HF instead of boric acid to avoid etching of the ICP torch. Digestion of the 
SiNPs in solution was concluded complete when recovered Si levels (via ICP-OES) 
approached the theoretical Si content based on SiNP mass analyzed (Equation 5.1). 
Silicon in the plants was then quantified by ICP-OES. As expected, plants 
exposed to SiNPs exhibited increased Si levels relative to plants grown in blank 
hydroponic solutions (Tables 5.4 and 5.5). The Si concentrations observed in the roots 
and rosettes were greater than in the stems, likely due to the minimal translocation of the 
SiNPs into the stem. This observation corroborates the lack of particles found in the 
stems via TEM. Due to limited sample mass and nontrivial solution preparation, the 
silicon elemental analysis data was determined using a single SiNP exposure treatment, 
with 3 replicate analyses from the ICP-OES.  
The data was subsequently normalized to depict SiNP uptake per unit of 
nanoparticle volume and determine the extent of particle uptake as a function of SiNP 
size (Tables 5.6 and 5.7). Using the particle sizes from TEM data (Table 5.1), the 
nanoparticle volumes were determined to be 1.70 x 103, 7.11 x 104, and 4.95 x 106 nm3 
for the 14, 50, and 200 nm SiNPs, respectively. As expected, increased uptake of the 
smaller, 14 nm particles was observed upon normalizing the data relative to the 50 and 
200 nm particles for all exposure conditions. Overall, these results indicate that the 14, 
50, and 200 nm SiNPs are in fact taken up through the root system of A. thaliana, 
followed by translocation into the rosette and stem in a size-dependent manner. 
The extent of SiNP uptake was also analyzed as a function of SiNP charge and 
exposure concentration. Although the charges of the 50 and 200 nm SiNPs were 
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Theoretical Si Content = Original SiNP
Concentration
× 0.467a % SiO2b×
a Mass % Si in SiO2
b Obtained by subtracting organic content determined with CHN
Equation 5.1 Equation for determining theoretical Si content from known SiNP 
concentration. 
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 Blank 14 nm 50 nm 200 nm
Sample pH 5.8 pH  
unadjusted
pH 5.8 pH 
unadjusted
pH 5.8 pH 
unadjusted
pH 5.8 pH 
unadjusted
Roots (mg Si/ kg tissue) 378 ± 14 1045 ± 8 43, 992 ± 939 47,575 ± 291 70,442 ± 176 26,384 ± 49 60,217 ± 482 71,186 ± 671
Rosette (mg Si/ kg tissue) 168 ± 9 112±13 890 ± 10 412 ± 5 737 ± 9 1,087 ± 15 1,242 ± 3 3,143 ± 34
Stem (mg Si/ kg tissue) 84 ± 2 58 ± 3 123 ± 3 119 ± 2 300 ± 2 342 ± 6 94 ± 2 1,759 ± 53
Table 5.4 Silicon determination in roots, rosette, and stems for 250 ppm exposure group 
after 6 weeks using ICP-OES. Results are reported in mg Si per kg plant tissue. Error 
represents variation between three instrument integrations.  
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 Blank 14 nm 50 nm 200 nm
Sample pH 5.8 pH 
unadjusted
pH 5.8 pH  
unadjusted
pH 5.8 pH  
unadjusted
pH 5.8 pH 
unadjusted
Roots (mg Si/ kg tissue) 483 ± 3 418 ± 26 54,281 ± 424 32,297 ± 139 131,515 ± 815 115,528 ± 209 37,267 ± 232 68,000 ± 396
Rosette (mg Si/ kg tissue) 72 ± 3 138 ± 5 707 ± 11 1,316 ± 17 1,084 ± 35 1,746 ± 7 2,244 ± 22 3,564 ± 81
Stem (mg Si/ kg tissue) 66 ± 3 92 ± 2 280 ± 7 200 ± 1 344 ± 1 2,538 ± 5 394 ± 3 3,109 ± 59
Table 5.5 Silicon determination in roots, rosette, and stems for 1000 ppm exposure group after 
6 weeks using ICP-OES. Results are reported in mg Si per kg plant tissue. Error represents 
variation between three instrument integrations. 
 
193 
  
14 nm 50 nm 200 nm
Sample pH 5.8 pH  
unadjusted
pH 5.8 pH 
unadjusted
pH 5.8 pH 
unadjusted
Roots (mg Si·kg tissue-1/nm3) 25.9 ± 0.6 28.0 ± 0.2 9.90 x 10-1 ± 0.002 3.70 x 10-2 ± 7.0 x 10-4 1.20 x 10-2 ± 1.0 x 10-4 1.40 x 10-2 ± 1.0 x 10-4
Rosette (mg Si·kg tissue-1/nm3) 5.20 x 10-1 ± 0.01 2.4 x 10-1 ± 0.003 1.00 x 10-2 ± 1.0 x 10-4 2.00 x 10-2 ± 2.0 x 10-4 3.00 x 10-4 ± 6.1 x 10-7 6.00 x 10-4 ± 7.0 x 10-6
Stem (mg Si·kg tissue-1/nm3) 7.00 x 10-2 ± 0.002 0.07 x 10-2 ± 0.001 4.00 x 10-3 ± 3.0 x 10-5 4.00 x 10-3 ± 3.0 x 10-5 2.00 x 10-5 ± 4.0 x 10-7 4.00 x 10-4 ± 1.0 x 10-5
Table 5.6 Si determination in roots, rosette, and stem for 250 ppm exposure group after 6 
weeks using ICP-OES. Results are normalized for the nanoparticle volume. 
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 14 nm 50 nm 200 nm
Sample pH 5.8 pH 
unadjusted
pH 5.8 pH 
unadjusted
pH 5.8 pH 
unadjusted
Roots (mg Si·kg tissue-1/nm3) 32.0 ± 0.3 19.0  ± 0.1 1.85  ± 0.01 1.62  ± 0.003 7.00 x 10-3 ± 5.0 x 10-5 1.40 x 10-2 ± 8.0 x 10-5
Rosette (mg Si·kg tissue-1/nm3) 4.20 x 10-1  ± 0.01 7.80 x 10-1 ± 0.01 2.00 x 10-2 ± 5.0 x 10-4 2.00 x 10-2 ± 1.0 x 10-4 4.00 x 10-4 ± 4.0 x 10-6 7.00 x 10-4 ± 2.0 x 10-5
Stem (mg Si·kg tissue-1/nm3) 1.60 x 10-1 ± 0.004 1.10 x 10-1 ± 5.0 x 10-4 5.00 x 10-3 ± 1.0 x 10-5 4.00 x 10-2 ± 7.0 x 10-5 8.00 x 10-5 ± 6.0 x 10-7 6.00 x 10-4 ±1.0 x 10-5
Table 5.7 Si determination in roots, rosette, and stem for 1000 ppm exposure group after 
6 weeks using ICP-OES. Results are normalized for the nanoparticle volume. 
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significantly negative (Table 5.1) and resulted in phytotoxicity when the pH of the 
medium was not controlled, for the most part SiNP uptake was not significantly different 
in plants where the pH was maintained at pH 5.8 (Tables 5.4 and 5.5). Likewise, charge 
did not readily influence uptake of the 14 nm SiNPs. While an increase in SiNP uptake 
was observed upon increasing exposure concentration from 250 to 1000 ppm, this trend 
was not linear. The non-linear increase suggests that there is an upper limit to the degree 
of SiNP uptake in the Arabidopsis plant.  
Generally, plant biologists believe that cellular uptake of particles less than ~300 
nm involves endocytosis.42 The idea of nanoparticle endocytosis in plant cells was 
originally dismissed because of the high turgor pressure in plant cells combined with the 
presence of the rigid cell wall hindering internalization. Rather, it was believed that 
nanoparticles must passively pass through cell wall pores (<50 nm).43 As such, many 
studies excluded nanomaterials larger than ~20 nm.44 Recent research has shown that 
plant cells are able to endocytose matter from the extracellular environment in a process 
resembling mammalian cell endocytosis.42 Indeed, plant cells can bioaccumulate 
nanomaterials including single-walled carbon nanotubes (length <500 nm),45 magnetite 
NPs (40 nm),46 Cu NPs (50 nm),5 and tannate-coated gold NPs (10–50 nm).47 A. thaliana, 
specifically, has been shown to take up ultrasmall anatase TiO248 (<5 nm) and AgNPs49 
(20 and 40 nm). However, other nanomaterials (e.g., CdSe/ZnS quantum dots8) are not 
internalized indicating somewhat selective bioaccumulation. 
Uptake of SiNPs into plants cells has also been previously observed. For example, 
mesoporous silica nanoparticles have been shown to penetrate tobacco mesophyll plant 
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cells and facilitate intracellular delivery of DNA.50 Accumulation of FITC-labeled SiNPs 
in rice seedlings represents a future use for SiNPS in biolabeling of plant cells.21 
Similarly, our work has shown that a range of SiNPs (i.e., 14–200 nm) will accumulate in 
A. thaliana root cells in a size-dependent manner, although translocation to other regions 
of the plant is minimal. Future studies should focus on understanding the endocytic 
pathway for SiNP internalization, identifying possible translocation mechanisms that 
enable movement of the SiNPs to other regions of the plant, and determine whether 
uptake is species dependent.  
5.3.2 Shape-dependent phytotoxicity and uptake 
5.3.2.1 Synthesis and characterization of silica nanoparticles with varied shape 
 Given the size-dependent uptake of silica nanoparticles in A. thaliana, the 
potential for shape-dependent SiNP phytotoxicity and uptake was also evaluated. A 
surface-templated method was utilized to synthesize both spherical (AR1) and rod-like  
(AR3) particles. The AR1 particles exhibited a length and width of ~ 62 ± 8 nm, while 
the AR3 particles exhibited a length of 241± 32 nm and width of 78 ± 6 nm (Figure 5.10). 
Despite the varied aspect ratios of the AR1 and AR3 SiNPs, they were appropriate 
candidates for examining shape-dependent effects since they had similar particle volume 
(~106 nm3) and thus similar interaction volume with the plant cells. 
5.3.2.2 Plant growth 
 Based on the previous studies with SiNPs of varied size (i.e., 14–200 nm), A. 
thaliana plants were grown in the presence of AR1 and AR3 particles at a concentration 
of 250 ppm for 6 weeks. The nutrient solution was maintained at pH 5.8 to mitigate any 
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A B
Figure  5.  10  Scanning  electron  micrographs  of  (A)  AR1  and  (B)  AR3  silica  particles.  
Scale  bar  is  500  nm  (A)  or  2  µm  (B). 
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 potential silanol effects. Plants exposed to the AR1 particles exhibited some reduced 
development, with biomass and rosette diameters of 52 ± 24 and 77 ± 18% relative to 
plants grown in blank nutrient solution, respectively. However, the stem length for plants 
exposed to the AR1 particles was similar to blanks (88 ± 25% normalized to blank). For 
the AR3 particles, neither the biomass, rosette diameter, nor length of the main stem was 
reduced compared to blanks (84 ± 64, 101 ± 40, 77 ± 45% normalized to blank). Plants 
grown in the presence of AR1 and AR3 particles were non-chlorotic and showed similar 
flowering behavior upon maturation. Thus, although the AR1 particles exhibited some 
growth reduction at 250 ppm over the 6 weeks, they were not deemed toxic. Overall, a 
significant dependence of shape on phytotoxicity was not observed. 
5.3.2.3 Transmission electron microscopy 
 Shape-dependent uptake of the AR1 and AR3 particles was subsequently 
examined with TEM. Root samples from plants exposed to the AR1 or AR3 particles 
were prepared according to the aforementioned protocol. As shown in Figure 5.11, the 
AR1 particles were observed in the root cells, while there was no indication for AR3 
particle uptake. The lack of AR3 particle uptake is not surprising given the lower 
exposure concentration, plant cell wall barrier, and the increased length (i.e., 241 ± 32 
nm) of the AR3 particles.32 Of note, some dissolution of the AR1 particles (~35%) was 
observed over the 6 week exposure based on TEM images. 
5.3.2.4 Silicon elemental analysis 
 Silicon elemental analysis of the plant tissue (i.e., roots, rosette, stem) was 
employed to quantitatively determine any uptake of the AR1 and AR3 silica particles. 
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A B
Figure  5.11  Transmission  electron  micrographs  of  root  cells  after  exposure  to  250  ppm 
(A)  AR1  or  (B)  AR3  particles.  Scale  bar  is  0.2  µm.  Arrow  points  to  AR1  particles. 
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 Analysis via ICP-OES confirmed little uptake of these particles into the plant roots, 
rosettes, or stems using the conditions studied (Table 5.8). However, silicon 
measurements for the blanks were also lower than previous experiments with similar 
growth conditions (e.g., 4 ± 3 vs. 378 ± 14 mg Si/kg plant tissue). Future experiments 
should examine increased exposure concentrations for the AR1 and AR3 particles to see 
if uptake is concentration dependent, while also utilizing more biomass for ICP-OES 
analysis. 
5.4 Conclusions 
The results suggest that SiNPs will not exhibit significant phytotoxicity upon 
mitigating any pH effects and/or silanol-nutrient adsorption, although significant uptake 
of smaller SiNPs (e.g., 14 and 50 nm) into the plant is still likely. Any pH-dependent 
phytotoxic effects of the SiNPs are expected to be further reduced in terrestrial 
environments where natural buffers aid in maintaining an ideal pH for plant growth.29 
Although nanoparticle shape has been shown to have significant influence over particle–
cell adhesion strength, internalization rate, and toxicity in mammalian cell drug 
delivery,33 the presence of a cell wall reduces the likelihood of uptake for plants.32 
However, nanoparticles of varied shape can be delivered to plant cells via bombardment 
strategies and continued evaluation of phytotoxicity is thus warranted.34 With respect to 
terrestrial environments, soil provides a large reactive sink for nanoparticles, and thus the 
applied dose employed in our study is greater than doses that may reach soil-based 
organisms.7 Notwithstanding, nanoparticles will undergo dissolution, 
sorption/aggregation, and migration in real environments. For those nanoparticles that 
201 
  
Sample Roots 
(mg Si/kg tissue)
Rosette 
(mg Si/kg tissue)
Stem 
(mg Si/kg tissue)
Blank 4.4 ± 3.1 0.2 ± 0.1 0.3 ± 0.1
AR1 4.8 ± 0.2 0.5 ± 0.1 0.0 ± 0.1
AR3 0.6 ± 0.5 1.2 ± 0.1 1.1 ± 0.4
Table  5.8  Silicon  determination   in   roots,   rosette,  and  stems  for  250  ppm  exposure   to  AR1  
and  AR3  particles  after  6  weeks  using  ICP-OES.  Results  are  reported  in  mg  Si  per  kg  plant  
tissue.  Error  represents  variation  between  three  instrument  integrations. 
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remain bioavailable in the soil, future work should focus on entry modes and mechanisms 
into the terrestrial food chain while continuing to evaluate phytotoxicity and potential 
biomagnification. 
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CHAPTER 6: SUMMARY AND FUTURE DIRECTIONS 
6.1 Summary 
 Nanomaterial physicochemical properties (e.g., size, shape, surface 
hydrophobicity, drug-release kinetics) were shown to influence association/fate and 
toxicity in both bacterial pathogens and terrestrial plants. Chapter 1 reviewed the rising 
societal use of nanomaterials and addressed the importance of understanding the impact 
of nanomaterial properties on cellular interaction and toxicity, whether deemed beneficial 
(e.g., bacterial pathogen killing) or detrimental (e.g., plant death). The design of NO-
releasing silica nanoparticles, dendrimers, and chitosan oligosaccharides with controlled 
size, shape, surface hydrophobicity, molecular weight, and NO-release kinetics was 
discussed for the eradication of clinically-relevant planktonic bacteria and biofilms. The 
effects of nanomaterial properties (e.g., composition, size, shape) on phytotoxicity toward 
terrestrial plants were also presented. Overall, the introduction served to address the 
challenges in evaluating engineered nanomaterial toxicity to biological systems. 
 In Chapter 2, nanomaterial (i.e., silica nanoparticle, dendrimer, chitosan) 
properties (e.g., size, shape, exterior functionality, and molecular weight) were found to 
significantly impact planktonic bacterial killing. Nitric oxide-releasing silica 
nanoparticles of three different sizes (i.e., 50, 100, and 200 nm) and similar total NO 
storage were utilized to evaluate biocidal action against P. aeruginosa as a function of 
208 
nanoparticle size. Particles with decreased size exhibited increased bactericidal efficacy 
due to improved nanoparticle–cell association. The shape (i.e., aspect ratio) of NO-
releasing silica nanoparticles also proved important in the killing of planktonic P. 
aeruginosa and S. aureus. Particles with increased aspect ratio (i.e., 8) had lower MBCs 
than particles with aspect ratios of 1 or 4 due to enhanced NO delivery, likely from 
increased particle surface area in contact with the cell.  
Killing of planktonic P. aeruginosa and S. aureus was also demonstrated for NO-
releasing PPI dendrimers as a function of exterior functionality and size (i.e., generation). 
The higher generation NO-releasing dendrimers (5 versus 2) exhibited increased biocidal 
action due to a greater concentration of N-diazeniumdiolates at the dendrimer surface. 
Additionally, NO-releasing-dendrimers modified with the more hydrophobic SO group 
exhibited lower MBCs than those functionalized with PO or PEG as a result of improved 
electrostatic interactions with the bacterial cell membrane.  
Lastly, the bactericidal efficacy of NO-releasing chitosan oligosaccharides was 
evaluated against P. aeruginosa as a function of molecular weight and exterior 
functionality. Of the three NO-releasing chitosan oligosaccharide molecular weights (i.e., 
2.5k, 5k, and 10k) examined, no significant differences in planktonic killing were 
observed. Rapid association of the positively-charged chitosan with the negatively-
charged bacterial cell membrane likely occurred independent of any potential molecular 
weight-related diffusion limitations. Similar to observations with the NO-releasing PPI 
dendrimers, the more neutral PEG-modified NO-releasing chitosan oligosaccharides 
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exhibited reduced biocidal action. Differences in susceptibility to NO from both silica 
and dendrimer scaffolds were noted between Gram-negative P. aeruginosa and Gram-
positive S. aureus, with S. aureus generally requiring increased NO doses for eradication. 
Furthermore, cytotoxicity against L929 mouse fibroblasts was evaluated for both control 
and NO-releasing scaffolds at their respective MBCs, with many of the scaffolds proving 
non-toxic at the concentrations necessary for killing planktonic bacteria.  
 Chapter 3 built upon the NO-releasing therapeutics utilized in Chapter 2 to 
understand the effects of nanomaterial properties on the eradication of clinically-relevant 
bacterial biofilms. The eradication of P. aeruginosa and S. aureus biofilms was evaluated 
as a function of NO-releasing silica nanoparticle size (i.e., 14, 50, and 150 nm) and shape 
(i.e., aspect ratio 1, 4, and 8). Similar to planktonic studies, NO-releasing silica 
nanoparticles of reduced size or increased aspect ratio were most effective. However, NO 
doses ~3–31x those for planktonic assays were required for biofilm killing, resulting in 
more significant toxicity toward healthy host cells. Despite cytotoxicity concerns for the 
silica scaffolds at the higher biofilm MBCs, the benefits of NO as an anti-biofilm agent, 
as well as the importance of particle size and shape were demonstrated. Differences in 
susceptibility to NO between Gram-negative P. aeruginosa and Gram-positive S. aureus 
biofilms were again observed, with S. aureus biofilms requiring increased NO doses for 
eradication.  
Similarly, NO-releasing amphiphilic PAMAM dendrimers were evaluated as anti-
biofilm agents as a function of size and exterior functionality (i.e., PO/ED ratio). As 
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expected, size-dependent killing of P. aeruginosa biofilms was observed, with improved 
efficacy of the generation 3 dendrimers over generation 1. The role of surface 
hydrophobicity in biofilm eradication was also prominent. Enhanced bactericidal efficacy 
was observed for the hydrophobic ED-modified dendrimers compared to the more 
hydrophilic PO-modified dendrimers. However, the ED-modified dendrimers were 
significantly cytotoxic at MBC concentrations necessary for biofilm killing. Thus, the PO 
to ED ratio was optimized (7:3 and 5:5) to obtain maximum biofilm eradication and 
minimal cytotoxicity.  
In addition to their utility in planktonic studies, NO-releasing chitosan 
oligosaccharides were evaluated for therapeutic potential against P. aeruginosa biofilms. 
Anti-biofilm efficacy of the NO-releasing chitosan oligosaccharides was demonstrated to 
be a function of both molecular weight (2.5k, 5k, and 10k) and exterior functionality. In 
contrast to planktonic studies, an increased MBC for the 10k chitosan oligosaccharide 
was observed and attributed to more restricted diffusion of the scaffold through the 
biofilm. Cationic chitosan oligosaccharides rapidly associated with bacterial cells and 
penetrated the P. aeruginosa biofilms, thus exhibiting improved efficacy compared to the 
neutral PEG-modified scaffolds. Of note, none of the NO-releasing chitosan 
oligosaccharides studied were cytotoxic to L929 mouse fibroblasts at concentrations 
necessary for biofilm eradication.  
 In Chapter 4, the role of NO-release kinetics on biocidal action was investigated 
against both P. aeruginosa and S. aureus planktonic bacteria and biofilms. Dendrimers 
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were synthesized with different ratios of PO and ACN to exhibit varied NO-release 
profiles (i.e., burst versus sustained release) and similar total NO storage (~1.89 µmol 
NO/mg). Planktonic cells exhibited greater susceptibility to NO-releasing PO-modified 
dendrimers (i.e., burst release). However, NO-releasing ACN-modified dendrimers (i.e., 
sustained release) were more effective at biofilm eradication. Control and NO-releasing 
PO, 1:1 PO/ACN, 1:7 PO/ACN, and ACN-modified dendrimers were non-toxic to 
healthy host cells at concentrations required for planktonic bacterial killing. Control 
dendrimers were also non-toxic at concentrations necessary for biofilm eradication, but 
significant reductions in fibroblast viability were observed at these concentrations for the 
NO-releasing dendrimers. Although cytotoxicity did not show a dependence on NO-
release kinetics, a clear association exists between high doses of NO and reduced 
fibroblast viability. 
 Chapter 5 investigated the effects of silica nanoparticle size and shape toward the 
terrestrial plant, Arabidopsis thaliana. Three sizes (i.e., 14, 50, and 200 nm) of silica 
nanoparticles with varied surface charge and composition were evaluated for 
phytotoxicity and plant uptake. Phytotoxic effects (up to 1000 ppm) were mitigated by 
adjusting the pH of the plant-growth nutrient solution or removal of the particle surface 
charge. However, size-dependent uptake of the silica particles was observed, with the 
smaller 14nm particles showing increased uptake in A. thaliana root cells. Silicon 
elemental analysis confirmed particle uptake into the rosettes and stems as well, although 
to a lesser extent. Silica particle phytotoxicity and uptake were also evaluated as a 
function of shape (i.e., aspect ratio 1 and 3). A. thaliana growth was not significantly 
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reduced after exposure to AR1 and AR3 particles at 250 ppm for 6 weeks. While AR1 
particles were observed in the root cells with TEM, silicon elemental analysis of the 
roots, rosette, and stems confirmed little uptake of the AR1 and AR3 particles. The 
minimal uptake observed was likely due to the low exposure concentration. Overall, the 
silica nanoparticles examined were found to be relatively non-toxic to A. thaliana plants.     
6.2 Future Directions 
 The true realization of the potential for engineered nanomaterials is still in its 
infancy. Nanomaterial use continues to increase rapidly, but much remains to learn about 
the behavior of these systems in clinical settings and the environment. Ultimately, a 
predictive approach for determining nanomaterial structure-activity relationships is 
desired for evaluating toxicity risk, whether beneficial or detrimental. The research 
presented in this thesis indicates the importance of nanomaterial physicochemical 
properties (e.g., size, shape, exterior hydrophobicity, drug-release kinetics) in improving 
the antibacterial action of NO-releasing therapeutics (e.g., silica particles, dendrimers, 
chitosan oligosaccharides) while minimizing cytotoxicity. In addition, we have initiated 
work to evaluate the effects of nanomaterial properties on other organisms (i.e., plants) 
and understand their broader environmental impact. Continued examination of the 
nanomaterial-bio interface is warranted for extending the utility of NO-releasing 
therapeutics to additional clinically-relevant infections and for determining the potential 
for nanomaterial toxicity, transformation, and biomagnification within the environment. 
6.2.1 Tuning nanomaterial surface charge and hydrophobicity  
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 With increasing antibiotic resistance, combination antibacterial therapies have 
become increasingly attractive. Ideally, combining two agents that exert biocidal action 
via differing mechanisms would prolong their utility and even result in synergistic 
killing. Long chain cationic quaternary ammoniums compounds have proven effective at 
both preventing bacterial adhesion and killing adhered bacteria.1, 2 The positively-charged 
ammonium group promotes association with the negatively-charged bacterial cell 
membrane, whereby the long alkyl chains are then able to insert into the membrane and 
cause disruption. Carpenter et al. reported on the bactericidal efficacy of quaternary 
ammonium-functionalized silica nanoparticles both with and without NO-release 
capabilities.3 The quaternary ammonium-functionalized silica particles were modified 
with varying chain lengths (i.e., methyl, buytl, octyl, and dodecyl). Scaffolds with longer 
chain lengths (i.e., octyl and dodecyl) exhibited potent antibacterial efficacy both with 
and without NO-release, however many of the scaffolds were cytotoxic to fibroblasts. 
Combining quaternary ammonium-functionalized silica particles with NO-release is thus 
attractive for the dual-mechanistic killing, reduced risk of antibacterial resistance, and 
ability of low levels of NO to help mitigate cytotoxic effects and promote fibroblast 
proliferation.   
Based on the work presented in Chapters 2 and 3, it is hypothesized that 
decreasing the size of the quaternary ammonium/NO-functionalized scaffold (<180 nm) 
would further improve bactericidal efficacy. As such, quaternary ammonium-modified 
dendrimers (~2 nm) both with and without NO-release capabilities should be evaluated 
for bacterial killing. Nitric oxide-releasing dendrimers were previously shown to 
214 
associate readily with both planktonic bacteria and biofilms,4, 5 thus coupling this scaffold 
with long chain (i.e., octyl and dodecyl), non-depleting quaternary ammoniums may 
further enhance bacterial eradication. Although quaternary ammonium-functionalized 
scaffolds previously demonstrated cytotoxicity to fibroblast cells, improved bacterial 
eradication for quaternary ammonium/NO-modified dendrimers (i.e., reduced material 
doses) would also likely reduce potential cytotoxicity. Thus, further tuning of the scaffold 
charge and hydrophobic chain length should be completed to enhance bacterial 
eradication, while minimizing toxicity to healthy host cells. 
6.2.2 Effects of nitric oxide against additional clinically-relevant bacterial strains  
Clinically-relevant infections are comprised of diverse communities of bacteria, 
and thus differential susceptibility to NO may play a significant role in overall 
bactericidal efficacy.6-8 As detailed in Chapters 2 and 3, planktonic P. aeruginosa and S. 
aureus exhibited differential susceptibility to NO, with S. aureus requiring increased 
doses for eradication. Hetrick et al. previously investigated the anti-biofilm efficacy of 
NO-releasing silica nanoparticles against Gram-negative P. aeruginosa and E. coli, as 
well as Gram-positive S. aureus and S. epidermidis.7 At the same concentration of NO-
releasing particles, a 5-log reduction in viability was observed for the Gram-negative 
bacteria (i.e., P. aeruginosa and E.coli), while only a 2-log reduction in viability was 
noted for the Gram-positive bacteria (i.e., S. aureus and S. epidermidis). Varied bacterial 
membrane structure may be a partial cause for these differences in antibacterial 
susceptibility.9 However, other properties of the bacteria may govern NO susceptibility as 
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well, including antioxidant enzyme levels10 and production of NO for cytoprotection.11 
The potential Gram-class dependence for NO susceptibility should be further evaluated 
as a function of scaffold properties, total NO storage, NO-release kinetics, and nutrient 
conditions for a greater number of bacterial strains (e.g., Gram-negative A. baumannii 
and Gram-positive E. faecalis). 
Furthermore, additional disease-related (e.g., cystic fibrosis) bacterial strains 
should be studied for susceptibility to NO-induced killing.12 Cystic fibrosis (CF) patients 
exhibit chronic lung inflammation with increased mucus in their respiratory system.13 
Normal clearance of bacteria from the CF respiratory system is prevented and bacterial 
biofilms readily form. Specifically, antibiotic-resistant, alginate-producing, mucoid P. 
aeruginosa biofilms are associated with the persistence of CF.14, 15 Inhaled, gaseous NO 
has shown promise in eradicating CF-relevant P. aeruginosa, but continuous exposure to 
the high NO concentrations required (~160–200 ppm) would lead to 
methemoglobinemia.16 As such, NO-releasing macromolecular scaffolds utilizing 
localized NO delivery should be studied for eradication of CF-relevant P. aeruginosa 
strains. Pulmonary delivery necessitates that the scaffold be biodegrable and thus the NO-
releasing chitosan oligosaccharides discussed in Chapters 2 and 3 are promising 
candidates for therapeutic evaluation. 
6.2.3 Effects of nitric oxide against polymicrobial biofilms 
 In considering the effects of NO against clinically-relevant bacteria, future 
research should focus on the NO-induced eradication of polymicrobial biofilms.17 For 
216 
example, infected burn wounds are often comprised of Pseudomonas and Staphylococcus 
bacterial strains as well as the fungi, Candida and Aspergillus. Hammond et al. 
demonstrated the differential efficacy of common antibiotics toward polymicrobial 
biofilms.18 Both species in the P. aeruginosa and S. aureus polymicrobial biofilms were 
eradicated with gentamycin, however mupirocin readily eradicated only S. aureus and 
triple antibiotic ointment was more effective against P. aeruginosa. Thus, examination of 
NO’s   broad-spectrum antibacterial action against polymicrobial biofilms is warranted. 
Preliminary studies determined the effects of NO-releasing G1 PE 73 dendrimers 
(discussed in Chapter 3) against P. aeruginosa and S. aureus polymicrobial biofilms. As 
shown in Figure 6.1, P. aeruginosa was preferentially eradicated over S. aureus. This 
result is expected given the differential NO susceptibility observed for the individual 
bacterial strains, however future work should focus on varying properties of the NO-
release scaffold and the initial ratio of P. aeruginosa and S. aureus within each biofilm. 
Additionally, eradication should be examined as a function of biofilm age and maturity. 
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Figure 6.1 Bacterial viability of P. aeruginosa (circle, right scale) and S. aureus (square, left 
scale) after 24 h exposure to NO-releasing G1 PE 73 dendrimers (Chapter 3). P. aeruginosa 
was fully eradicated at 300 µg/mL, but ~106 colony forming units of S. aureus remained. 
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6.2.4 Phytotoxicity as a function of plant species and nanomaterial characteristics 
Due to the increased prevalence of new nanomaterials, continued evaluation of 
phytotoxicity as a function of nanomaterial physicochemical properties is critical. 
Screening of additional plant types for phytotoxicity is also warranted since nanomaterial 
uptake and translocation may differ between species and some plants may be more 
susceptible to toxicity than others.19 Hydroponic plant growth is suitable for initial 
toxicity determinations,20 however if substantial toxicity nanomaterial toxicity is noted, 
more relevant soil-based experiments should be conducted. The potential for 
nanomaterial biodistribution and biomagnification should also be examined. For 
example, gold nanoparticles taken up into tobacco plants were passed onto hornworms 
through ingestion.21 A myriad of nanomaterials and plant species exist for phytotoxicity 
testing, and thus researchers should carefully consider nanomaterial exposure routes, 
possible nanomaterial transformations, and the potential end organisms when developing 
their studies.   
6.3 Conclusions 
 The work presented here detailed the importance of nanomaterial 
physicochemical properties in evaluating biological interactions and toxicity. Silica, 
dendrimer, and chitosan oligossacharide NO-releasing scaffolds with varied size, shape, 
and exterior functionality were demonstrated to be effective against common pathogenic 
bacteria. Nitric oxide-releasing nanomaterials with small size, increased aspect ratio, and 
hydrophobic exteriors proved the most toxic to bacteria, albeit cytotoxicity to healthy 
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host cells was also observed in some cases. The determinations made in the preceding 
chapters will aid in designing future NO-releasing scaffolds to exhibit maximum 
bactericidal action, while preventing unwanted cytotoxic effects. Furthermore, the 
evaluation of nanoparticle phytotoxicity in relation to size, surface composition, and 
shape showed that even if plants exhibit significant particle uptake, extensive toxicity 
may not be observed. These studies also emphasized the need to evaluate the potential for 
nanomaterial biodistribution and biomagnification in the environment, especially with 
regard to the food chain.  
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